Bearbeitungsstand: 30.6.2006#)

Publikationen aus dem DKFZ 2005 (Anlage zum Zentrumsbericht 2005)

Sortierung nach Publikationstyp (Zeitschriftenartike, Monographien, Buchbeiträge, Habilitationsschriften, Dissertationen) und dann nach den Forschungsschwerpunkten und der Kostenstelle des ersten internen Autors. Angehängt an das Zitat sind ggf. die Kostenstellennummern von internen Kooperationspartnern. Externe Kooperationspartner sind mit * gekennzeichnet.

Zeitschriftenartikel Forschungsschwerpunkt A A010 Bosch,F.X.*; Andl,C.*; Abel,U.*; Kartenbeck,J.

E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components. International Journal of Cancer 114 (5) (2005) 779-790.

A010 Damm,E.M.*; Pelkmans,L.*; Kartenbeck,J.; Mezzacasa,A.*; Kurzchalia,T.*; Helenius,A.* Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. Journal of Cell Biology 168 (3) (2005) 477-488.

A010 Eilbracht,J.; Kneissel,S.; Hofmann,A.; Schmidt-Zachmann,M.S. Protein NO52 - a constitutive nucleolar component sharing high sequence homologies to protein NO66. European Journal of Cell Biology 84 (2-3) (2005) 279-294.

A010 Heid,H.W.; Keenan,T.W.* Intracellular origin and secretion of milk fat globules. European Journal of Cell Biology 84 (2-3) (2005) 245-258.

A010 Isono,K.*; Mizutani-Koseki,Y.*; Komori,T.*; Schmidt-Zachmann,M.S.; Koseki,H.* Mammalian Polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1. Genes & Development 19 (5) (2005) 536-541.

A010 Kartenbeck,J.; Haselmann,U.; Gassler,N.* Synthesis of junctional proteins in metastasizing colon cancer cells. European Journal of Cell Biology 84 (2-3) (2005) 417-430.

A010 Langbein,L.; Rogers,M.A.; Praetzel,S.*; Cribier,B.*; Peltre,B.*; Gassler,N.*; Schweizer,J. Characterization of a novel human type II epithelial keratin K1b, specifically expressed in eccrine sweat glands. Journal of Investigative Dermatology 125 (3) (2005) 428-444. A145.

A010 Langbein,L.; Schweizer,J. Keratins of the human hair follicle. International Review of Cytology 243 (2005) 1-78. A145.

A010 Lay,D.*; Grosshans,B.L.*; Heid,H.; Gorgas,K.*; Just,W.W.* Binding and functions of ADP-ribosylation factor on mammalian and yeast peroxisomes. Journal of Biological Chemistry 280 (41) (2005) 34489-34499.

A010 Peitsch,W.K.; Hofmann,I.; Bulkescher,J.; Hergt,M.; Spring,H.; Bleyl,U.*; Goerdt,S.*; Franke,W.W. Drebrin, an actin-binding, cell-type characteristic protein: Induction and localization in epithelial skin tumors and cultured keratinocytes. Journal of Investigative Dermatology 125 (4) (2005) 761-774. A120.

A010 Riedel,I.*; Liang,F.X.*; Deng,F.M.*; Tu,L.Y.*; Kreibich,G.*; Wu,X.R.*; Sun,T.T.*; Hergt,M.; Moll,R.* Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder? European Journal of Cell Biology 84 (2-3) (2005) 393-405.

#) Es liegen einige Korrekturen vor, die derzeit in die Datenbank eingeabeitet werden

2

A015 Jaeger,R.*; Hahne,J.*; Jacob,A.; Egert,A.*; Schenkel,J.; Wernert,N.*; Schorle,H.*; Wellmann,A.* Mice transgenic for NPM-ALK develop non-hodgkin lymphomas. Anticancer Research 25 (5) (2005) 3191-3196.

A015 Wayss,K.; Klefenz,M.; Schenkel,J. Cryopreservation of transgenic mouse embryos - an eight years' experience. Journal of Experimental Animal Science 43 (2) (2005) 69-85.

A020 Alberti,S.*; Krause,S.M.*; Kretz,O.*; Philippar,U.*; Lemberger,T.; Casanova,E.; Wiebel,F.F.*; Schwarz,H.*; Frotscher,M.*; Schütz,G.; Nordheim,A.* Neuronal migration in the murine rostral migratory stream requires serum response factor. Proceedings of the National Academy of Sciences of the United States of America 102 (17) (2005) 6148-6153.

A020 Giachino,C.*; De Marchis,S.*; Giampietro,C.*; Parlato,R.; Perroteau,I.*; Schütz,G.; Fasolo,A.*; Peretto,P.* cAMP response element-binding protein regulates differentiation and survival of newborn neurons in the olfactory bulb. Journal of Neuroscience 25 (44) (2005) 10105-10118.

A020 Karst,H.*; Berger,S.; Turiault,M.*; Tronche,F.*; Schütz,G.; Joels,M.* Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proceedings of the National Academy of Sciences of the United States of America 102 (52) (2005) 19204-19207.

A020 Li,N.*; Zhang,Y.*; Naylor,M.J.*; Schatzmann,F.*; Maurer,F.*; Wintermantel,T.; Schütz,G.; Mueller,U.*; Streuli,C.H.*; Hynes,N.E.* beta 1 integrins regulate mammary gland proliferation and maintain the integrity of mammary alveoli. Embo Journal 24 (11) (2005) 1942-1953.

A020 Naylor,M.J.*; Li,N.*; Cheung,J.*; Lowe,E.T.*; Lambert,E.*; Marlow,R.*; Wang,P.B.*; Schatzmann,F.*; Wintermantel,T.; Schütz,G.; Clarke,A.R.*; Mueller,U.*; Hynes,N.E.*; Streuli,C.H.* Ablation of beta 1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation. Journal of Cell Biology 171 (4) (2005) 717-728.

A020 Ramanan,N.*; Shen,Y.*; Sarsfield,S.*; Lemberger,T.; Schütz,G.; Linden,D.J.*; Ginty,D.D.* SRF mediates activity-induced gene expression and synaptic plasticity but not neuronal viability. Nature Neuroscience 8 (6) (2005) 759-767.

A020 Ridder,S.; Chourbaji,S.*; Hellweg,R.*; Urani,A.*; Zacher,C.*; Schmid,W.; Zink,M.*; Hortnagl,H.*; Flor,H.*; Henn,F.A.*; Schütz,G.; Gass,P.* Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. Journal of Neuroscience 25 (26) (2005) 6243-6250.

A020 Unsicker,K.*; Huber,K.*; Schütz,G.; Kalcheim,C.* The chromaffin cell and its development. Neurochemical Research 30 (6-7) (2005) 921-925.

A020 Wintermantel,T.A.; Berger,S.; Greiner,E.F.; Schütz,G. Evaluation of steroid receptor function by gene targeting in mice. Journal of Steroid Biochemistry and Molecular Biology 93 (2-5) (2005) 107-112.

A020 Wintermantel,T.M.; Bock,D.; Fleig,V.; Greiner,E.F.; Schütz,G. The epithelial glucocorticoid receptor is required for the normal timing of cell proliferation during mammary lobuloalveolar development but is dispensable for milk production. Molecular Endocrinology 19 (2) (2005) 340-349.

A030 Arabi,A.*; Wu,S.Q.*; Ridderstrale,K.*; Bierhoff,H.; Shiue,C.*; Fatyol,K.; Fahlen,S.*; Hydbring,P.*; Soderberg,O.*; Grummt,I.; Larsson,L.G.*; Wright,A.P.H.* c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nature Cell Biology 7 (3) (2005) 303-310.

A030 Li,J.W.; Santoro,R.; Koberna,K.*; Grummt,I. The chromatin remodeling complex NoRC controls replication timing of rRNA genes. Embo Journal 24 (1) (2005) 120-127.

3

A030 Mayer,C.; Bierhoff,H.; Grummt,I. The nucleolus as a stress sensor: JNK2 inactivates the transcription factor TIF-IA and down-regulates rRNA synthesis. Genes & Development 19 (8) (2005) 933-941.

A030 Mayer,C.; Grummt,I. Cellular stress and nucleolar function. Cell Cycle 4 (8) (2005) 1036-1038.

A030 Santoro,R. The silence of the ribosomal RNA genes. Cellular and Molecular Life Sciences 62 (18) (2005) 2067-2079.

A030 Santoro,R.; De Lucia,F.* Many players, one goal: how chromatin states are inherited during cell division. Biochemistry and Cell Biology-Biochimie et Biologie Cellulaire 83 (3) (2005) 332-343.

A030 Santoro,R.; Grummt,I. Epigenetic mechanism of rRNA gene silencing: Temporal order of NoRC-mediated histone modification, chromatin remodeling, and DNA methylation. Molecular and Cellular Biology 25 (7) (2005) 2539-2546.

A030 Yuan,X.J.; Zhou,Y.G.; Casanova,E.*; Chai,M.Q.; Kiss,E.; Gröne,H.J.; Schütz,G.; Grummt,I. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Molecular Cell 19 (1) (2005) 77-87. A020. E090.

A030 Zhou,Y.G.; Grummt,I. The PHD finger/bromodomain of NoRC interacts with acetylated histone H4K16 and is sufficient for rDNA silencing. Current Biology 15 (15) (2005) 1434-1438.

A040 Alone,D.P.*; Tiwari,A.K.*; Mandal,L.*; Li,M.F.; Mechler,B.M.; Roy,J.K.* Rab11 is required during Drosophila eye development. International Journal of Developmental Biology 49 (7) (2005) 873-879.

A040 Anne,J.; Mechler,B.M. Valois, a component of the nuage and pole plasm, is involved in assembly of these structures, and binds to Tudor and the methyltransferase Capsuleen. Development 132 (9) (2005) 2167-2177.

A050 Baldessari,D.; Shin,Y.*; Krebs,O.; Koenig,R.; Koide,T.*; Vinayagam,A.; Fenger,U.; Mochii,M.*; Terasaka,C.*; Kitayama,A.*; Peiffer,D.*; Ueno,N.*; Eils,R.; Cho,K.W.*; Niehrs,C. Global gene expression profiling and cluster analysis in Xenopus laevis. Mechanisms of Development 122 (3) (2005) 441-475. B080. B020.

A050 Boettcher,R.T.; Niehrs,C. Fibroblast growth factor signaling during early vertebrate development. Endocrine Reviews 26 (1) (2005) 63-77.

A050 Davidson,G.; Wu,W.; Shen,J.L.; Bilic,J.; Fenger,U.; Stannek,P.; Glinka,A.; Niehrs,C. Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438 (7069) (2005) 867-872.

A050 Niehrs,C. Axis formation: Redundancy rules. Current Biology 15 (10) (2005) R391-R393

A050 Pollet,N.; Muncke,N.; Verbeek,B.; Li,Y.; Fenger,U.; Delius,H.; Niehrs,C. An atlas of differential gene expression during early Xenopus embryogenesis. Mechanisms of Development 122 (3) (2005) 365-439.

A060 Breitenlechner,C.B.*; Friebe,W.G.*; Brunet,E.*; Guido,W.*; Graul,M.*; Thomas,U.*; Kuenkele,K.P.*; Schaefer,W.*; Gassel,M.; Bossemeyer,D.; Huber,R.*; Engh,R.A.*; Masjost,B.* Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase a and mutants. Journal of Medicinal Chemistry 48 (1) (2005) 163-170.

A060 Klingler-Hoffmann,M.; Barth,H.*; Richards,J.; Konig,N.; Kinzel,V. Downregulation of protein phosphatase 2A activity in HeLa cells at the G2-mitosis transition and unscheduled reactivation induced by 12-O-tetradecanoyl phorbol-13-acetate (TPA). European Journal of Cell Biology 84 (8) (2005) 719-732.

4

A080 Reinheckel,T.*; Hagemann,S.*; Dollwet-Mack,S.*; Martinez,E.*; Lohmueller,T.; Zlatkovic,G.*; Tobin,D.J.*; Maas-Szabowski,N.; Peters,C.* The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling. Journal of Cell Science 118 (15) (2005) 3387-3395.

A080 Zhang,W.T.*; Vaccariello,M.A.*; Wang,Y.*; Alt-Holland,A.*; Fusenig,N.E.; Garlick,J.A.* Escape from microenvironmental control and progression of intraepithelial neoplasia. International Journal of Cancer 116 (6) (2005) 885-893.

A090 Bronger,H.; Koenig,J.; Kopplow,K.; Steiner,H.H.*; Ahmadi,R.*; Herold-Mende,C.*; Keppler,D.; Nies,A.T. ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Research 65 (24) (2005) 11419-11428.

A090 Keitel,V.*; Burdelski,M.*; Keppler,D.; Haeussinger,D.*; Kubitz,R.* Vagaries of impaired transporter function in PFIC 2 and 3 - Reply. Hepatology 42 (4) (2005) 978

A090 Keitel,V.*; Burdelski,M.*; Warskulat,U.*; Kuhlkamp,T.*; Keppler,D.; Haeussinger,D.*; Kubitz,R.* Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 41 (5) (2005) 1160-1172.

A090 Keppler,D. Uptake and efflux transporters for conjugates in human hepatocytes. Phase II Conjugation Enzymes and Transport Systems 400 (2005) 531-542.

A090 Koenig,J.; Hartel,M.*; Nies,A.T.; Martignoni,M.E.*; Guo,J.C.*; Büchler,M.W.*; Friess,H.*; Keppler,D. Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. International Journal of Cancer 115 (3) (2005) 359-367.

A090 Kopplow,K.; Letschert,K.; Konig,J.; Walter,B.; Keppler,D. Human hepatobiliary transport of organic anions analyzed by quadruple-transfected cells. Molecular Pharmacology 68 (4) (2005) 1031-1038.

A090 Letschert,K.; Komatsu,M.; Hummel-Eisenbeiss,J.; Keppler,D. Vectorial transport of the peptide CCK-8 by double-transfected MDCKII cells stably expressing the organic anion transporter OATP1B3 (OATP8) and the export pump ABCC2. Journal of Pharmacology and Experimental Therapeutics 313 (2) (2005) 549-556.

A090 Rius,M.; Thon,W.F.*; Keppler,D.; Nies,A.T. Prostanoid transport by multidrug resistance protein 4 (MRP4/ABCC4) localized in tissues of the human urogenital tract. Journal of Urology 174 (6) (2005) 2409-2414.

A100 Florin,L.; Maas-Szabowski,N.; Werner,S.*; Szabowski,A.; Angel,P. Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts. Journal of Cell Science 118 (9) (2005) 1981-1989. A080.

A100 Gack,S.; Marme,A.*; Marme,F.*; Wrobel,G.; Vonderstrass,B.; Bastert,G.*; Lichter,P.; Angel,P.; Schorpp-Kistner,M. Preeclampsia: increased expression of soluble ADAM 12. Journal of Molecular Medicine-Jmm 83 (11) (2005) 887-896. B060.

A100 Gebhardt,C.; Breitenbach,U.; Richter,K.H.; Fürstenberger,G.; Mauch,C.*; Angel,P.; Hess,J. C-fos-dependent induction of the small ras-related GTPase Rab11a in skin carcinogenesis. American Journal of Pathology 167 (1) (2005) 243-253. B060. A140.

A100 Loffek,S.*; Zigrino,P.*; Angel,P.; Anwald,B.*; Krieg,T.*; Mauch,C.* High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1 alpha and basic fibroblast growth factor-mediated mechanisms. Journal of Investigative Dermatology 124 (3) (2005) 638-643.

A100 Zenz,R.*; Eferl,R.*; Kenner,L.*; Florin,L.; Hummerich,L.; Mehic,D.*; Scheuch,H.*; Angel,P.; Tschachler,E.*; Wagner,E.F.*

5

Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437 (7057) (2005) 369-375. B060.

A101 Miller,D.W.; Vosseler,S.; Mirancea,N.; Hicklin,D.J.*; Bohlen,P.*; Volcker,H.E.*; Holz,F.G.*; Fusenig,N.E. Rapid vessel regression, protease inhibition, and stromal normalization upon short-term vascular endothelial growth factor receptor 2 inhibition in skin carcinoma heterotransplants. American Journal of Pathology 167 (5) (2005) 1389-1403.

A101 Vosseler,S.; Mirancea,N.; Bohlen,P.*; Müller,M.M.; Fusenig,N.E. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metal loproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. Cancer Research 65 (4) (2005) 1294-1305.

A105 De Servi,B.; Hermani,A.; Medunjanin,S.; Mayer,D. Impact of PKC-delta on estrogen receptor localization and activity in breast cancer cells. Oncogene 24 (31) (2005) 4946-4955.

A105 Hermani,A.; Hess,J.; De Servi,B.; Medunjanin,S.; Grobholz,R.*; Trojan,L.*; Angel,P.; Mayer,D. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clinical Cancer Research 11 (14) (2005) 5146-5152. A100.

A105 Kopplow,K.; Wayss,K.; Enzmann,H.*; Mayer,D. Dehydroepiandrosterone causes hyperplasia and impairs regeneration in rat liver. International Journal of Oncology 27 (6) (2005) 1551-1558. A015.

A105 Liao,Y.D.; Abel,U.*; Grobholz,R.*; Hermani,A.; Biol,D.; Trojan,L.*; Angel,P.; Mayer,D. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade. Human Pathology 36 (11) (2005) 1186-1196. A100.

A105 Medunjanin,S.; Hermani,A.; De Servi,B.; Grisouard,J.; Rincke,G.; Mayer,D. Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor-alpha and is involved in the regulation of receptor activity. Journal of Biological Chemistry 280 (38) (2005) 33006-33014.

A105 Rost,D.*; Kopplow,K.; Gehrke,S.*; Mueller,S.*; Friess,H.*; Ittrich,C.; Mayer,D.; Stiehl,A.* Gender-specific expression of liver organic anion transporters in rat. European Journal of Clinical Investigation 35 (10) (2005) 635-643. C060.

A110 Boukamp,P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 26 (10) (2005) 1657-1667.

A110 Boukamp,P. Skin aging: A role for telomerase and telomere dynamics? Current Molecular Medicine 5 (2) (2005) 171-177.

A110 Boukamp,P. UV-induced skin cancer: similarities - variations. Journal der Deutschen Dermatologischen Gesellschaft 3 (2005) 493-503.

A110 Boukamp,P.; Popp,S.; Krunic,D. Telomere-dependent chromosomal instability. Journal of Investigative Dermatology Symposium Proceedings 10 (2) (2005) 89-94.

A110 Huber,M.*; Siegenthaler,G.*; Mirancea,N.; Marenholz,I.*; Nizetic,D.*; Breitkreutz,D.; Mischke,D.*; Hohl,D.* Isolation and characterization of human repetin, a member of the fused gene family of the epidermal differentiation complex. Journal of Investigative Dermatology 124 (5) (2005) 998-1007.

A110 Kleideiter,E.*; Bangerter,U.*; Schwab,M.*; Boukamp,P.; Koscielniak,E.*; Klotz,U.*; Greil,J.* Telomeres and telomerase in paediatric patients with T-cell acute lymphoblastic leukaemia (T-ALL). Leukemia 19 (2) (2005) 296-298.

A110 Louis,S.F.*; Vermolen,B.J.*; Garini,Y.*; Young,I.T.*; Guffei,A.*; Lichtensztejn,Z.*; Kuttler,F.*; Chuang,T.C.Y.*; Moshir,S.; Mougey,V.*; Chuang,A.Y.C.*; Kerr,P.D.*; Fest,T.*; Boukamp,P.; Mai,S.

6

c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proceedings of the National Academy of Sciences of the United States of America 102 (27) (2005) 9613-9618.

A110 Margulis,A.*; Zhang,W.T.*; Alt-Holland,A.*; Crawford,H.C.*; Fusenig,N.E.; Garlick,J.A.* E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Cancer Research 65 (5) (2005) 1783-1791.

A110 Narath,R.*; Loerch,T.*; Greulich-Bode,K.M.; Boukamp,P.; Ambros,P.F.* Automatic telomere length measurements in interphase nuclei by IQ-FISH. Cytometry Part A 68A (2) (2005) 113-120.

A110 Schell-Steven,A.*; Stein,K.*; Amoros,M.; Landgraf,C.*; Volkmer-Engert,R.*; Rottensteiner,H.*; Erdmann,R.* Identification of a novel, intraperoxisomal Pex14-binding site in Pex13: Association of Pex13 with the docking complex is essential for peroxisomal matrix protein import. Molecular and Cellular Biology 25 (8) (2005) 3007-3018.

A120 Bohlmann,M.K.*; Fischer,R.; Tengg-Kobligk,H.; Strowitzki,T.*; Hendrik,H.J.* Outcome of a pregnancy in a patient with Moyamoya syndrome and secondary recurrent miscarriages - a case report. Geburtshilfe und Frauenheilkunde 65 (1) (2005) 87-90. E010.

A120 Maschler,S.*; Wirl,G.*; Spring,H.; Bredow,D.V.*; Sordat,I.*; Beug,H.*; Reichmann,E.* Tumor cell invasiveness correlates with changes in integrin expression and localization. Oncogene 24 (12) (2005) 2032-2041.

A120 Spring,H.; Schueler,T.; Arnold,B.; Hämmerling,G.J.; Ganss,R. Chemokines direct endothelial progenitors into tumor neovessels. Proceedings of the National Academy of Sciences of the United States of America 102 (50) (2005) 18111-18116. D050.

A125 Bestvater,F.; Dallner,C.; Spiess,E. The C-terminal subunit of artificially truncated human cathepsin B mediates its nuclear targeting and contributes to cell viability. BMC Cell Biology 6 (2005) M010.

A125 Spiess,E.; Bestvater,F.; Heckel-Pompey,A.; Toth,K.; Hacker,M.*; Stobrawa,G.*; Feurer,T.*; Wotzlaw,C.*; Berchner-Pfannschmidt,U.*; Porwol,T.*; Acker,H.* Two-photon excitation and emission spectra of the green fluorescent protein variants ECFP, EGFP and EYFP. Journal of Microscopy-Oxford 217 (3) (2005) 200-204. B040.

A130 Brueckner,B.; Boy,R.G.; Siedlecki,P.; Musch,T.; Kliem,H.C.; Zielenkiewicz,P.*; Suhai,S.; Wiessler,M.; Lyko,F. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Research 65 (14) (2005) 6305-6311. E080. B020.

A130 Kuhlmann,M.*; Borisova,B.E.*; Kaller,M.*; Larsson,P.*; Stach,D.; Na,J.B.*; Eichinger,L.*; Lyko,F.; Ambros,V.*; Soederbom,F.*; Hammann,C.*; Nellen,W.* Silencing of retrotransposons in Dictyostelium by DNA methylation and RNAi. Nucleic Acids Research 33 (19) (2005) 6405-6417.

A130 Lyko,F. Novel methods for analysis of genomic DNA methylation. Analytical and Bioanalytical Chemistry 381 (1) (2005) 67-68.

A130 Lyko,F.; Brown,R.* DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. Journal of the National Cancer Institute 97 (20) (2005) 1498-1506.

A130 Mund,C.; Beier,V.; Bewerunge,P.; Dahms,M.*; Lyko,F.; Hoheisel,J.D. Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16(INK4A) promoter in colon carcinoma cell lines. Nucleic Acids Research 33 (8) (2005) B070. B080.

A130 Mund,C.; Hackanson,B.*; Stresemann,C.; Lubbert,M.*; Lyko,F. Characterization of DNA demethylation effects induced by 5-aza-2 '-deoxycytidine in patients with

7

myelodysplastic syndrome. Cancer Research 65 (16) (2005) 7086-7090.

A135 Ackermann,K.; Neidhart,T.; Gerber,J.*; Waxmann,A.; Pyerin,W. The catalytic subunit alpha ' gene of human protein kinase CK2 (CSNK2A2): Genomic organization, promoter identification and determination of Ets1 as a key regulator. Molecular and Cellular Biochemistry 274 (1-2) (2005) 91-101.

A135 Ackermann,K.; Pyerin,W. Zwiegespräche zwischen Knochen- und Tumorzellen. Orthinform (1) (2005) 38-40.

A135 Kasperk,C.*; Hillmeier,J.*; Noldge,G.*; Grafe,I.A.*; DaFonseca,K.*; Raupp,D.*; Bardenheuer,H.*; Libicher,M.*; Liegibel,U.M.*; Sommer,U.*; Hilscher,U.*; Pyerin,W.; Vetter,M.; Meinzer,H.P.; Meeder,P.J.*; Taylor,R.S.*; Nawrothl,P.* Treatment of painful vertebral fractures by kyphoplasty in patients with primary osteoporosis: A prospective nonrandomized controlled study. Journal of Bone and Mineral Research 20 (4) (2005) 604-612. E130.

A135 Pyerin,W.; Barz,T.; Ackermann,K. Protein kinase CK2 in gene control at cell cycle entry. Molecular and Cellular Biochemistry 274 (1-2) (2005) 189-200.

A135 Sorg,B.L.; Hull,W.E.; Kliem,H.C.; Mier,W.*; Wiessler,M. Synthesis and NMR characterization of hydroxyurea and mesylglycol glycoconjugates as drug candidates for targeted cancer chemotherapy. Carbohydrate Research 340 (2) (2005) 181-189. B090. E080.

A140 Alestas Th.*; Ganceviciene R.*; Fimmel S.*; Müller-Decker K.; Zouboulis CC.* Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are activated in sebaceous glands involved in acne lesions. Journal of Molecular Medicine 2005 Dec 31 [Epub ahead of print]

A140 Eckl,K.M.*; Krieg,P.; Kuester,W.*; Traupe,H.*; Andre,F.*; Wittstruck,N.*; Fürstenberger,G.; Hennies,H.C.* Mutation spectrum and functional analysis of epidermis-type lipoxygenases in patients with autosomal recessive congenital ichthyosis. Human Mutation 26 (4) (2005) 351-361.

A140 Fürstenberger,G.; Müller-Decker,K. Cyclooxygenase-2 und Krebs. Bioforum (7/8) (2005) 50-52.

A140 Klein,R.D.*; Van Pelt,C.S.*; Sabichi,A.L.*; dela Cerda,J.*; Fischer,S.M.*; Fürstenberger,G.; Müller-Decker,K. Transitional cell hyperplasia and carcinomas in urinary bladders of Transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression. Cancer Research 65 (5) (2005) 1808-1813.

A140 Meruvu,S.*; Walther,M.*; Ivanov,I.*; Hammarstrom,S.*; Fürstenberger,G.; Krieg,P.; Reddanna,P.*; Kuehn,H.* Sequence determinants for the reaction specificity of murine (12R)-lipoxygenase - Targeted substrate modification and site-directed mutagenesis. Journal of Biological Chemistry 280 (44) (2005) 36633-36641.

A140 Müller-Decker,K.; Berger,I.*; Ackermann,K.; Ehemann,V.*; Zoubova,S.*; Aulmann,S.*; Pyerin,W.; Fürstenberger,G. Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2. American Journal of Pathology 166 (2) (2005) 575-584. A135.

A140 Müller-Decker,K.; Manegold,G.; Butz,H.; Hinz,D.E.; Huttner,D.; Richter,K.H.*; Tremmel,M.; Weissflog,R.; Marks,F. Inhibition of cell proliferation by bacterial lipopolysaccharides in TLR4-positive epithelial cells: Independence of nitric oxide and cytokine release. Journal of Investigative Dermatology 124 (3) (2005) 553-561. Marks.

A145 Rogers,M.A.; Edler,L.; Winter,H.; Langbein,L.; Beckmann,I.; Schweizer,J. Characterization of new members of the human type II keratin gene family and a general

8

evaluation of the keratin gene domain on chromosome 12q13.13. Journal of Investigative Dermatology 124 (3) (2005) 536-544. C060. A010.

A145 Rogers,M.A.; Schweizer,J. Human KAP genes, only the half of it? Extensive size polymorphisms in hair keratin-associated protein genes. Journal of Investigative Dermatology 124 (6) (2005) VII-VIX

A145 Schweizer,J. The keratins of the human hair follicle. Dermatology 211 (1) (2005) 12

A150 Klingmüller,U. Systems Biology and Cancer. Zellbiologie Aktuell 3 (2005) (2005) 29-32.

A150 Schilling,M.; Maiwald,T.*; Bohl,S.; Kollmann,M.*; Kreutz,C.*; Timmer,J.*; Klingmüller,U. Computational processing and error reduction strategies for standardized quantitative data in biological networks. Febs Journal 272 (24) (2005) 6400-6411.

A150 Schilling,M.; Maiwald,T.*; Bohl,S.; Kollmann,M.*; Kreutz,C.*; Timmer,J.*; Klingmuller,U. Quantitative data generation for systems biology: the impact of randomisation, calibrators and normalisers. Iee Proceedings Systems Biology 152 (4) (2005) 193-200.

A170 Barthel,A.*; Herzig,S.; Mueller,H.W.*; Harborth,J.*; Bornstein,S.R.* RNA interference-based strategies for metabolic syndrome treatment. Hormone and Metabolic Research 37 (2) (2005) 59-62.

A170 Dimova,E.Y.*; Moller,U.*; Herzig,S.; Fink,T.*; Zachar,V.*; Ebbesen,P.*; Kietzmann,T.* Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells. Thrombosis and Haemostasis 93 (6) (2005) 1176-1184.

A000 Kost,C.*; de Oliveira,E.G.*; Knoch,T.A.; Wirth,R. Spatio-temporal permanence and plasticity of foraging trails in young and mature leaf-cutting ant colonies (Atta spp.). Journal of Tropical Ecology 21 (2005) 677-688.

Forschungsschwerpunkt B B020 Bende,A.; Suhai,S.

BSSE-corrected geometry and harmonic and anharmonic vibrational frequencies of formamide-water and formamide-formamide dimers. International Journal of Quantum Chemistry 103 (6) (2005) 841-853.

B020 Bende,A.; Vibok,A.*; Halasz,G.J.*; Suhai,S. Theoretical study of hydrogen bonds between acetylene and selected proton donor systems. International Journal of Quantum Chemistry 101 (2) (2005) 186-200.

B020 Bondar,A.N.; Elstner,M.; Suhai,S.; Fischer,S.*; Smith,J.C.* Direct proton transfer in a putative L-state intermediate of the bacteriorhodopsin photocycle. Phase Transitions 78 (1-3) (2005) 5-9.

B020 Bondar,A.N.; Fischer,S.*; Suhai,S.; Smith,J.C.* Tuning of retinal twisting in bacteriorhodopsin controls the directionality of the early photocycle steps. Journal of Physical Chemistry B 109 (31) (2005) 14786-14788.

B020 Howard,I.A.*; March,N.H. s-Wave component of the ground-state electron density in the Hookean model compared with the helium atom. Chemical Physics Letters 413 (1-3) (2005) 168-170.

B020 Janosfalvi,Z.; Sen,K.D.*; Nagy,A.* Cusp conditions for non-interacting kinetic energy density of the density functional theory. Physics Letters A 344 (1) (2005) 1-6.

B020 Kumar,A.*; Mishra,P.C.*; Suhai,S. Adiabatic electron affinities of the polyhydrated adenine-thymine base pair: A density functional

9

study. Journal of Physical Chemistry A 109 (17) (2005) 3971-3979.

B020 Mishra,P.C.*; Singh,A.K.*; Suhai,S. Interaction of singlet oxygen and superoxide radical anion with guanine and formation of its mutagenic modification 8-oxoguanine. International Journal of Quantum Chemistry 102 (3) (2005) 282-301.

B020 Nagy,A.*; Howard,I.A.*; March,N.H.*; Janosfalvi,Z. Subspace density of the first excited state for two harmonically interacting electrons with isotropic harmonic confinement. Physics Letters A 335 (5-6) (2005) 347-350.

B020 Niehaus,T.A.; Heringer,D.*; Torralva,B.*; Frauenheim,T.* Importance of electronic self-consistency in the TDDFT based treatment of nonadiabatic molecular dynamics. European Physical Journal D 35 (3) (2005) 467-477.

B020 Niehaus,T.A.; Rohlfing,M.*; Della Sala,F.*; Di Carlo,A.*; Frauenheim,T.* Quasiparticle energies for large molecules: A tight-binding-based Green's-function approach. Physical Review A 71 (2) (2005)

B020 Paizs,B.; Suhai,S. Fragmentation pathways of protonated peptides. Mass Spectrometry Reviews 24 (4) (2005) 508-548.

B020 Polfer,N.C.*; Oomens,J.*; Suhai,S.; Paizs,B. Spectroscopic and theoretical evidence for oxazolone ring formation in collision-induced dissociation of peptides. Journal of the American Chemical Society 127 (49) (2005) 17154-17155.

B020 Polfer,N.C.*; Paizs,B.; Snoek,L.C.*; Compagnon,I.*; Suhai,S.; Meijer,G.*; von Helden,G.*; Oomens,J.* Infrared fingerprint spectroscopy and theoretical studies of potassium ion tagged amino acids and peptides in the gas phase. Journal of the American Chemical Society 127 (23) (2005) 8571-8579.

B020 Range,K.*; Riccardi,D.*; Cui,Q.*; Elstner,M.; York,D.M.* Benchmark calculations of proton affinities and gas-phase basicities of molecules important in the study of biological phosphoryl transfer. Physical Chemistry Chemical Physics 7 (16) (2005) 3070-3079.

B020 Simdyankin,S.I.*; Elstner,M.; Niehaus,T.A.; Frauenheim,T.*; Elliott,S.R.* Influence of copper on the electronic properties of amorphous chalcogenides. Physical Review B 72 (2) (2005)

B020 Vibok,A.*; Halasz,G.J.*; Suhai,S.; Baer,M.* Assigning signs to the electronic nonadiabatic coupling terms: The {H-2,O} system as a case study. Journal of Chemical Physics 122 (13) (2005)

B020 Wanko,M.*; Hoffmann,M.*; Strodet,P.*; Koslowski,A.*; Thiel,W.*; Neese,F.*; Frauenheim,T.; Elstner,M. Calculating absorption shifts for retinal proteins: Computational challenges. Journal of Physical Chemistry B 109 (8) (2005) 3606-3615.

B030 Bilke,S.*; Chen,Q.R.*; Westerman,F.; Schwab,M.; Catchpoole,D.*; Khan,J.* Inferring a tumor progression model for neuroblastoma from genomic data. Journal of Clinical Oncology 23 (29) (2005) 7322-7331.

B030 Krasnoselsky,A.L.*; Whiteford,C.C.*; Wei,J.S.*; Bilke,S.*; Westermann,F.; Chen,Q.R.*; Khan,J.* Altered expression of cell cycle genes distinguishes aggressive neuroblastoma. Oncogene 24 (9) (2005) 1533-1541.

B040 Baudendistel,N.; Müller,G.; Waldeck,W.; Angel,P.; Langowski,J. Two-hybrid fluorescence cross-correlation spectroscopy detects protein-protein interactions in vivo. Chemphyschem 6 (5) (2005) 984-990. A100.

B040 Bernacchi,S.; Ennifar,E.*; Tóth,K.; Walter,P.*; Langowski,J.; Dumas,P.* Mechanism of hairpin-duplex conversion for the HIV-1 dimerization initiation site. Journal of Biological Chemistry 280 (48) (2005) 40112-40121.

10

B040 Bussiek,M.; Tóth,K.; Brun,N.; Langowski,J. DNA-loop formation on nucleosomes shown by in situ scanning force microscopy of supercoiled DNA. Journal of Molecular Biology 345 (4) (2005) 695-706.

B040 Klenin,K.V.; Kusnezow,W.; Langowski,J. Kinetics of protein binding in solid-phase immunoassays: Theory. Journal of Chemical Physics 122 (21) (2005) B070.

B040 Mücke,N.; Kirmse,R.; Wedig,T.; Leterrier,J.F.*; Kreplak,L.* Investigation of the morphology of intermediate filaments adsorbed to different solid supports. Journal of Structural Biology 150 (3) (2005) 268-276. B065.

B040 Tóth,K.F.; Mazurkiewicz,J.*; Rippe,K.* Association states of nucleosome assembly protein 1 and its complexes with histones. Journal of Biological Chemistry 280 (16) (2005) 15690-15699.

B040 Zupan,K.*; Herenyi,L.*; Tóth,K.; Egyeki,M.*; Csik,G.* Binding of cationic porphyrin to isolated DNA and nucleoprotein complex: Quantitative analysis of binding forms under various experimental conditions. Biochemistry 44 (45) (2005) 15000-15006.

B050 Arlt,D.; Huber,W.; Liebel,U.; Schmidt,C.; Majety,M.; Sauermann,M.*; Rosenfelder,H.; Bechtel,S.; Mehrle,A.; Bannasch,D.; Schupp,I.; Seiler,M.; Simpson,J.C.*; Hahne,F.; Moosmayer,P.; Ruschhaupt,M.; Guilleaume,B.; Wellenreuther,R.; Pepperkok,R.*; Sültmann,H.; Poustka,A.; Wiemann,S. Functional profiling: From microarrays via cell-based assays to novel tumor relevant modulators of the cell cycle. Cancer Research 65 (17) (2005) 7733-7742.

B050 Beissbarth,T.; Tye-Din,J.A.*; Smyth,G.K.*; Speed,T.P.*; Anderson,R.P.* A systematic approach for comprehensive T-cell epitope discovery using peptide libraries. Bioinformatics 21 (2005) I29-I37

B050 Bonora,E.*; Lamb,J.A.*; Barnby,G.*; Sykes,N.*; Moberly,T.*; Beyer,K.S.; Klauck,S.M.; Poustka,F.*; Bacchelli,E.*; Blasi,F.*; Maestrini,E.*; Battaglia,A.*; Haracopos,D.*; Pedersen,L.*; Isager,T.*; Eriksen,G.*; Viskum,B.*; Sorensen,E.U.*; Brondum-Nielsen,K.*; Cotterill,R.*; von Engeland,H.*; de Jonge,M.*; Kemner,C.*; Steggehuis,K.*; Scherpenisse,M.*; Rutter,M.*; Bolton,P.F.*; Parr,J.R.*; Poustka,A.; Bailey,A.J.* u.a. Mutation screening and association analysis of six candidate genes for autism on chromosome 7q. European Journal of Human Genetics 13 (2) (2005) 198-207.

B050 Buness,A.; Huber,W.; Steiner,K.; Sültmann,H.; Poustka,A. arrayMagic: two-colour cDNA microarray quality control and preprocessing. Bioinformatics 21 (4) (2005) 554-556.

B050 De Masi,F.*; Chiarella,P.*; Wilhelm,H.; Massimi,M.*; Belinda,B.*; Ansorge,W.*; Sawyer,A.* High throughput production of mouse monoclonal antibodies using antigen microarrays. Proteomics 5 (16) (2005) 4070-4081.

B050 Durinck,S.*; Moreau,Y.*; Kasprzyk,A.*; Davis,S.*; De Moor,B.*; Brazma,A.*; Huber,W. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21 (16) (2005) 3439-3440.

B050 End,C.; Lyer,S.; Renner,M.; Stahl,C.; Ditzer,J.*; Holloschi,A.*; Kuhn,H.M.*; Flammann,H.T.*; Poustka,A.; Hafner,M.*; Mollenhauer,J.; Kioschis,P.* Generation of a vector system facilitating cloning of DMBT1 variants and recombinant expression of functional full-length DMBT1. Protein Expression and Purification 41 (2) (2005) 275-286. E040.

B050 Guilleaume,B.; Buness,A.; Schmidt,C.; Klimek,F.; Moldenhauer,G.; Huber,W.; Arlt,D.; Korf,U.; Wiemann,S.; Poustka,A. Systematic comparison of surface coating for protein microarrays. Proteomics 5 (18) (2005) 4705-4712. D050.

B050 Haller,F.*; Gunawan,B.*; von Heydebreck,A.*; Schwager,S.*; Schulten,H.J.*; Wolf-Salgo,J.*; Langer,C.*; Ramadori,G.*; Sültmann,H.; Fuzesi,L.*

11

Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors. Clinical Cancer Research 11 (18) (2005) 6589-6597.

B050 Hawtin,P.*; Hardern,I.*; Wittig,R.; Mollenhauer,J.; Poustka,A.; Salowsky,R.*; Wulff,T.*; Rizzo,C.*; Wilson,B.* Utility of lab-on-a-chip technology for high-throughput nucleic acid and protein analysis. Electrophoresis 26 (19) (2005) 3674-3681.

B050 Hublitz,P.*; Kunowska,N.*; Mayer,U.P.*; Mueller,J.M.; Heyne,K.*; Yin,N.*; Fritzsche,C.*; Poli,C.*; Miguet,L.*; Schupp,I.W.; van Grunsven,L.A.*; Potiers,N.*; van Dorsselaer,A.*; Metzger,E.*; Roemer,K.*; Schule,R.* NIR is a novel INHAT repressor that modulates the transcriptional activity of p53. Genes & Development 19 (23) (2005) 2912-2924.

B050 Karenko,L.*; Hahtola,S.*; Paivinen,S.*; Karhu,R.*; Syrja,S.*; Kahkonen,M.*; Nedoszytko,B.*; Kytola,S.*; Zhou,Y.*; Blazevic,V.*; Pesonen,M.*; Nevala,H.*; Kupponen,N.*; Sihto,H.*; Krebs,I.; Poustka,A.; Roszkiewicz,J.*; Saksela,K.*; Peterson,P.*; Visakorpi,T.*; Ranki,A.* Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Research 65 (18) (2005) 8101-8110.

B050 Korf,U.; Kohl,T.; van der Zandt,H.*; Zahn,R.; Schleeger,S.; Ueberle,B.; Wandschneider,S.; Bechtel,S.; Schnölzer,M.; Ottleben,H.*; Wiemann,S.; Poustka,A. Large-scale protein expression for proteome research. Proteomics 5 (14) (2005) 3571-3580. B100.

B050 Korf,U.; Wiemann,S. Protein microarrays as a discovery tool for studying protein-protein interactions. Expert Review of Proteomics 2 (1) (2005) 13-26.

B050 Michaelovsky,E.*; Frisch,A.*; Leor,S.*; Stein,D.*; Danziger,Y.*; Carel,C.*; Fennig,S.*; Mimouni,M.*; Klauck,S.M.; Benner,A.; Poustka,A.; Apter,A.*; Weizman,A.* Haplotype analysis of the COMT-ARVCF gene region in Israeli anorexia nervosa family trios. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 139B (1) (2005) 45-50. C060.

B050 Neubrand,V.E.*; Will,R.D.; Moebius,W.*; Poustka,A.; Wiemann,S.; Schu,P.*; Dotti,C.G.*; Pepperkok,R.*; Simpson,J.C.* gamma-BAR, a novel AP-1-interacting protein involved in post-Golgi trafficking. Embo Journal 24 (6) (2005) 1122-1133.

B050 Robbe,C.*; Paraskeva,C.*; Mollenhauert,J.; Michalski,J.C.*; Sergi,C.*; Corfield,A.* DMBT1 expression and glycosylation during the adenoma-carcinoma sequence in colorectal cancer. Biochemical Society Transactions 33 (2005) 730-732.

B050 Ross,M.T.*; Grafham,D.V.*; Coffey,A.J.*; Scherer,S.*; Mclay,K.*; Muzny,D.*; Platzer,M.*; Howell,G.R.*; Burrows,C.*; Bird,C.P.*; Frankish,A.*; Lovell,F.L.*; Howe,K.L.*; Ashurst,J.L.*; Fulton,R.S.*; Sudbrak,R.*; Wen,G.P.*; Jones,M.C.*; Hurles,M.E.*; Andrews,T.D.*; Scott,C.E.*; Searle,S.*; Ramser,J.*; Whittaker,A.*; Deadman,R.*; Carter,N.P.*; Hunt,S.E.*; Chen,R.*; Cree,A.*; Gunaratne,P.* u.a. The DNA sequence of the human X chromosome. Nature 434 (7031) (2005) 325-337.

B050 Schaber,J.*; Rispe,C.*; Wernegreen,J.*; Buness,A.; Delmotte,F.*; Silva,F.J.*; Moya,A.* Gene expression levels influence amino acid usage and evolutionary rates in endosymbiotic bacteria. Gene 352 (2005) 109-117.

B050 Schlomm,T.*; Luebke,A.M.*; Sültmann,H.; Hellwinkel,O.J.C.*; Sauer,U.*; Poustka,A.; David,K.A.*; Chun,F.K.H.*; Haese,A.*; Graefen,M.*; Erbersdobler,A.*; Huland,H.* Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis. International Journal of Oncology 27 (3) (2005) 713-720.

B050 Sültmann,H.; von Heydebreck,A.*; Huber,W.*; Kuner,R.; Buness,A.; Vogt,M.; Gunawan,B.*; Vingron,M.*; Fuzesi,L.*; Poustka,A. Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis

12

formation, and patient survival. Clinical Cancer Research 11 (2) (2005) 646-655. F065.

B050 Wiemann,S.; Kolb-Kokocinski,A.; Poustka,A. Alternative pre-mRNA processing regulates cell-type specific expression of the IL4I1 and NUP62 genes. BMC Biology 3 (2005)

B050 Wittig,R.; Salowsky,R.*; Blaich,S.; Lyer,S.; Maa,J.S.*; Mueller,O.*; Mollenhauer,J.; Poustka,A. Multiplex reverse transcription-polymerase chain reaction combined with on-chip electrophoresis as a rapid screening tool for candidate gene sets. Electrophoresis 26 (9) (2005) 1687-1691.

B055 Abraham,B.K.*; Justenhoven,C.*; Pesch,B.*; Harth,V.*; Weirich,G.*; Baisch,C.*; Rabstein,S.*; Ko,Y.D.*; Bruning,T.*; Fischer,H.P.*; Haas,S.*; Brod,S.*; Oberkanins,C.*; Hamann,U.; Brauch,H.* Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer. Cancer Epidemiology Biomarkers & Prevention 14 (5) (2005) 1102-1107.

B055 Justenhoven,C.*; Hamann,U.; Pierl,C.B.*; Rabstein,S.*; Pesch,B.*; Harth,V.*; Baisch,C.*; Vollmert,C.*; Illig,T.*; Bruning,T.*; Ko,Y.*; Brauch,H.* One-carbon metabolism and breast cancer risk: No association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiology Biomarkers & Prevention 14 (12) (2005) 3015-3018.

B055 Pesch,B.*; Ko,Y.*; Brauch,H.*; Hamann,U.; Harth,V.*; Rabstein,S.*; Pierl,C.*; Fischer,H.P.*; Baisch,C.; Justenhoven,C.*; Ranft,U.*; Bruening,T.* Factors modifying the association between hormone-replacement therapy and breast cancer risk. European Journal of Epidemiology 20 (8) (2005) 699-711.

B060 Bridger,J.M.; Kalla,C.; Wodrich,H.*; Weitz,S.; King,J.A.*; Khazaie,K.*; Kräusslich,H.G.*; Lichter,P. Nuclear RNAs confined to a reticular compartment between chromosome territories. Experimental Cell Research 302 (2) (2005) 180-193.

B060 Freier,K.; Flechtenmacher,C.*; Walch,A.*; Devens,F.; Muehling,J.*; Lichter,P.; Joos,S.; Hofele,C.* Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland. Oral Oncology 41 (9) (2005) 934-939.

B060 Freier,K.*; Flechtenmacher,C.*; Walch,A.*; Ohl,S.; Devens,F.; Burke,B.*; Hassfeld,S.*; Lichter,P.; Joos,S.; Hofele,C.* Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genetics and Cytogenetics 159 (1) (2005) 89-95.

B060 Görisch,S.M.; Wachsmuth,M.*; Toeth,K.F.*; Lichter,P.; Rippe,K.* Histone acetylation increases chromatin accessibility. Journal of Cell Science 118 (24) (2005) 5825-5834.

B060 Görisch,S.M.; Lichter,P.; Rippe,K.* Mobility of multi-subunit complexes in the nucleus: accessibility and dynamics of chromatin subcompartments. Histochemistry and Cell Biology 123 (3) (2005) 217-228.

B060 Kai,N.B.; Schnittger,S.*; Brors,B.; Tews,B.; Kokocinski,F.; Haferlach,T.*; Müller,J.; Hahn,M.; Hiddemann,W.*; Eils,R.; Lichter,P.; Schoch,C.* Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype. Oncogene 24 (9) (2005) 1580-1588. B080.

B060 Kalla,C.; Mertens,D.; Lichter,P. ARHGAP20 gene at 11q22.3-q23.1 oncogenomic recombination hot spot - Response. Genes Chromosomes & Cancer 44 (1) (2005) 111-112.

B060 Kalla,C.; Nentwich,H.; Schlotter,M.; Mertens,D.; Wildenberger,K.; Döhner,H.*; Stilgenbauer,S.*; Lichter,P. Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes. Genes Chromosomes & Cancer 42 (2) (2005) 128-143.

13

B060 Kokocinski,F.*; Delhomme,N.; Wrobel,G.*; Huemmerich,L.; Toedt,G.; Lichter,P. FACT - a framework for the functional interpretation of high-throughput experiments. BMC Bioinformatics 6 (2005)

B060 Martinez,R.*; Schackert,H.K.*; Kirsch,M.*; Paulus,W.*; Joos,S.; Schackert,G.* Comparative genetic analysis of metachronous anaplastic oligoastrocytomas with extended recurrence-free interval. Journal of Neuro-Oncology 72 (2) (2005) 95-102.

B060 Mathas,S.*; Johrens,K.*; Joos,S.; Lietz,A.*; Hummel,F.*; Janz,M.*; Jundt,F.*; Anagnostopoulos,I.*; Bommert,K.*; Lichter,P.; Stein,H.*; Scheidereit,C.*; Doerken,B.* Elevated NF-kappa B p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas. Blood 106 (13) (2005) 4287-4293.

B060 Mendrzyk,F.; Radlwimmer,B.; Joos,S.; Kokocinski,F.*; Benner,A.; Stange,D.E.; Neben,K.*; Fiegler,H.*; Carter,N.P.*; Reifenberger,G.*; Korshunov,A.*; Lichter,P. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. Journal of Clinical Oncology 23 (34) (2005) 8853-8862. C060.

B060 Nessling,M.; Richter,K.; Schwaenen,C.*; Roerig,P.*; Wrobel,G.*; Wessendorf,S.*; Fritz,B.*; Bentz,M.*; Sinn,H.P.; Radlwimmer,B.; Lichter,P. Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. Cancer Research 65 (2) (2005) 439-447. E030.

B060 Poppema,S.*; Kluiver,J.L.*; Atayar,C.*; van den Berg,A.*; Rosenwald,A.*; Hummel,M.*; Lenze,D.*; Lammert,H.*; Stein,H.*; Joos,S.; Barth,T.*; Dyer,M.*; Lichter,P.; Klein,U.*; Cattoretti,G.*; Gloghini,A.*; Tu,Y.H.*; Stolovitzky,G.A.*; Califano,A.*; Carbone,A.*; Dalla-Favera,R.*; Melzner,I.*; Bucur,A.J.*; Bruderlein,S.*; Dorsch,K.*; Hasel,C.*; Barth,T.F.E.*; Leithauser,F.*; Moller,P.* Report: workshop on mediastinal grey zone lymphoma. European Journal of Haematology 75 (2005) 45-52.

B060 Richter,K.; Reichenzeller,M.; Görisch,S.M.; Schmidt,U.; Scheuermann,M.O.; Herrmann,H.; Lichter,P. Characterization of a nuclear compartment shared by nuclear bodies applying ectopic protein expression and correlative light and electron microscopy. Experimental Cell Research 303 (1) (2005) 128-137. B065.

B060 Roerig,P.*; Nessling,M.; Radlwimmer,B.; Joos,S.; Wrobel,G.*; Schwaenen,C.*; Reifenberger,G.*; Lichter,P. Molecular classification of human gliomas using matrix-based comparative genomic hybridization. International Journal of Cancer 117 (1) (2005) 95-103.

B060 Scheuermann,M.O.; Murmann,A.E.*; Richter,K.; Görisch,S.*; Herrmann,H.; Lichter,P. Characterization of nuclear compartments identified by ectopic markers in mammalian cells with distinctly different karyotype. Chromosoma 114 (1) (2005) 39-53. B065.

B060 Scheuermann,M.O.; Tajbakhsh,J.; Kurz,A.; Saracoglu,K.; Eils,R.; Lichter,P. Topology of genes and nontranscribed sequences in human interphase nuclei (vol 301, pg 266, 2004). Experimental Cell Research 304 (1) (2005) 337-338. B080.

B060 Schlingemann,J.; Habtemichael,N.*; Ittrich,C.; Toedt,G.; Kramer,H.; Hambek,M.*; Knecht,R.*; Lichter,P.; Stauber,R.*; Hahn,M. Patient-based cross-platform comparison of oligonucleotide microarray expression profiles. Laboratory Investigation 85 (8) (2005) 1024-1039. C060.

B060 Schlingemann,J.; Thuerigen,O.; Ittrich,C.; Toedt,G.; Kramer,H.; Hahn,M.; Lichter,P. Effective transcriptome amplification for expression profiling on sense-oriented oligonucleotide microarrays. Nucleic Acids Research 33 (3) (2005) C060.

B060 Schneeweiss,A.*; Schuetz,F.*; Rudlowski,C.*; Hahn,M.; Lauschner,I.*; Sinn,H.P.; von Fournier,D.*; Sohn,C.* Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially

14

followed by docetaxel for early breast cancer: final results of a phase I/II trial. Anti-Cancer Drugs 16 (9) (2005) 1023-1028. E030.

B060 Sticht,C.; Hofele,C.*; Flechtenmacher,C.*; Bosch,F.X.*; Freier,K.*; Lichter,P.; Joos,S. Amplification of Cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma (HNSCC). British Journal of Cancer 92 (4) (2005) 770-774.

B060 Taipale,M.*; Rea,S.*; Richter,K.; Vilar,A.*; Lichter,P.; Imhof,A.*; Akhtar,A.* HMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells. Molecular and Cellular Biology 25 (15) (2005) 6798-6810.

B060 Winkler,D.*; Schneider,C.*; Krober,A.*; Pasqualucci,L.*; Lichter,P.; Döhner,H.*; Stilgenbauer,S.* Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). Leukemia 19 (7) (2005) 1211-1215.

B060 Wrobel,G.*; Roerig,P.*; Kokocinski,F.*; Neben,K.*; Hahn,M.; Reifenberger,G.*; Lichter,P. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. International Journal of Cancer 114 (2) (2005) 249-256.

B060 Zielinski,B.; Gratias,S.*; Toedt,G.; Mendrzyk,F.; Stange,D.E.; Radlwimmer,B.; Lohmann,D.R.*; Lichter,P. Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes & Cancer 43 (3) (2005) 294-301.

B065 Bär,H.; Fischer,D.*; Goudeau,B.*; Kley,R.A.*; Clemen,C.S.*; Vicart,P.*; Herrmann,H.; Vorgerd,M.*; Schroeder,R.* Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro. Human Molecular Genetics 14 (10) (2005) 1251-1260.

B065 Bär,H.; Mücke,N.; Kostareva,A.*; Sjoeberg,G.*; Aebi,U.*; Herrmann,H. Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages. Proceedings of the National Academy of Sciences of the United States of America 102 (42) (2005) 15099-15104. B040.

B065 Kreplak,L.*; Bär,H.; Leterrier,J.F.*; Herrmann,H.; Aebi,U.* Exploring the mechanical behavior of single intermediate filaments. Journal of Molecular Biology 354 (3) (2005) 569-577.

B065 Shumaker,D.K.*; Lopez-Soler,R.I.*; Adam,S.A.*; Herrmann,H.; Moir,R.D.*; Spann,T.P.*; Goldman,R.D.* Functions and dysfunctions of the nuclear lamin Ig-fold domain in nuclear assembly, growth, and Emery-Dreifuss muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America 102 (43) (2005) 15494-15499.

B065 Wickert,U.; Mücke,N.; Wedig,T.; Mueller,S.A.*; Aebi,U.*; Herrmann,H. Characterization of the in vitro co-assembly process of the intermediate filament proteins vimentin and desmin: mixed polymers at all stages of assembly. European Journal of Cell Biology 84 (2-3) (2005) 379-391. B040.

B070 Angenendt,P. Progress in protein and antibody microarray technology. Drug Discovery Today 10 (7) (2005) 503-511.

B070 Angenendt,P.; Lehrach,H.*; Kreutzberger,J.*; Gloekler,J.* Subnanoliter enzymatic assays on microarrays. Proteomics 5 (2) (2005) 420-425.

B070 Brems,S.; Guilbride,D.L.*; Gundlesdodjir-Planck,D.*; Busold,C.; Luu,V.D.*; Schanne,M.; Hoheisel,J.; Clayton,C.* The transcriptomes of Trypanosoma brucei Lister 427 and TREU927 bloodstream and procyclic trypomastigotes. Molecular and Biochemical Parasitology 139 (2) (2005) 163-172.

15

B070 Buchholz,M.*; Kestler,H.A.*; Bauer,A.; Bock,W.*; Rau,B.*; Leder,G.*; Kratzer,W.*; Bommer,M.*; Scarpa,A.*; Schilling,M.K.*; Adler,G.*; Hoheisel,J.D.; Gress,T.M.* Specialized DNA arrays for the differentiation of pancreatic tumors. Clinical Cancer Research 11 (22) (2005) 8048-8054.

B070 Busold,C.H.; Winter,S.*; Hauser,N.*; Bauer,A.; Dippon,J.*; Hoheisel,J.D.; Fellenberg,K. Integration of GO annotations in Correspondence Analysis: facilitating the interpretation of microarray data. Bioinformatics 21 (10) (2005) 2424-2429.

B070 Habl,G.*; Bohm,H.*; Marme,N.; Knemeyer,J.P. A new assay for single nucleotide polymorphism analysis based on displacement reactions in PNA-DNA double helices. International Journal of Environmental Analytical Chemistry 85 (9-11) (2005) 613-623.

B070 Kersten,B.*; Wanker,E.E.*; Hoheisel,J.D.; Angenendt,P. Multiplex approaches in protein microarray technology. Expert Review of Proteomics 2 (4) (2005) 499-510.

B070 Knemeyer,J.P.; Marme,N.*; Hafner,B.*; Habl,G.*; Schaefer,G.*; Mueller,M.*; Nolte,O.*; Sauer,M.*; Wolfrum,J.* Self-quenching DNA probes based on dye dimerization for identification of mycobacteria. International Journal of Environmental Analytical Chemistry 85 (9-11) (2005) 625-637.

B070 Marme,N.*; Habl,G.; Knemeyer,J.P. Aggregation behavior of the red-absorbing oxazine derivative MR 121: A new method for determination of pure dimer spectra. Chemical Physics Letters 408 (4-6) (2005) 221-225.

B070 Schanne,M.; Bodem,J.*; Kräusslich,H.G.*; Jacob,A.; Hoheisel,J.D. Microarray-basierte Resistenzbestimmung in HIV. LaborMedizin & Diagnostik 05 (01) (2005) 19

B080 Bentele,M.; Eils,R. General stochastic hybrid method for the simulation of chemical reaction processes in cells. Computational Methods in Systems Biology 3082 (2005) 248-251.

B080 Bolzer,A.*; Kreth,G.*; Solovei,I.*; Koehler,D.*; Saracoglu,K.; Fauth,C.*; Mueller,S.*; Eils,R.; Cremer,C.*; Speicher,M.R.*; Cremer,T.* Three-dimensional maps of all chromosomes in human male fibroblast nuclei and prometaphase rosettes. Plos Biology 3 (5) (2005) 826-842.

B080 Brors,B. Microarray annotation and biological information on function. Methods of Information in Medicine 44 (3) (2005) 468-472.

B080 Bulashevska,S.; Eils,R. Inferring genetic regulatory logic from expression data. Bioinformatics 21 (11) (2005) 2706-2713.

B080 Castellanos,J.*; Rohr,K.; Tolxdorff,T.*; Wagenknecht,G.* Automatic parameter optimization for de-noising MR data. Medical Image Computing and Computer-Assisted Intervention - Miccai 2005, Pt 2 3750 (2005) 320-327.

B080 Frantz,S.*; Rohr,K.; Stiehl,H.S.* Development and validation of a multi-step approach to improved detection of 3D point landmarks in tomographic images. Image and Vision Computing 23 (11) (2005) 956-971.

B080 Kohlrausch,J.*; Rohr,K.; Stiehl,H.* A new class of elastic body splines for nonrigid registration of medical images. Journal of Mathematical Imaging and Vision 23 (3) (2005) 253-280.

B080 Kronenwett,R.*; Butterweck,U.*; Steidl,U.*; Kliszewski,S.*; Neumann,F.*; Bork,S.*; Blanco,E.D.*; Roes,N.*; Graf,T.*; Brors,B.; Eils,R.; Maercker,C.*; Kobbe,G.*; Gattermann,N.*; Haas,R.* Distinct molecular phenotype of malignant CD34+hematopoietic stem and progenitor cells in chronic myelogenous leukemia. Oncogene 24 (34) (2005) 5313-5324.

16

B080 Lenart,P.*; Bacher,C.P.; Daigle,N.*; Hand,A.R.*; Eils,R.; Terasaki,M.*; Ellenberg,J.* A contractile nuclear actin network drives chromosome congression in oocytes. Nature 436 (7052) (2005) 812-818.

B080 Murmann,A.E.*; Gao,J.T.; Encinosa,M.*; Gautier,M.*; Peter,M.E.*; Eils,R.; Lichter,P.; Rowley,J.D.* Local gene density predicts the spatial position of genetic loci in the interphase nucleus. Experimental Cell Research 311 (1) (2005) 14-26. B060.

B080 Neumann,F.*; Teutsch,N.*; Kliszewski,S.*; Bork,S.*; Brors,B.; Schimkus,N.*; Roes,N.*; Germing,U.*; Hildebrandt,B.*; Royer-Pokora,B.*; Eils,R.; Gattermann,N.*; Haas,R.*; Kronenwett,R.* Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib. Leukemia 19 (3) (2005) 458-460.

B080 Rohr,K. Fundamental limits in 3D landmark localization. Lecture Notes in Computer Science 3565 (2005) 286-298.

B080 Schardt,J.A.*; Meyer,M.*; Hartmann,C.H.*; Schubert,F.; Schmidt-Kittler,O.*; Fuhrmann,C.*; Polzer,B.*; Petronio,M.*; Eils,R.; Klein,C.A.* Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell 8 (3) (2005) 227-239.

B080 Schramm,A.*; Schulte,J.H.*; Klein-Hitpass,L.*; Havers,W.*; Sieverts,H.*; Berwanger,B.*; Christiansen,H.*; Warnat,P.; Brors,B.; Eils,J.; Eils,R.; Eggert,A.* Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling. Oncogene 24 (53) (2005) 7902-7912.

B080 Schubert,F.; Tausch,B.; Joos,S.; Eils,R. CGH-profiler: Data mining based on genomic aberration profiles. BMC Bioinformatics 6 (2005) B060.

B080 Schulte,J.H.*; Schramm,A.*; Klein-Hitpass,L.*; Klenk,M.*; Wessels,H.*; Hauffa,B.P.*; Eils,J.R.; Eils,R.; Brodeur,G.M.*; Schweigerer,L.*; Havers,W.*; Eggert,A.* Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas. Oncogene 24 (1) (2005) 165-177.

B080 Volz,D.; Eigel,M.; Athale,C.; Bastian,P.*; Herrmann,H.; Kappel,C.; Eils,R. Spatial modeling and simulation of diffusion in nuclei of living cells. Lecture Notes in Computer Science 3082 (2005) 161-171. B065.

B080 Warnat,P.; Eils,R.; Brors,B. Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes. BMC Bioinformatics 6 (2005)

B080 Woelfle,U.*; Breit,E.*; Zafrakas,K.*; Otte,M.*; Schubert,F.; Mueller,V.*; Izbicki,J.R.*; Loning,T.*; Pantel,K.* Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients. Journal of Immunological Methods 300 (1-2) (2005) 136-145.

B085 Jakobsen,A.F.*; Mouritsen,O.G.*; Weiss,M. Close-up view of the modifications of fluid membranes due to phospholipase A(2). Journal of Physics-Condensed Matter 17 (47) (2005) S4015-S4024

B090 Bohne-Lang,A.*; der Lieth,C.W. GlyProt: in silico glycosylation of proteins. Nucleic Acids Research 33 (2005) W214-W219

B090 Bohne-Lang,A.*; Groch,W.D.*; Ranzinger,R. AISMIG - an interactive server-side molecule image generator. Nucleic Acids Research 33 (2005) W705-W709

17

B090 Goetz,T.; der Lieth,C.W. PubFinder: a tool for improving retrieval rate of relevant PubMed abstracts. Nucleic Acids Research 33 (2005) W774-W778

B090 Krueger,R.; Hung,C.W.; Edelson-Averbukh,M.; Lehmann,W.D. Iodoacetamide-alkylated methionine can mimic neutral loss of phosphoric acid from phosphopeptides as exemplified by nano-electrospray ionization quadrupole time-of-flight parent ion scanning. Rapid Communications in Mass Spectrometry 19 (12) (2005) 1709-1716.

B090 Luetteke,T.; Frank,M.; der Lieth,C.W. Carbohydrate Structure Suite (CSS): analysis of carbohydrate 3D structures derived from the PDB. Nucleic Acids Research 33 (2005) D242-D246

B090 Lutz,N.W.*; Franks,S.E.; Frank,M.H.*; Pomer,S.*; Hull,W.E. Investigation of multidrug resistance in cultured human renal cell carcinoma cells by P-31-NMR spectroscopy and treatment survival assays. Magnetic Resonance Materials in Physics Biology and Medicine 18 (3) (2005) 144-161.

B090 Mayatepek,E.*; Badiou,S.*; Bellet,H.*; Lehmann,W.D. A patient with neurological symptoms and abnormal leukotriene metabolism: A new defect in leukotriene biosynthesis. Annals of Neurology 58 (6) (2005) 968-970.

B090 Pereg,Y.*; Shkedy,D.*; de Graaf,P.*; Meulmeester,E.*; Edelson-Averbukh,M.; Salek,M.; Biton,S.*; Teunisse,A.F.A.S.*; Lehmann,W.D.; Jochemsen,A.G.*; Shiloh,Y.* Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage. Proceedings of the National Academy of Sciences of the United States of America 102 (14) (2005) 5056-5061.

B090 Preisinger,C.*; Korner,R.*; Wind,M.; Lehmann,W.D.; Kopajtich,R.*; Barr,F.A.* Plk1 docking to GRASP65 phosphorylated by Cdk1 suggests a mechanism for Golgi checkpoint signalling. Embo Journal 24 (4) (2005) 753-765.

B090 Salek,M.; Di Bartolo,V.*; Cittaro,D.*; Borsotti,D.*; Wei,J.H.; Acuto,O.*; Rappsilber,J.*; Lehmann,W.D. Sequence tag scanning: A new explorative strategy for recognition of unexpected protein alterations by nanoelectrospray ionization-tandem mass spectrometry. Proteomics 5 (3) (2005) 667-674.

B090 Salek,M.; Lehmann,W.D. Analysis of thyroglobulin iodination by tandem mass spectrometry using immonium ions of monoiodo- and diiodo-tyrosine. Proteomics 5 (2) (2005) 351-353.

B090 Wind,M.; Wegener,A.*; Kellner,R.*; Lehmann,W.D. Analysis of CheA histidine phosphorylation and its influence on protein stability by high-resolution element and electrospray mass spectrometry. Analytical Chemistry 77 (7) (2005) 1957-1962.

B100 Dormeyer,W.; Ott,M.*; Schnölzer,M. Analysis of p300 acetyltransferase substrate specificity by MALDI TOF mass spectrometry. Methods 36 (4) (2005) 376-382.

B100 Dormeyer,W.; Ott,M.*; Schnölzer,M. Probing lysine acetylation in proteins - Strategies, limitations, and pitfalls of in vitro acetyltransferase assays. Molecular & Cellular Proteomics 4 (9) (2005) 1226-1239.

B100 Ely,M.R.*; Nees,M.*; Karsai,S.*; Magele,I.*; Bogumil,R.*; Vorderwulbecke,S.*; Ruess,A.*; Dietz,A.*; Schnölzer,M.; Bosch,F.X.* Transcript and proteome analysis reveals reduced expression of calgranulins in head and neck squamous cell carcinoma. European Journal of Cell Biology 84 (2-3) (2005) 431-444.

B100 Hagl,C.I.*; Thil,O.*; Holland-Cunz,S.*; Faissner,R.*; Wandschneider,S.; Schnölzer,M.; Löhr,M.; Schäfer,K.H.*

18

Proteome analysis of isolated myenteric plexus reveals significant changes in protein expression during postnatal development. Autonomic Neuroscience-Basic & Clinical 122 (1-2) (2005) 1-8. E180.

B100 Hetzer,C.; Dormeyer,W.; Schnölzer,M.; Ott,M.* Decoding Tat: the biology of HIV Tat posttranslational modifications. Microbes and Infection 7 (13) (2005) 1364-1369. F040.

B100 Hilgenfeldt,U.*; Stannek,C.*; Lukasova,M.*; Schnölzer,M.; Lewicka,S.* Rat tissue kallikrein releases a kallidin-like peptide from rat low-molecular-weight kininogen. British Journal of Pharmacology 146 (7) (2005) 958-963.

B100 Kuhn,J.*; Schnölzer,M.; Schoen,S.*; Mueller,S.*; Prante,C.*; Goetting,C.*; Kleesiek,K.* Xylosyltransferase I acceptor properties of fibroblast growth factor and its fragment bFGF (1-24). Biochemical and Biophysical Research Communications 333 (1) (2005) 156-166.

B100 Urbani,A.*; Poland,J.*; Bernardini,S.*; Bellincampi,L.*; Biroccio,A.*; Schnölzer,M.; Sinha,P.*; Federici,G.* A proteomic investigation into etoposide chemo-resistance of neuroblastoma cell lines. Proteomics 5 (3) (2005) 796-804.

B110 Arziman,Z.; Horn,T.; Boutros,M. E-RNAi: a web application to design optimized RNAi constructs. Nucleic Acids Research 33 (2005) W582-W588

B110 Choe,S.E.*; Boutros,M.; Michelson,A.M.*; Church,G.M.*; Halfon,M.S.* Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset. Genome Biology 6 (2) (2005)

B110 Gesellchen,V.; Kuttenkeuler,D.; Steckel,M.; Pelte,N.; Boutros,M. An RNA interference screen identifies Inhibitor of Apoptosis Protein 2 as a regulator of innate immune signalling in Drosophila. Embo Reports 6 (10) (2005) 979-984.

B110 Mueller,P.*; Kuttenkeuler,D.; Gesellchen,V.; Zeidler,M.P.*; Boutros,M. Identification of JAK/STAT signalling components by genome-wide RNA interference. Nature 436 (7052) (2005) 871-875.

Forschungsschwerpunkt C C010 Bartsch,H.; Gerhäuser,C.; Nair,J.

Molekulare Forschungsansätze zur Vorbeugung von Krebserkrankungen (Chemoprävention). Forum DKG 20 (2005) 6-9.

C010 Bartsch,H.; Miller,A.B. Editors' Comments, "Epidemiologic studies of nutrition and cancer". International Journal of Cancer 116 (5) (2005) 661 C020.

C010 Bartsch,H.; Nair,J. Accumulation of lipid peroxidation-derived DNA lesions: Potential lead markers for chemoprevention of inflammation-driven malignancies. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 591 (1-2) (2005) 34-44.

C010 Becher,H.*; Ramroth,H.*; Ahrens,W.*; Risch,A.; Schmezer,P.; Dietz,A.* Occupation, exposure to polycyclic aromatic hydrocarbons and laryngeal cancer risk. International Journal of Cancer 116 (3) (2005) 451-457.

C010 Berger,T.G.*; Dieckmann,D.*; Efferth,T.; Schultz,E.S.*; Funk,J.O.*; Baur,A.*; Schuler,G.* Artesunate in the treatment of metastatic uveal melanoma - first experiences. Oncology Reports 14 (6) (2005) 1599-1603.

C010 Berwanger,S.*; Frank,N.; Knauft,J.; Becker,H.* Biosynthetic C-14-labelling of xanthohumol in hop cones. Molecular Nutrition & Food Research 49 (9) (2005) 857-860.

C010 Bohr,G.*; Gerhäuser,C.; Knauft,J.; Zapp,J.*; Becker,H.* Anti-inflammatory acylphloroglucinol derivatives from hops (Humulus lupulus). Journal of Natural Products 68 (10) (2005) 1545-1548.

19

C010 Castegnaro,M.*; Pfohl-Leszkowicz,A.*; Bartsch,H.; Tillmann,T.*; Mohr,U.* Re: Comments on paper by Son et al. Toxicology Letters 156 (2) (2005) 315

C010 Efferth,T.; Chen,Z.*; Kaina,B.*; Wang,G.* Molecular determinants of response of tumor cells to berberine. Cancer Genomics and Proteomics 2 (2005) 115-125.

C010 Efferth,T.; Volm,M. Pharmacogenetics and individualized cancer chemotherapy (Review). Pharmacology and Therapeutics 107 (2005) 155-176.

C010 Gerhäuser,C. Beer constituents as potential cancer chemopreventive agents. European Journal of Cancer 41 (13) (2005) 1941-1954.

C010 Gerhäuser,C. Broad spectrum antiinfective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites. Molecular Nutrition & Food Research 49 (9) (2005) 827-831.

C010 Gerhäuser,C.; Frank,N. Xanthohumol, a new all-rounder? Molecular Nutrition & Food Research 49 (9) (2005) 821-+

C010 Hanske,L.*; Hussong,R.; Frank,N.; Gerhäuser,C.; Blaut,M.; Braune,A.* Xanthohumol does not affect the composition of rat intestinal microbiota. Molecular Nutrition & Food Research 49 (9) (2005) 868-873.

C010 Heiss,E.; Gerhäuser,C. Time-dependent modulation of thioredoxin reductase activity might contribute to sulforaphane-mediated inhibition of NF-kappa B binding to DNA. Antioxidants & Redox Signaling 7 (11-12) (2005) 1601-1611.

C010 Hussong,R.; Frank,N.; Knauft,J.; Ittrich,C.; Owen,R.; Becker,H.*; Gerhäuser,C. A safety study of oral xanthohumol administration and its influence on fertility in Sprague Dawley rats. Molecular Nutrition & Food Research 49 (9) (2005) 861-867. C060.

C010 Karadsheh,N.S.*; Gelbart,T.*; Schulten,H.J.*; Efferth,T.; Awidi,A.* Relationship between molecular variants and clinical manifestions in twelve glucose-6-phosphate dehydrogenase-deficient patients in Jordan. Acta Haematologica 114 (2) (2005) 125-126.

C010 Khallouki,F.; Spiegelhalder,B.; Bartsch,H.; Owen,R.W. Secondary metabolites of the argan tree (Morocco) may have disease prevention properties. African Journal of Biotechnology 4 (2005) 381-389.

C010 Nair,J.; Sinitsina,O.*; Vasunina,E.A.*; Nevinsky,G.A.*; Laval,J.*; Bartsch,H. Age-dependent increase of etheno-DNA-adducts in liver and brain of ROS overproducing OXYS rats. Biochemical and Biophysical Research Communications 336 (2) (2005) 478-482.

C010 Nair,J.; Strand,S.*; Frank,N.; Knauft,J.; Wesch,H.; Galle,P.R.*; Bartsch,H. Apoptosis and age-dependant induction of nuclear and mitochondrial etheno-DNA adducts in Long-Evans Cinnamon (LEC) rats: enhanced DNA damage by dietary curcumin upon copper accumulation. Carcinogenesis 26 (7) (2005) 1307-1315. E020.

C010 Pan,L.; Becker,H.*; Gerhäuser,C. Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway. Molecular Nutrition & Food Research 49 (9) (2005) 837-843.

C010 Raimondi,S.*; Boffetta,P.*; Anttila,S.*; Brockmoller,J.*; Butkiewicz,D.*; Cascorbi,I.*; Clapper,M.L.*; Dragani,T.A.*; Garte,S.*; Gsur,A.*; Haidinger,G.*; Hirvonen,A.*; Ingelman-Sundberg,M.*; Kalina,I.*; Lan,Q.*; Leoni,V.P.*; Marchand,L.L.*; London,S.J.*; Neri,M.*; Povey,A.C.*; Rannug,A.*; Reszka,E.*; Ryberg,D.*; Risch,A.; Romkes,M.*; Ruano-Ravina,A.*; Schoket,B.*; Spinola,M.*; Sugimura,H.*; Wu,X.* u.a. Metabolic gene polymorphisms and lung cancer risk in non-smokers: An update of the GSEC

20

study. Mutatation Research 592 (2005) 45-57.

C010 Raschke,S.*; Balz,V.*; Efferth,T.; Schulz,W.A.*; Florl,A.R.* Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines. Genes Chromosomes & Cancer 42 (1) (2005) 58-67.

C010 Rohrbacher,M.; Risch,A.; Kropp,S.; Chang-Claude,J. The A(-336)C insulin-like growth factor binding protein-3 promoter polymorphism is not a modulator of breast cancer risk in Caucasian women. Cancer Epidemiology Biomarkers & Prevention 14 (1) (2005) 289-290. C020.

C010 Romero,M.R.*; Efferth,T.; Serrano,M.A.*; Castano,B.*; Macias,R.I.R.*; Briz,O.*; Marin,J.J.G.* Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system. Antiviral Research 68 (2) (2005) 75-83.

C010 Ruefer,C.E.*; Gerhäuser,C.; Frank,N.; Becker,H.*; Kulling,S.E.* In vitro phase II metabolism of xanthohumol by human UDP-glucuronosyltransferases and sulfotransferases. Molecular Nutrition & Food Research 49 (9) (2005) 851-856.

C010 Sudjaroen,Y.; Haubner,R.; Würtele,G.; Hull,W.E.; Erben,G.; Spiegelhalder,B.; Changbumrung,S.*; Bartsch,H.; Owen,R.W. Isolation and structure elucidation of phenolic antioxidants from Tamarind (Tamarindus indica L.) seeds and pericarp. Food and Chemical Toxicology 43 (11) (2005) 1673-1682. B090.

C010 Wang,J.S.*; Zheng,Y.T.*; Efferth,T.; Wang,R.R.*; Shen,Y.M.*; Hao,X.J.* Indole and carbazole alkaloids from Glycosmis montana with weak anti-HIV and cytotoxic activities. Phytochemistry 66 (6) (2005) 697-701.

C010 Wick,U.*; Kirsch,M.*; Rauch,A.*; Chudoba,I.*; Lausen,B.*; Efferth,T.; Gebhart,E.* FISH studies on the telomeric regions of the T-cell acute lymphoblastic leukemia cell line CCRF-CEM. Cytogenetics and Genome Research 111 (2005) 34-40.

C010 Wittich,S.*; Scherf,H.; Xie,C.P.; Heltweg,B.*; Dequiedt,F.*; Verdin,E.*; Gerhäuser,C.; Jung,M.* Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell lines. Anti-Cancer Drugs 16 (6) (2005) 635-643.

C010 Zitron,E.*; Scholz,E.*; Owen,R.W.; Lueck,S.*; Kiesecker,C.*; Thomas,D.; Kathofer,S.*; Niroomand,F.*; Kiehn,J.*; Kreye,V.A.W.*; Katus,H.A.*; Schoels,W.*; Karle,C.A.* QTc prolongation by grapefruit juice and its potential pharmacological basis - HERG channel blockade by flavonoids. Circulation 111 (7) (2005) 835-838. D070.

C020 Airoldi,L.*; Vineis,P.*; Colombi,A.*; Olgiati,L.*; Dell'Osta,C.*; Fanelli,R.*; Manzi,L.*; Veglia,F.*; Autrup,H.*; Dunning,A.*; Garte,S.*; Hainaut,P.*; Hoek,G.*; Krzyzanowski,M.*; Malaveille,C.*; Matullo,G.*; Overvad,K.*; Tjonneland,A.*; Clavel-Chapelon,F.*; Linseisen,J.; Boeing,H.*; Trichopoulou,A.*; Palli,D.*; Peluso,M.*; Krogh,V.*; Tumino,R.*; Panico,S.*; Bueno-de-Mesquita,H.B.*; Peeters,P.H.*; Lund,E.* u.a. 4-aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European prospective investigation into cancer and nutrition prospective study. Cancer Epidemiology Biomarkers & Prevention 14 (9) (2005) 2118-2124.

C020 Al Delaimy,W.K.*; Ferrari,P.*; Slimani,N.*; Pala,V.*; Johansson,I.*; Nilsson,S.*; Mattisson,I.*; Wirfalt,E.*; Galasso,R.*; Palli,D.*; Vineis,P.*; Tumino,R.*; Dorronsoro,M.*; Pera,G.*; Ocke,M.C.*; Bueno-de-Mesquita,H.B.*; Overvad,K.*; Chirlaque,M.A.D.*; Trichopoulou,A.*; Naska,A.*; Tjonneland,A.*; Olsen,A.*; Lund,E.*; Alsaker,E.H.R.*; Barricarte,A.*; Kesse,E.*; Boutron-Ruault,M.C.*; Clavel-Chapelon,F.*; Key,T.J.*; Spencer,E.* u.a. Plasma carotenoids as biomarkers of intake of fruits and vegetables: individual-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC). European Journal of Clinical Nutrition 59 (12) (2005) 1387-1396.

21

C020 Al Delaimy,W.K.*; Slimani,N.*; Ferrari,P.*; Key,T.*; Spencer,E.*; Johansson,I.*; Johansson,G.*; Mattisson,I.*; Wirfalt,E.*; Sieri,S.*; Agudo,A.*; Celentano,E.*; Palli,D.*; Sacerdote,C.*; Tumino,R.*; Dorronsoro,M.*; Ocke,M.C.*; Bueno-de-Mesquita,H.B.*; Overvad,K.*; Chirlaque,M.D.*; Trichopoulou,A.*; Naska,A.*; Tjonneland,A.*; Olsen,A.*; Lund,E.*; Skeie,G.*; Ardanaz,E.*; Kesse,E.*; Boutron-Ruault,M.C.*; Clavel-Chapelon,F.* u.a. Plasma carotenoids as biomarkers of intake of fruits and vegetables: ecological-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC). European Journal of Clinical Nutrition 59 (12) (2005) 1397-1408.

C020 Antoniou,A.C.*; Goldgar,D.E.*; Andrieu,N.*; Chang-Claude,J.; Brohet,R.*; Rookus,M.A.*; Easton,D.F.* A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genetic Epidemiology 29 (1) (2005) 1-11.

C020 Bamia,C.*; Orfanos,P.*; Ferrari,P.*; Overvad,K.*; Hundborg,H.H.*; Tjonneland,A.*; Olsen,A.*; Kesse,E.*; Boutron-Ruault,M.C.*; Clavel-Chapelon,F.*; Nagel,G.; Boffetta,P.; Boeing,H.; Hoffmann,K.; Trichopoulos,D.*; Baibas,N.*; Psaltopoulou,T.*; Norat,T.*; Slimani,N.*; Palli,D.*; Krogh,V.*; Panico,S.*; Tumino,R.*; Sacerdote,C.*; Bueno-de-Mesquita,H.B.*; Ocke,M.C.*; Peeters,P.H.*; van Rossum,C.T.*; Quiros,J.R.*; Sanchez,M.J.* u.a. Dietary patterns among older Europeans: the EPIC-Elderly study. British Journal of Nutrition 94 (1) (2005) 100-113.

C020 Becker,N.; Deeg,E.; Ruediger,T.*; Nieters,A. Medical history and risk for lymphoma: results of a population-based case-control study in Germany. European Journal of Cancer 41 (1) (2005) 133-142.

C020 Beckmann,L.; Fischer,C.*; Obreiter,M.*; Rabes,M.; Chang-Claude,J. Haplotype-sharing analysis using Mantel statistics for combined genetic effects. BMC Genetics 6 (2005)

C020 Beckmann,L.; Thomas,D.C.*; Fischer,C.*; Chang-Claude,J. Haplotype sharing analysis using mantel statistics. Human Heredity 59 (2) (2005) 67-78.

C020 Beckmann,L.; Ziegler,A.*; Duggal,P.*; Bailey-Wilson,J.E.* Haplotypes and haplotype-tagging single-nucleotide polymorphism: Presentation group 8 of genetic analysis workshop 14. Genetic Epidemiology 29 (2005) S59-S71

C020 Bergmann,S.*; Royer-Pokora,B.*; Fietze,E.*; Juerchott,K.*; Hildebrandt,B.*; Trost,D.*; Leenders,F.*; Claude,J.C.; Theuring,F.*; Bargou,R.*; Dietel,M.*; Royer,H.D.* YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Research 65 (10) (2005) 4078-4087.

C020 Berndt,S.I.*; Carter,H.B.*; Landis,P.K.*; Hallfrisch,J.*; Rohrmann,S.; Metter,E.J.*; Platz,E.A.* Prediagnostic plasma vitamin C levels and the subsequent risk of prostate cancer. Nutrition 21 (6) (2005) 686-690.

C020 Bezemer,I.D.*; Rinaldi,S.*; Dossus,L.*; van Gils,C.H.*; Peeters,P.H.M.*; Noord,P.A.H.*; Bueno-de-Mesquita,H.B.*; Johnsen,S.P.*; Overvad,K.*; Olsen,A.*; Tjonneland,A.*; Boeing,H.*; Lahmann,P.H.*; Linseisen,J.; Nagel,G.; Allen,N.*; Roddam,A.*; Bingham,S.*; Khaw,K.T.*; Kesse,E.*; Tehard,B.*; Clavel-Chapelon,F.*; Agudo,A.*; Ardanaz,E.*; Quiros,J.R.*; Amiano,P.*; Martinez-Garcia,C.*; Tormo,M.J.*; Pala,V.*; Panico,S.* u.a. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes & Control 16 (5) (2005) 561-572.

C020 Bingham,S.A.*; Norat,T.*; Moskal,A.*; Ferrari,P.*; Slimani,N.*; Clavel-Chapelon,F.*; Kesse,E.*; Nieters,A.; Boeing,H.*; Tjonneland,A.*; Overvad,K.*; Martinez,C.*; Dorronsoro,M.*; Gonzalez,C.A.*; Ardanaz,E.*; Navarro,C.*; Quiros,J.R.*; Key,T.J.*; Day,N.E.*; Trichopoulou,A.*; Naska,A.*; Krogh,V.*; Tumino,R.*; Palli,D.*; Panico,S.*; Vineis,P.*; Bueno-de-Mesquita,H.B.*; Ocke,M.C.*; Peeters,P.H.M.*; Berglund,G.* u.a. Is the association with fiber from foods in colorectal cancer confounded by folate intake? Cancer Epidemiology Biomarkers & Prevention 14 (6) (2005) 1552-1556.

22

C020 Bolarinwa,A.*; Linseisen,J. Validated application of a new high-performance liquid chromatographic method for the determination of selected flavonoids and phenolic acids in human plasma using electrochemical detection. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences 823 (2) (2005) 143-151.

C020 Burstyn,I.*; Kromhout,H.*; Partanen,T.*; Svane,O.*; Langard,S.*; Ahrens,W.*; Kauppinen,T.*; Stucker,I.*; Shaham,J.*; Heederik,D.*; Ferro,G.*; Heikkila,P.*; Hooiveld,M.*; Johansen,C.*; Randem,B.G.*; Boffetta,P. Polycyclic aromatic hydrocarbons and fatal ischemic heart disease. Epidemiology 16 (6) (2005) 744-750.

C020 Campa,D.*; Hung,R.J.*; Mates,D.*; Zaridze,D.*; Szeszenia-Dabrowska,N.*; Rudnai,P.*; Lissowska,J.*; Fabianova,E.*; Bencko,V.*; Foretova,L.*; Janout,V.*; Boffetta,P.; Brennan,P.*; Canzian,F. Lack of association between-251 T > A polymorphism of IL8 and lung cancer risk. Cancer Epidemiology Biomarkers & Prevention 14 (10) (2005) 2457-2458. C055.

C020 Chang-Claude,J.; Hermann,S.*; Eilber,U.; Steindorf,K. Lifestyle determinants and mortality in German vegetarians and health-conscious persons: Results of a 21-year follow-up. Cancer Epidemiology Biomarkers & Prevention 14 (4) (2005) 963-968. C030.

C020 Chang-Claude,J.; Popanda,O.; Tan,X.L.; Kropp,S.; Helmbold,I.; von Fournier,D.*; Haase,W.*; Sautter-Bihl,M.L.*; Wenz,F.*; Schmezer,P.; Ambrosone,C.B.* Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clinical Cancer Research 11 (13) (2005) 4802-4809. C010. M019.

C020 De Stefani,E.*; Boffetta,P.; Ronco,A.L.*; Brennan,P.*; Correa,P.*; Deneo-Pellegrini,H.*; Gutierrez,L.P.*; Mendilaharsu,M.* Squamous and small cell carcinomas of the lung: similarities and differences concerning the role of tobacco smoking. Lung Cancer 47 (1) (2005) 1-8.

C020 Held,L.*; Natario,I.*; Fenton,S.E.*; Rue,H.*; Becker,N. Towards joint disease mapping. Statistical Methods in Medical Research 14 (1) (2005) 61-82.

C020 Hoff,S.*; Seiler,H.*; Heinrich,J.*; Kompauer,I.*; Nieters,A.; Becker,N.; Nagel,G.; Gedrich,K.*; Karg,G.*; Wolfram,G.*; Linseisen,J. Allergic sensitisation and allergic rhinitis are associated with n-3 polyunsaturated fatty acids in the diet and in red blood cell membranes. European Journal of Clinical Nutrition 59 (9) (2005) 1071-1080.

C020 Hoffmann,K.*; Boeing,H.*; Boffetta,P.*; Nagel,G.; Orfanos,P.*; Ferrari,P.*; Bamia,C.* Comparison of two statistical approaches to predict all-cause mortality by dietary patterns in German elderly subjects. British Journal of Nutrition 93 (5) (2005) 709-716.

C020 Jenab,M.*; Ferrari,P.*; Mazuir,M.*; Tjonneland,A.*; Clavel-Chapelon,F.*; Linseisen,J.; Trichopoulou,A.*; Tumino,R.*; Bueno-de-Mesquita,H.B.*; Lund,E.*; Gonzalez,C.A.*; Johansson,G.*; Key,T.J.*; Riboli,E.* Variations in lycopene blood levels and tomato consumption across European countries based on the European prospective investigation into, cancer and nutrition (EPIC) study. Journal of Nutrition 135 (8) (2005) 2032S-2036S.

C020 Kaaks,R.*; Berrino,F.*; Key,T.*; Rinaldi,S.*; Dossus,L.*; Biessy,C.*; Secreto,G.*; Amiano,P.*; Bingham,S.*; Boeing,H.*; de Mesquita,H.B.B.*; Chang-Claude,J.*; Clavel-Chapelon,F.O.*; Fournier,A.S.*; van Gils,C.H.*; Gonzalez,C.A.*; Gurrea,A.B.*; Critselis,E.*; Khaw,K.T.*; Krogh,V.*; Lahmann,P.H.*; Nagel,G.; Olsen,A.*; Onland-Moret,N.C.*; Overvad,K.*; Palli,D.*; Panico,S.*; Peeters,P.*; Quiros,J.R.*; Roddam,A.* u.a. Serum sex steroids in premenopausal women and breast cancer risk within the European prospective investigation into cancer and nutrition (EPIC). Journal of the National Cancer Institute 97 (10) (2005) 755-765.

23

C020 Kaaks,R.*; Rinaldi,S.*; Key,T.J.*; Berrino,F.*; Peeters,P.H.M.*; Biessy,C.*; Dossus,L.*; Lukanova,A.*; Binghan,S.*; Khaw,K.T.G.*; Allen,N.E.*; Bueno-de-Mesquita,H.B.*; van Gils,C.H.*; Grobbee,D.*; Boeing,H.*; Lahmann,P.H.*; Nagel,G.; Chang-Claude,J.; Clavel-Chapelon,F.*; Fournier,A.*; Thiebaut,A.*; Gonzalez,C.A.*; Quiros,J.R.*; Tormo,M.J.*; Ardanaz,E.*; Amiano,P.*; Krogh,V.*; Palli,D.*; Panico,S.*; Tumino,R.* u.a. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocrine-Related Cancer 12 (4) (2005) 1071-1082.

C020 Kelemen,L.*; James,M.*; Spurdle,A.*; Campbell,I.*; Chang-Claude,J.; Peel,D.*; Anton-Culver,H.*; Berchuck,A.*; Schildkraut,J.*; Whittemore,A.*; McGurie,V.*; DiCioccio,R.A.*; Duffy,D.*; Chenevix-Trench,G.* BRAF polymorphisms and the risk of ovarian cancer of low malignant potential. Gynecologic Oncology 97 (3) (2005) 807-812.

C020 Kompauer,I.*; Demmelmair,H.*; Koletzko,B.*; Bolte,G.*; Linseisen,J.; Heinrich,J.* Association of fatty acids in serum phospholipids with hay fever, specific and total immunoglobulin E. British Journal of Nutrition 93 (4) (2005) 529-535.

C020 Kuschel,B.*; Chenevix-Trench,G.*; Spurdle,A.B.*; Chen,X.Q.*; Hopper,J.L.*; Giles,G.G.*; McCredie,M.*; Chang-Claude,J.; Gregory,C.S.*; Day,N.E.*; Easton,D.F.*; Ponder,B.A.J.*; Dunning,A.M.*; Pharoah,P.D.P.* Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiology Biomarkers & Prevention 14 (7) (2005) 1828-1831.

C020 Lakhani,S.R.*; Reis-Filho,J.S.*; Fulford,L.*; Penault-Llorca,F.*; van der Vjiver,M.*; Parry,S.*; Bishop,T.*; Benitez,J.*; Rivas,C.*; Bignon,Y.J.*; Chang-Claude,J.; Hamann,U.; Cornelisse,C.J.*; Devilee,P.*; Beckmann,M.W.*; Nestle-Kramling,C.*; Daly,P.A.*; Haites,N.*; Varley,J.*; Lalloo,F.*; Evans,G.*; Maugard,C.*; Meijers-Heijboer,H.*; Klijn,J.G.M.*; Olah,E.*; Gusterson,B.A.*; Pilotti,S.*; Radice,P.*; Scherneck,S.*; Sobol,H.* u.a. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clinical Cancer Research 11 (14) (2005) 5175-5180. B055.

C020 Lilla,C.; Koehler,T.*; Kropp,S.; Wang-Gohrke,S.*; Chang-Claude,J. Alcohol dehydrogenase 1B (ADH1B) genotype, alcohol consumption and breast cancer risk by age 50 years in a German case-control study. British Journal of Cancer 92 (11) (2005) 2039-2041.

C020 Lilla,C.; Risch,A.; Kropp,S.; Chang-Claude,J. SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case-control study. Breast Cancer Research 7 (2) (2005) R229-R237 C010.

C020 Nagel,G.; Altenburg,H.P.; Nieters,A.; Boffetta,P.*; Linseisen,J. Reproductive and dietary determinants of the age at menopause in EPIC-Heidelberg. Maturitas 52 (3-4) (2005) 337-347.

C020 Nagel,G.; Linseisen,J. Dietary intake of fatty acids, antioxidants and selected food groups and asthma in adults'. European Journal of Clinical Nutrition 59 (1) (2005) 8-15.

C020 Nagel,G.; Mack,U.*; von Fournier,D.*; Linseisen,F. Dietary phytoestrogen intake and mammographic density - Results of a pilot study. European Journal of Medical Research 10 (9) (2005) 389-394.

C020 Nieters,A.; Yuan,J.M.*; Sun,C.L.*; Zhang,Z.Q.*; Stoehlmacher,J.*; Govindarajan,S.*; Yu,M.C.* Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer 103 (4) (2005) 740-748.

C020 Norat,T.*; Bingham,S.*; Ferrari,P.*; Slimani,N.*; Jenab,M.*; Mazuir,M.*; Overvad,K.*; Olsen,A.*; Tjonneland,A.*; Clavel,F.*; Boutron-Ruault,M.C.*; Kesse,E.*; Boeing,H.*; Bergmann,M.M.*; Nieters,A.; Linseisen,J.; Trichopoulou,A.*; Trichopoulos,D.*; Tountas,Y.*; Berrino,F.*; Palli,D.*; Panico,S.*; Tumino,R.*; Vineis,P.*; Bueno-de-Mesquita,H.B.*; Peeters,P.H.M.*; Engeset,D.*; Lund,E.*; Skeie,G.*; Ardanaz,E.* u.a. Meat, fish, and colorectal cancer risk: The European prospective investigation into cancer and

24

nutrition. Journal of the National Cancer Institute 97 (12) (2005) 906-916.

C020 Obreiter,M.; Fischer,C.*; Chang-Claude,J.; Beckmann,L. SDMinP: a program to control the family wise error rate using step-down minP adjusted P-values. Bioinformatics 21 (14) (2005) 3183-3184.

C020 Onland-Moret,N.C.*; Peeters,P.H.M.*; van Gils,C.H.*; Clavel-Chapelon,F.*; Key,T.*; Tjonneland,A.*; Trichopoulou,A.*; Kaaks,R.*; Manjer,J.*; Panico,S.*; Palli,D.*; Tehard,B.*; Stoikidou,M.*; Bueno-de-Mesquita,H.B.*; Boeing,H.*; Overvad,K.*; Lenner,P.*; Quiros,J.R.*; Chirlaque,M.D.*; Miller,A.B.; Khaw,K.T.*; Riboli,E.* Age at menarche in relation to adult height. American Journal of Epidemiology 162 (7) (2005) 623-632.

C020 Peluso,M.*; Munnia,A.*; Hoek,G.*; Krzyzanowski,M.*; Veglia,F.*; Airoldi,L.*; Autrup,H.*; Dunning,A.*; Garte,S.*; Hainaut,P.*; Malaveille,C.*; Gormally,E.*; Matullo,G.*; Overvad,K.*; Raaschou-Nielsen,O.*; Clavel-Chapelon,F.*; Linseisen,J.; Boeing,H.*; Trichopoulou,A.*; Trichopoulos,D.*; Kaladidi,A.*; Palli,D.*; Krogh,V.*; Tumino,R.*; Panico,S.*; Bueno-de-Mesquita,H.B.*; Peeters,P.H.*; Kumle,M.*; Gonzalez,C.A.*; Martinez,C.* u.a. DNA adducts and lung cancer risk: A prospective study. Cancer Research 65 (17) (2005) 8042-8048.

C020 Platz,E.A.*; Rohrmann,S.; Pearson,J.D.*; Corrada,M.M.*; Watson,D.J.*; De Marzo,A.M.*; Landis,P.K.*; Metter,E.J.*; Carter,H.B.* Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging. Cancer Epidemiology Biomarkers & Prevention 14 (2) (2005) 390-396.

C020 Rohrmann,S.; Crespo,C.J.*; Weber,J.R.*; Smit,E.*; Giovannucci,E.*; Platz,E.A.* Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey. Bju International 96 (1) (2005) 77-82.

C020 Rohrmann,S.; De Marzo,A.M.*; Smit,E.*; Giovannucci,E.*; Platz,E.A.* Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III). Prostate 62 (1) (2005) 27-33.

C020 Rohrmann,S.; Paltoo,D.N.*; Platz,E.A.*; Hoffman,S.C.*; Comstock,G.W.*; Helzlsouer,K.J.* Association of vasectomy and prostate cancer among men in a Maryland cohort. Cancer Causes & Control 16 (10) (2005) 1189-1194.

C020 Rohrmann,S.; Smit,E.*; Giovannucci,E.*; Platz,E.A.* Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). International Journal of Obesity 29 (3) (2005) 310-316.

C020 Ruf,T.; Nagel,G.; Altenburg,H.P.; Miller,A.B.; Thorand,B.* Food and nutrient intake, anthropometric measurements and smoking according to alcohol consumption in the EPIC Heidelberg study. Annals of Nutrition and Metabolism 49 (1) (2005) 16-25.

C020 Sausenthaler,S.*; Kompauer,I.*; Brasche,S.*; Linseisen,J.; Heinrich,J.* Sodium intake and bronchial hyperresponsiveness in adults. Respiratory Medicine 99 (7) (2005) 864-870.

C020 Schulz,M.*; Lahmann,P.H.*; Boeing,H.*; Hoffmann,K.; Allen,N.*; Key,T.J.A.*; Bingham,S.*; Wirfalt,E.*; Berglund,G.*; Lundin,E.*; Hallmans,G.*; Lukanova,A.*; Garcia,C.M.*; Gonzalez,C.A.*; Tormo,M.J.*; Quiros,J.R.*; Ardanaz,E.*; Larranaga,N.*; Lund,E.*; Gram,I.T.*; Skeie,G.*; Peeters,P.H.M.*; van Gils,C.H.*; Bueno-de-Mesquita,H.B.*; Buchner,F.L.*; Pasanisi,P.*; Galasso,R.*; Palli,D.*; Tumino,R.*; Vineis,P.* u.a. Fruit and vegetable consumption and risk of epithelial ovarian cancer: The European prospective investigation into cancer and nutrition. Cancer Epidemiology Biomarkers & Prevention 14 (11) (2005) 2531-2535.

C020 van Gils,C.H.*; Peeters,P.H.T.*; Bueno-de-Mesquita,H.B.*; Boshuizen,H.C.*; Lahmann,P.H.*; Clavel-Chapelon,F.*; Thiebaut,A.*; Kesse,E.*; Sieri,S.*; Palli,D.*; Tumino,R.*; Panico,S.*; Vineis,P.*; Gonzalez,C.A.*; Ardanaz,E.*; Sanchez,M.J.*; Amiano,P.*; Navarro,C.*; Quiros,J.R.*;

25

Key,T.J.*; Allen,N.*; Khaw,K.T.*; Bingham,S.A.*; Psaltopoulou,T.*; Koliva,M.*; Trichopoulou,A.*; Nagel,G.; Linseisen,J.; Boeing,H.*; Berglund,G.* u.a. Consumption of vegetables and fruits and risk of breast cancer. Jama-Journal of the American Medical Association 293 (2) (2005) 183-193.

C020 Verla-Tebit,E.; Chang-Claude,J. Anthropometric factors and the risk of premenopausal breast cancer in Germany. European Journal of Cancer Prevention 14 (4) (2005) 419-426.

C020 Verla-Tebit,E.; Wang-Gohrke,S.*; Chang-Claude,J. CYP17 5 '-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study. Breast Cancer Research 7 (4) (2005) R455-R464

C020 Wang-Gohrke,S.*; Chang-Claude,J. Re: Integrin beta 3 Leu33Pro homozygosity and risk of cancer. Journal of the National Cancer Institute 97 (10) (2005) 778-779.

C020 Yeomans,V.C.*; Linseisen,J.; Wolfram,G.* Interactive effects of polyphenols, tocopherol and ascorbic acid on the Cu2+-mediated oxidative modification of human low density lipoproteins. European Journal of Nutrition 44 (7) (2005) 422-428.

C030 Schlehofer,B.; Hettinger,I.; Ryan,P.*; Blettner,M.*; Preston-Martin,S.*; Little,J.*; Arslan,A.*; Ahlbom,A.*; Giles,G.G.*; Howe,G.R.*; Menegoz,F.*; Rodvall,Y.*; Choi,W.N.*; Wahrendorf,J. Occupational risk factors for low grade and high grade glioma: Results from an international case control study of adult brain tumours. International Journal of Cancer 113 (1) (2005) 116-125.

C030 Schlehofer,B.; Hettinger,I.*; Blettner,M.*; Preston-Martin,S.*; Arslan,A.*; Ahlbom,A.*; Choi,W.N.*; Gies,G.G.*; Howe,G.R.*; Little,J.*; Menegoz,F.*; Rodvall,Y.*; Ryan,P.*; Wahrendorf,J. Reply to: Occupational risk factors for low grade and high grade glioma by B. Hocking. International Journal of Cancer 116 (1) (2005) 165

C030 Steindorf,K.; Jedrychowski,W.*; Schmidt,M.; Popiela,T.*; Penar,A.*; Galas,A.*; Wahrendorf,J. Case-control study of lifetime occupational and. recreational physical activity and risks of colon and rectal cancer. European Journal of Cancer Prevention 14 (4) (2005) 363-371.

C040 Jaworski,M.*; Hailfinger,S.*; Buchmann,A.*; Hergenhahn,M.; Hollstein,M.; Ittrich,C.; Schwarz,M.* Human p53 knock-in (hupki) mice do not differ in liver tumor response from their counterparts with murine p53. Carcinogenesis 26 (10) (2005) 1829-1834. C060.

C040 Liu,Z.P.; Muehlbauer,K.R.; Schmeiser,H.H.; Hergenhahn,M.; Belharazem,D.; Hollstein,M.C. p53 mutations in benzo(a)pyrene-exposed human p53 knock-in murine fibroblasts correlate with p53 mutations in human lung tumors. Cancer Research 65 (7) (2005) 2583-2587. E080.

C040 Lleonart,M.E.*; Kirk,G.D.*; Villar,S.*; Lesi,O.A.*; Dasgupta,A.*; Goedert,J.J.*; Mendy,M.*; Hollstein,M.C.; Montesano,R.*; Groopman,J.D.*; Hainaut,P.*; Friesen,M.D.* Quantitative analysis of plasma TP53 249(Ser)-mutated DNA by electrospray ionization mass spectrometry. Cancer Epidemiology Biomarkers & Prevention 14 (12) (2005) 2956-2962.

C050 Akslen,L.A.*; Angelini,S.*; Straume,O.*; Bachmann,I.M.*; Molven,A.*; Hemminki,K.; Kumar,R. BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. Journal of Investigative Dermatology 125 (2) (2005) 312-317.

C050 Altieri,A.; Bermejo,J.L.; Hemminki,K. Familial aggregation of lymphoplasmacytic lymphoma with non-Hodgkin lymphoma and other neoplasms. Leukemia 19 (12) (2005) 2342-2343.

C050 Altieri,A.; Bermejo,J.L.; Hemminki,K. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood 106 (2) (2005) 668-672.

26

C050 Angelini,S.*; Kumar,R.; Carbone,F.*; Maffei,F.*; Forti,G.C.*; Violante,F.S.*; Lodi,V.*; Curti,S.*; Hemminki,K.; Hrelia,P.* Micronuclei in humans induced by exposure to low level of ionizing radiation: influence of polymorphisms in DNA repair genes. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 570 (1) (2005) 105-117.

C050 Bermejo,J.L.; Hemminki,K. Familial risk of cancer shortly after diagnosis of the first familial tumor. Journal of the National Cancer Institute 97 (21) (2005) 1575-1579.

C050 Bermejo,J.L.; Hemminki,K. A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA1 and BRCA2 mutations. Annals of Oncology 16 (2) (2005) 322-329.

C050 Bermejo,J.L.; Hemminki,K. Familial lung cancer and aggregation of smoking habits: A simulation of the effect of shared environmental factors on the familial risk of cancer. Cancer Epidemiology Biomarkers & Prevention 14 (7) (2005) 1738-1740.

C050 Bloethner,S.; Chen,B.W.; Hemminki,K.; Mueller-Berghaus,J.; Ugurel,S.; Schadendorf,D.; Kumar,R. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines. Carcinogenesis 26 (7) (2005) 1224-1232. D070.

C050 Brennan,P.*; Scelo,G.*; Hemminki,K.; Mellemkjaer,L.*; Tracey,E.*; Andersen,A.*; Brewster,D.H.*; Pukkala,E.*; McBride,M.L.*; Kliewer,E.V.*; Tonita,J.M.*; Seow,A.*; Pompe-Kirn,V.*; Martos,C.*; Jonasson,J.G.*; Colin,D.*; Boffetta,P.* Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. British Journal of Cancer 93 (1) (2005) 159-166.

C050 Burwinkel,B.; Wirtenberger,M.; Klaes,R.*; Schmutzler,R.K.*; Grzybowska,E.*; Foersti,A.; Frank,B.; Bermejo,J.L.; Bugert,P.*; Wappenschmidt,B.*; Butkiewicz,D.*; Pamula,J.*; Pekala,W.*; Zientek,H.*; Mielzynska,D.*; Siwinska,E.*; Bartram,C.R.*; Hemminki,K. Association of NCOA3 polymorphisms with breast cancer risk. Clinical Cancer Research 11 (6) (2005) 2169-2174.

C050 Couto,E.*; Chen,B.; Hemminki,K. Association of childhood acute lymphoblastic leukaemia with cancers in family members. British Journal of Cancer 93 (11) (2005) 1307-1309.

C050 Daugherty,S.E.*; Pfeiffer,R.M.*; Mellemkjaer,L.*; Hemminki,K.; Goldin,L.R.* No evidence for anticipation in lymphoproliferative tumors in population-based samples. Cancer Epidemiology Biomarkers & Prevention 14 (5) (2005) 1245-1250.

C050 Festa,F.*; Kumar,R.; Sanyal,S.*; Unden,B.*; Nordfors,L.*; Lindholm,B.*; Snellman,E.*; Schalling,M.*; Foersti,A.; Hemminki,K. Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 574 (1-2) (2005) 105-111.

C050 Frank,B.; Bermejo,J.L.; Hemminki,K.; Klaes,R.*; Bugert,P.*; Wappenschmidt,B.*; Schmutzler,R.K.*; Burwfnkel,B.* Association of a common variant of the CASP8 gene with reduced risk of breast cancer. Journal of the National Cancer Institute 97 (13) (2005) 1012

C050 Frank,B.; Hemminki,K.; Bermejo,J.L.; Klaes,R.*; Bugert,P.*; Wappenschmidt,B.*; Schmutzler,R.K.*; Burwinkel,B. TP53-binding protein variants and breast cancer risk: a case-control study. Breast Cancer Research 7 (4) (2005) R502-R505

C050 Frank,B.; Hemminki,K.; Shanmugam,K.S.; Meindl,A.*; Klaes,R.*; Schmutzler,R.K.*; Wappenschmidt,B.*; Untch,M.*; Bugert,P.*; Bartram,C.R.*; Burwinkel,B. Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk. Carcinogenesis 26 (11) (2005) 1975-1977.

C050 Frank,B.; Hemminki,K.; Wirtenberger,M.; Bermejo,J.L.; Bugert,P.*; Klaes,R.*; Schmutzler,R.K.*; Wappenschmidt,B.*; Bartram,C.R.*; Burwinkel,B.

27

The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk. Carcinogenesis 26 (3) (2005) 643-647.

C050 Frank,B.; Hemminki,K.; Burwinkel,B. A bias in genotyping the ERBB2 (HER2) Ile655Val variant. Carcinogenesis 26 (9) (2005) 1649

C050 Frank,B.; Klaes,R.*; Burwinkel,B. Familial cancer and ARLTS1. New England Journal of Medicine 353 (3) (2005) 313-314.

C050 Gast,A.; Foersti,A.; Soderberg,M.*; Hemminki,K.; Kumar,R. B-RAF mutations in tumors from melanoma-breast cancer families. International Journal of Cancer 113 (2) (2005) 336-337.

C050 Goldin,L.R.*; Landgren,O.*; McMaster,M.L.*; Gridley,G.*; Hemminki,K.; Li,X.J.; Mellemkjaer,L.*; Olsen,J.H.*; Linet,M.S.* Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiology Biomarkers & Prevention 14 (10) (2005) 2402-2406.

C050 Gustafsson,B.*; Angelini,S.*; Sander,B.*; Christensson,B.*; Hemminki,K.; Kumar,R. Mutations in the BRAF and N-ras genes in childhood acute lymphoblastic leukaemia. Leukemia 19 (2) (2005) 310-312.

C050 Hemminki,K.; Bermejo,J.L. Effects of screening for breast cancer on its age-incidence relationships and familial risk. International Journal of Cancer 117 (1) (2005) 145-149.

C050 Hemminki,K.; Bermejo,J.L. The impact of hormone replacement therapy on the incidence of breast cancer in Norway - Reply. Journal of Clinical Oncology 23 (15) (2005) 3637-3638.

C050 Hemminki,K.; Bermejo,J.L.; Granstroem,C.* Endometrial cancer: Population attributable risks from reproductive, familial and socioeconomic factors. European Journal of Cancer 41 (14) (2005) 2155-2159.

C050 Hemminki,K.; Chen,B. Familial risks for colorectal cancer show evidence on recessive inheritance. International Journal of Cancer 115 (5) (2005) 835-838.

C050 Hemminki,K.; Chen,B.W. Are twins at risk of cancer: Results from the Swedish family-cancer database. Twin Research and Human Genetics 8 (5) (2005) 509-514.

C050 Hemminki,K.; Chen,B.W. Familial association of prostate cancer with other cancers in the Swedish family-cancer database. Prostate 65 (2) (2005) 188-194.

C050 Hemminki,K.; Eng,C.*; Chen,B.W. Familial risks for nonmedullary thyroid cancer. Journal of Clinical Endocrinology and Metabolism 90 (10) (2005) 5747-5753.

C050 Hemminki,K.; Li,X.J. Familial risk for lung cancer by histology and age of onset: Evidence for recessive inheritance. Experimental Lung Research 31 (2) (2005) 205-215.

C050 Hemminki,K.; Li,X.J.*; Johansson,S.E.*; Sundquist,K.*; Sundquist,J.* Familial risks for migraine and other headaches among siblings based on hospitalizations in Sweden. Neurogenetics 6 (4) (2005) 217-224.

C050 Hemminki,K.; Rawal,R.*; Bermejo,J.L. Prostate cancer screening, changing age-specific incidence trends and implications on familial risk. International Journal of Cancer 113 (2) (2005) 312-315.

C050 Hemminki,K.; Scelo,G.*; Boffetta,P.*; Mellemkjaer,L.*; Tracey,E.*; Andersen,A.*; Brewster,D.H.*; Pukkala,E.*; McBride,M.*; Kliewer,E.V.*; Chia,K.S.*; Pompe-Kirn,V.*; Martos,C.*; Jonasson,J.G.*; Li,X.*; Brennan,P.* Second primary malignancies in patients with male breast cancer. British Journal of Cancer 92 (7) (2005) 1288-1292.

28

C050 Ji,J.G.*; Couto,E.*; Hemminki,K. Incidence differences for gallbladder cancer between occupational groups suggest an etiological role for alcohol. International Journal of Cancer 116 (3) (2005) 492-493.

C050 Ji,J.G.*; Granstrom,C.*; Hemminki,K. Occupation and bladder cancer: a cohort study in Sweden. British Journal of Cancer 92 (7) (2005) 1276-1278.

C050 Ji,J.G.*; Hemminki,K. Occurrences of leukemia subtypes by socioeconomic and occupational groups in Sweden. Journal of Occupational and Environmental Medicine 47 (11) (2005) 1131-1140.

C050 Ji,J.G.*; Hemminki,K. Variation in the risk for liver and gallbladder cancers in socioeconomic and occupational groups in Sweden with etiological implications. International Archives of Occupational and Environmental Health 78 (8) (2005) 641-649.

C050 Jin,Q.R.*; Hemminki,K.; Enquist,K.*; Lenner,P.*; Grzybowska,E.*; Klaes,R.*; Henriksson,R.*; Chen,B.W.; Pamula,J.*; Pekala,W.*; Zientek,H.*; Rogozinska-Szczepka,J.*; Utracka-Hutka,B.*; Hallmans,G.*; Foersti,A. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clinical Cancer Research 11 (10) (2005) 3647-3653.

C050 Kotova,N.*; Hemminki,K.; Segerback,D.* Urinary thymidine dimer as a marker of total body burden of UV-inflicted DNA damage in humans. Cancer Epidemiology Biomarkers & Prevention 14 (12) (2005) 2868-2872.

C050 Landgren,O.*; Kerstann,K.F.*; Gridley,G.*; Mellemkjaer,L.*; Hemminki,K.; Linet,M.S.*; Goldin,L.R.* Re: Familial clustering of Hodgkin lymphoma and multiple sclerosis. Journal of the National Cancer Institute 97 (7) (2005) 543-544.

C050 Li,X.J.*; Hemminki,K. Familial multiple primary lung cancers: a population-based analysis from Sweden. Lung Cancer 47 (3) (2005) 301-307.

C050 Li,Y.L.*; Karjalainen,A.*; Koskinen,H.*; Hemminki,K.; Vainio,H.*; Shnaidman,M.*; Ying,Z.L.*; Pukkala,E.*; Brandt-Rauf,P.W.* p53 autoantibodies predict subsequent development of cancer. International Journal of Cancer 114 (1) (2005) 157-160.

C050 Niesler,B.*; Frank,B.; Hebebrand,J.*; Rappold,G.* Serotonin receptor genes HTR3A and HTR3B are not involved in Gilles de la Tourette syndrome. Psychiatric Genetics 15 (4) (2005) 303-304.

C050 Nitz,I.*; Doering,F.*; Schrezenmeir,J.*; Burwinkel,B. Identification of new acyl-CoA binding protein transcripts in human and mouse. International Journal of Biochemistry & Cell Biology 37 (11) (2005) 2395-2405.

C050 Rawal,R.; Bermejo,J.L.; Hemminki,K. Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening. British Journal of Cancer 92 (1) (2005) 162-166.

C050 Ryk,C.*; Berggren,P.*; Kumar,R.; Hemminki,K.; Larsson,P.*; Steineck,G.*; Lambert,B.*; Hou,S.M.* Influence of GSTM1, GSTT1, GSTP1 and NAT2 genotypes on the p53 mutational spectrum in bladder tumours. International Journal of Cancer 113 (5) (2005) 761-768.

C050 Salvesen,H.B.*; Kumar,R.; Stefansson,I.*; Angelini,S.*; MacDonald,N.*; Smeds,J.*; Jacobs,I.J.*; Hemminki,K.; Das,S.*; Alkslen,L.A.* Low frequency of BRAF and CDKN2A mutations in endometrial cancer. International Journal of Cancer 115 (6) (2005) 930-934.

C050 Thirumaran,R.K.; Gast,A.; Flohr,T.; Burwinkel,B.; Bartram,C.; Hemminki,K.; Kumar,R. MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood 106 (7) (2005) 2590-2591.

29

C050 Tiemann,C.*; Buehrer,C.*; Burwinkel,B.; Wirtenberger,M.; Hoehn,T.*; Huebner,C.*; van Landeghem,F.K.H.*; Stoltenburg,G.*; Obladen,M.* Arthrogryposis multiplex with deafness, inguinal hernias, and early death: A family report of a probably autosomal recessive trait. American Journal of Medical Genetics Part A 137A (2) (2005) 125-129.

C050 Wagner,K.; Hemminki,K.; Israelsson,E.*; Grzybowska,E.*; Soderberg,M.*; Pamula,J.*; Pekala,W.*; Zientek,H.*; Mielzynska,D.*; Siwinska,E.*; Foersti,A. Polymorphisms in the IGF-1 and IGFBP3 promoter and the risk of breast cancer. Breast Cancer Research and Treatment 92 (2) (2005) 133-140.

C050 Wilkening,S.; Burwinkel,B.; Grzybowska,E.*; Klaes,R.*; Pamula,J.*; Pekala,W.*; Zientek,H.*; Hemminki,K.; Foersti,A. Polyglutamine repeat length in the NCOA3 does not affect risk in familial breast cancer. Cancer Epidemiology Biomarkers & Prevention 14 (1) (2005) 291-292.

C050 Wirtenberger,M.; Hemminki,K.; Chen,B.W.; Burwinkel,B. SNP microarray analysis for genome-wide detection of crossover regions. Human Genetics 117 (4) (2005) 389-397.

C050 Wirtenberger,M.; Hemminki,K.; Foersti,A.; Klaes,R.*; Schmutzler,R.K.*; Grzybowska,E.*; Bermejo,J.L.; Wappenschmidt,B.*; Bugert,P.*; Butkiewicz,D.*; Pamula,J.*; Pekala,W.*; Zientek,H.*; Bartram,C.R.*; Burwinkel,B. C-MYC Asn11Ser is associated with increased risk for familial breast cancer. International Journal of Cancer 117 (4) (2005) 638-642.

C050 Zhang,B.*; Ferrence,R.*; Cohen,J.*; Bondy,S.*; Ashley,M.J.*; Rehm,J.*; Jain,M.*; Rohan,T.*; Miller,A. Smoking cessation and lung cancer mortality in a cohort of middle-aged Canadian women. Annals of Epidemiology 15 (4) (2005) 302-309.

C055 Canzian,F.; Mckay,J.D.*; Cleveland,R.J.*; Dossus,L.*; Biessy,C.*; Boillot,C.*; Rinaldi,S.*; Llewellyn,M.*; Chajes,V.*; Clavel-Chapelon,F.*; Tehard,B.*; Chang-Claude,J.; Linseisen,J.; Lahmann,P.H.*; Pischon,T.*; Trichopoulos,D.*; Trichopoulou,A.*; Zilis,D.*; Palli,D.*; Tumino,R.*; Vineis,P.*; Berrino,F.*; Bueno-de-Mesquita,H.B.*; van Gils,C.H.*; Peeters,P.H.M.*; Pera,G.*; Barricarte,A.*; Chirlaque,M.D.*; Quiros,J.R.*; Larranaga,N.* u.a. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: Results from the European Prospective Investigation into Cancer and Nutrition Study. Cancer Epidemiology Biomarkers & Prevention 14 (10) (2005) 2316-2325. C020.

C055 Lu,Y.H.*; Gioia-Patricola,L.*; Gomez,J.V.*; Plummer,M.*; Franceschi,S.*; Kato,I.*; Canzian,F. Use of whole genome amplification to rescue DNA from plasma samples. Biotechniques 39 (4) (2005) 511-515.

C055 Monnier,S.*; Cox,D.G.*; Albion,T.*; Canzian,F. TIMS: TaqMan Information Management System, tools to organize data flow in a genotyping laboratory. BMC Bioinformatics 6 (2005)

C055 Wilkening,S.; Hemminki,K.; Thirumaran,R.K.*; Bermejo,J.L.; Bonn,S.*; Foersti,A.; Kumar,R. Determination of allele frequency in pooled DNA: comparison of three PCR-based methods. Biotechniques 39 (6) (2005) 853-858. C050.

C060 Blonski,K.*; Schumacher,U.*; Burkholder,I.; Edler,L.; Nikbakht,H.*; Boeters,I.*; Peters,A.*; Kugler,C.*; Horny,H.P.*; Langer,M.*; Wilhelm-Ogunbiyi,K.*; Witthohn,K.*; Laack,E.* Binding of recombinant mistletoe lectin (Aviscumine) to resected human adenocarcinoma of the lung. Anticancer Research 25 (5) (2005) 3303-3307.

C060 Buckowitz,A.*; Knaebel,H.P.*; Benner,A.; Blaeker,H.*; Gebert,J.*; Döberitz,M.V.*; Kloor,M.* Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. British Journal of Cancer 92 (9) (2005) 1746-1753.

C060 Cremer,F.W.*; Bila,J.*; Buck,I.*; Kartal,M.*; Hose,D.*; Ittrich,C.; Benner,A.; Raab,M.S.*; Theil,A.C.*; Moos,M.*; Goldschmidt,H.*; Bartram,C.R.*; Jauch,A.* Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on

30

interphase cytogenetics. Genes Chromosomes & Cancer 44 (2) (2005) 194-203.

C060 Cremer,F.W.*; Bouko,Y.*; Samson,D.*; Apperley,J.F.*; Thielemans,K.*; Van Camp,B.*; Benner,A.; Goldschmidt,H.*; Moos,M.*; Bakkus,M.H.C.* Response to Owen and Rawstron. British Journal of Haematology 128 (5) (2005) 733-734.

C060 Daehn,S.*; Schwalbach,P.*; Maksan,S.*; Woehleke,F.*; Benner,A.; Kuntz,C.* Influence of different gases used for laparoscopy (helium, carbon dioxide, room air, and xenon) on tumor volume, histomorphology, and leukocyte-tumor-endothelium interaction in intravital microscopy. Surgical Endoscopy and Other Interventional Techniques 19 (1) (2005) 65-70.

C060 Deichmann,M.*; Thome,M.*; Benner,A.; Kirschner,M.*; Hassanzadeh,J.*; Kurzen,H.* Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases. BMC Cancer 5 (2005)

C060 Edler,L.; Kopp-Schneider,A. Origins of the mutational origin of cancer. International Journal of Epidemiology 34 (5) (2005) 1168-1170.

C060 Findeisen,P.*; Kloor,M.*; Merx,S.*; Sutter,C.*; Woerner,S.M.*; Dostmann,N.*; Benner,A.; Dondog,B.; Pawlita,M.; Dippold,W.; Wagner,R.*; Gebert,J.*; Döberitz,M.V.* T-25 repeat in the 3 ' untranslated region of the CASP2 gene: A sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Research 65 (18) (2005) 8072-8078. F020.

C060 Gerull,S.*; Goerner,M.*; Benner,A.; Hegenbart,U.*; Klein,U.*; Schaefer,H.*; Goldschmidt,H.*; Ho,A.D.* Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma. Bone Marrow Transplantation 36 (11) (2005) 963-969.

C060 Gnad-Vogt,S.U.*; Hofheinz,R.D.*; Saussele,S.*; Kreil,S.*; Willer,A.*; Willeke,F.*; Pilz,L.; Hehlmann,R.*; Hochhaus,A.* Pegylated liposomal doxorubicin and mitomycin C in combination with infusional 5-fluorouracil and sodium folinic acid in the treatment of advanced gastric cancer: results of a phase II trial. Anti-Cancer Drugs 16 (4) (2005) 435-440.

C060 Goern,M.*; Anige,M.*; Burkholder,I.; Mueller,B.*; Scheffler,A.*; Edler,L.; Boeters,I.*; Panse,J.*; Schuch,G.*; Hossfeld,D.K.*; Laack,E.* Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC). Lung Cancer 49 (1) (2005) 71-76.

C060 Hofheinz,R.D.*; Gnad-Vogt,U.*; Wein,A.*; Saussele,S.*; Kreil,S.*; Pilz,L.; Hehlmann,R.*; Hochhaus,A.* Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study. Anti-Cancer Drugs 16 (1) (2005) 39-45.

C060 Ittrich,C. Normalization for two-channel microarray data. Methods of Information in Medicine 44 (3) (2005) 418-422.

C060 Ittrich,C.; Richter,W.D.* Exact tests and confidence regions in nonlinear regression. Statistics 39 (1) (2005) 13-42.

C060 Kienle,D.L.*; Korz,C.*; Hosch,B.*; Benner,A.; Mertens,D.; Habermann,A.*; Krober,A.*; Jadger,U.*; Lichter,P.; Dohner,H.*; Stilgenbauer,S.* Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes. Journal of Clinical Oncology 23 (16) (2005) 3780-3792. B060.

31

C060 Kienle,P.*; Z'graggen,K.*; Schmidt,J.*; Benner,A.; Weitz,J.*; Büchler,M.W.* Laparoscopic restorative proctocolectomy. British Journal of Surgery 92 (1) (2005) 88-93.

C060 Kirschner,M.*; Helmke,B.*; Starz,H.*; Benner,A.; Thome,M.*; Deichmann,M.* Preponderance of the oncogenic V599E and V599K mutations in the B-raf kinase domain is enhanced in melanoma lymph node metastases. Melanoma Research 15 (5) (2005) 427-434.

C060 Kloor,M.*; Becker,C.*; Benner,A.; Woerner,S.M.*; Gebert,J.*; Ferrone,S.; Döberitz,M.V.* Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. Cancer Research 65 (14) (2005) 6418-6424.

C060 Laack,E.*; Andritzky,B.*; Durk,H.*; Burkholder,I.; Edler,L.; Schuch,G.*; Boeters,I.*; Gorn,M.*; Lipp,R.*; Horst,H.*; Popp,J.*; Hossfeld,D.K.* Docetaxel and cisplatin as first-line treatment for patients with metastatic esophageal cancer: A pilot study. Onkologie 28 (12) (2005) 647-650.

C060 Laack,E.*; Scheffler,A.*; Burkholder,I.; Boeters,I.*; Andritzky,B.*; Schuch,G.*; Goern,M.*; Vohwinkel,G.*; Edler,L.; Fiedler,W.*; Hossfeld,D.K.* Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC). Lung Cancer 50 (1) (2005) 51-58.

C060 Oberemm,A.*; Meckert,C.*; Brandenburger,L.*; Herzig,A.*; Lindner,Y.*; Kalenberg,K.*; Krause,E.*; Ittrich,C.; Kopp-Schneider,A.; Stahlmann,R.*; Richter-Reichhelm,H.B.*; Gundert-Remy,U.* Differential signatures of protein expression in marmoset liver and thymus induced by single-dose TCDD treatment. Toxicology 206 (1) (2005) 33-48.

C060 Rashid,M.U.*; Jakubowska,A.*; Justenhoven,C.*; Harth,V.*; Pesch,B.*; Baisch,C.*; Pierl,C.B.*; Bruning,T.*; Ko,Y.*; Benner,A.; Wichmann,H.E.*; Rauch,H.*; Hamann,U. German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer. European Journal of Cancer 41 (18) (2005) 2896-2903. B055.

C060 Schlenk,R.F.*; Germing,U.*; Hartmann,F.*; Glasmacher,A.*; Fischer,J.T.*; Fuentes,F.D.Y.*; Gotze,K.*; Pralle,H.*; Nerl,C.*; Salwender,H.*; Grimminger,W.*; Petzer,A.*; Hensel,M.*; Benner,A.; Zick,L.*; Doehner,K.*; Frohling,S.*; Döhner,H.* High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia 19 (6) (2005) 978-983.

C060 Schoenberg,S.O.*; Rieger,J.*; Weber,C.H.*; Michaely,H.J.*; Waggershauser,T.*; Ittrich,C.; Dietrich,O.*; Reiser,M.F.* High-spatial-resolution MR angiography of renal arteries with integrated parallel acquisitions: Comparison with digital subtraction angiography and US. Radiology 235 (2) (2005) 687-698.

C060 Stahl,S.*; Ittrich,C.; Marx-Stoelting,P.*; Koehle,C.*; Altug-Teber,O.*; Riess,O.*; Bonin,M.*; Jobst,J.*; Kaiser,S.*; Buchmann,A.*; Schwarz,M.* Genotype-phenotype relationships in hepatocellular tumors from mice and man. Hepatology 42 (2) (2005) 353-361.

C060 Stahl,S.*; Ittrich,C.; Marx-Stoelting,P.*; Kohle,C.*; Ott,T.*; Buchmann,A.*; Schwarz,M.* Effect of the tumor promoter phenobarbital on the pattern of global gene expression in liver of connexin32-wild-type and connexin32-deficient mice. International Journal of Cancer 115 (6) (2005) 861-869.

Forschungsschwerpunkt D D010 Adams,Y.*; Smith,S.L.*; Schwartz-Albiez,R.; Andrews,K.T.*

Carrageenans inhibit the in vitro growth of Plasmodium falciparum and cytoadhesion to CD36. Parasitology Research 97 (4) (2005) 290-294.

D010 Andrews,K.T.*; Adams,Y.*; Viebig,N.K.*; Lanzer,M.*; Schwartz-Albiez,R. Adherence of Plasmodium falciparum infected erythrocytes to CHO-745 cells and inhibition of

32

binding by protein A in the presence of human serum. International Journal for Parasitology 35 (10) (2005) 1127-1134.

D010 Andrews,K.T.*; Klatt,N.*; Adams,Y.*; Mischnick,P.*; Schwartz-Albiez,R. Inhibition of chondroitin-4-sulfate-specific adhesion of Plasmodium falciparum-infected erythrocytes by sulfated polysaccharides. Infection and Immunity 73 (7) (2005) 4288-4294.

D010 Beckhove,P.; Helmke,B.M.*; Ziouta,Y.; Bucur,M.; Dorner,W.*; Mogler,C.*; Dyckhoff,G.*; Herold-Mende,C.* Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis. Clinical Cancer Research 11 (8) (2005) 2899-2906.

D010 Bian,H.J.*; Fournier,P.; Moormann,R.*; Peeters,B.*; Schirrmacher,V. Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus. Cancer Gene Therapy 12 (3) (2005) 295-303.

D010 Bian,H.J.*; Fournier,P.; Moormann,R.*; Peeters,B.*; Schirrmacher,V. Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein. International Journal of Oncology 26 (2) (2005) 431-439.

D010 Bian,H.J.*; Fournier,P.; Peeters,B.*; Schirrmacher,V. Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein. International Journal of Oncology 27 (2) (2005) 377-384.

D010 Chlichlia,K.*; Schirrmacher,V.; Sandaltzopoulos,R. Cancer Immunotherapy: Battling tumors with gene vaccines. Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents 4 (2005) 353-365.

D010 Choi,C.*; Witzens,M.*; Bucur,M.; Feuerer,M.*; Sommerfeldt,N.*; Trojan,A.; Ho,A.; Schirrmacher,V.; Goldschmidt,H.; Beckhove,P. Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma. Blood 105 (5) (2005) 2132-2134. E160.

D010 Gast,D.; Riedle,S.; Schabath,H.; Schlich,S.; Schneider,A.; Issa,Y.; Stoeck,A.; Fogel,M.*; Joumaa,S.; Wenger,T.; Herr,I.; Gutwein,P.; Altevogt,P. L1 augments cell migration and tumor growth but not beta 3 integrin expression in ovarian carcinomas. International Journal of Cancer 115 (4) (2005) 658-665. E095.

D010 Gavert,N.*; Conacci-Sorrell,M.*; Gast,D.; Schneider,A.; Altevogt,P.; Brabletz,T.*; Ben Ze'ev,A.* L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. Journal of Cell Biology 168 (4) (2005) 633-642.

D010 Gutwein,P.; Stoeck,A.; Riedle,S.; Gast,D.; Runz,S.; Condon,T.P.*; Marme,A.*; Phong,M.C.*; Linderkamp,O.*; Skorokhod,A.; Altevogt,P. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clinical Cancer Research 11 (7) (2005) 2492-2501.

D010 Haas,C.; Lulei,M.; Fournier,P.; Arnold,A.; Schirrmacher,V. A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes. International Journal of Cancer 118 (3) (2006) 658-667.

D010 Haas,C.; Lulei,M.; Fournier,P.; Arnold,A.; Schirrmacher,V. T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine. Vaccine 23 (19) (2005) 2439-2453.

D010 Herold-Mende,C.*; Karcher,J.*; Dyckhoff,G.*; Schirrmacher,V. Anti-tumor immunization of HNSCC patients with a virus-modified autologous tumor cell vaccine. Current Research in Head and Neck Cancer Adv Otorhinolaryngol 62 (2005) 173-183.

D010 Karagianni,N.*; Ly,M.C.*; Psarras,S.*; Chlichlia,K.; Schirrmacher,V.; Gounari,F.*; Khazaie,K.* Novel adenomatous polyposis coli gene promoter is located 40 kb upstream of the initiating

33

methionine. Genomics 85 (2) (2005) 231-237.

D010 Mahnke,Y.D.; Schwendemann,J.; Beckhove,P.; Schirrmacher,V. Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells. Immunology 115 (3) (2005) 325-336.

D010 Maretzky,T.*; Schulte,M.*; Ludwig,A.*; Rose-John,S.*; Blobel,C.*; Hartmann,D.*; Altevogt,P.; Saftig,P.*; Reiss,K.* L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Molecular and Cellular Biology 25 (20) (2005) 9040-9053.

D010 Schirrmacher,V. Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory. Cancer Immunology Immunotherapy 54 (6) (2005) 587-598.

D010 Schirrmacher,V. T cell-mediated immunotherapy of metastases: state of the art in 2005. Expert Opinion on Biological Therapy 5 (8) (2005) 1051-1068.

D010 Schirrmacher,V.; Beckhove,P.; Choi,C.; Griesbach,A.; Mahnke,Y. Tumor-immune memory T cells from the bone marrow exert GvL without GvH reactivity in advanced metastasized cancer. International Journal of Oncology 27 (4) (2005) 1141-1149.

D010 Schmitz-Winnenthal,F.H.*; Volk,C.*; Z'graggen,K.*; Galindo,L.*; Nummer,D.; Ziouta,Y.; Bucur,M.; Weitz,J.*; Schirrmacher,V.; Büchler,M.W.*; Beckhove,P. High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients. Cancer Research 65 (21) (2005) 10079-10087.

D010 Schwendemann,J.; Choi,C.; Schirrmacher,V.; Beckhove,P. Dynamic differentiation of activated human peripheral blood CD8(+) and CD4(+) effector memory T cells. Journal of Immunology 175 (3) (2005) 1433-1439.

D010 Weichert,W.*; Denkert,C.*; Burkhardt,M.*; Gansukh,T.*; Bellach,J.*; Altevogt,P.; Dietel,M.*; Kristiansen,G.* Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clinical Cancer Research 11 (18) (2005) 6574-6581.

D010 Zola,H.*; Swart,B.*; Nicholson,I.*; Aasted,B.*; Bensussan,A.*; Boumsell,L.*; Buckley,C.*; Clark,G.*; Drbal,K.*; Engel,P.*; Hart,D.*; Horejsi,V.*; Isacke,C.*; Macardle,P.*; Malavasi,F.*; Mason,D.*; Olive,D.*; Saalmueller,A.*; Schlossman,S.F.*; Schwartz-Albiez,R.; Simmons,P.*; Tedder,T.F.*; Uguccioni,M.*; Warren,H.* CD molecules 2005: human cell differentiation molecules. Blood 106 (9) (2005) 3123-3126.

D020 Bonaterra,G.A.*; Hildebrandt,W.; Bodens,A.*; Sauer,R.*; Dugi,K.A.*; Deigner,H.P.*; Dröge,W.; Metz,J.*; Kinscherf,R.* Increased cyclooxygenase-2 expression in peripheral blood mononuclear cells of smokers and hyperlipidemic subjects. Free Radical Biology and Medicine 38 (2) (2005) 235-242.

D020 Dröge,W. Oxidative aging and insulin receptor signaling. Journals of Gerontology Series A-Biological Sciences and Medical Sciences 60 (11) (2005) 1378-1385.

D020 Dröge,W. Oxidative enhancement of insulin receptor signaling: Experimental findings and clinical implications. Antioxidants & Redox Signaling 7 (7-8) (2005) 1071-1077.

D020 Dröge,W. Oxidative stress and ageing: is ageing a cysteine deficiency syndrome?

34

Philosophical Transactions of the Royal Society B-Biological Sciences 360 (1464) (2005) 2355-2372.

D020 Martignoni,M.E.*; Kunze,P.*; Hildebrandt,W.; Kunzli,B.*; Berberat,P.*; Giese,T.*; Kloeters,O.*; Hammer,J.*; Büchler,M.W.*; Giese,N.A.*; Friess,H.* Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia. Clinical Cancer Research 11 (16) (2005) 5802-5808.

D020 Schmitt,T.L.; Hotz-Wagenblatt,A.; Klein,H.*; Dröge,W. Interdependent regulation of insulin receptor kinase activity by ADP and hydrogen peroxide. Journal of Biological Chemistry 280 (5) (2005) 3795-3801. B020.

D030 Arnold,R.; Patzak,I.M.*; Neuhaus,B.*; Vancauwenbergh,S.*; Veillette,A.*; Van Lint,J.*; Kiefer,F.* Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1. Molecular and Cellular Biology 25 (6) (2005) 2364-2383.

D030 Baumann,S.; Dostert,A.*; Novac,N.*; Bauer,A.*; Schmid,W.; Fas,S.C.; Krueger,A.; Heinzel,T.*; Kirchhoff,S.*; Schütz,G.; Krammer,P.H. Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer. Blood 106 (2) (2005) 617-625. A020.

D030 Beier,C.P.*; Wischhusen,J.R.R.*; Gleichmann,M.*; Gerhardt,E.*; Pekanovic,A.*; Krueger,A.; Taylor,V.*; Suter,U.*; Krammer,P.H.; Endres,M.*; Weller,M.*; Schulz,J.B.* FasL (CD95L/APO-1L) resistance of neurons mediated by phosphatidylinositol 3-kinase-Akt protein kinase B-dependent expression of lifeguard/neuronal membrane protein. Journal of Neuroscience 25 (29) (2005) 6765-6774.

D030 Bernhard,M.*; Gries,A.*; Kremer,R.*; Martin-Villalba,A.; Boettiger,B.W.* Prehospital management of spinal cord injuries. Anaesthesist 54 (4) (2005) 357-376.

D030 Brenner,D.; Golks,A.; Kiefer,F.*; Krammer,P.H.; Arnold,R. Activation or suppression of NF kappa B by HPK1 determines sensitivity to activation-induced cell death. Embo Journal 24 (24) (2005) 4279-4290.

D030 Fritzsching,B.; Oberle,N.; Eberhardt,N.; Quick,S.; Haas,J.*; Wildemann,B.*; Krammer,P.H.; Suri-Payer,E. Cutting edge: In contrast to effector T cells, CD4(+)CD25(+) FoxP3(+) regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. Journal of Immunology 175 (1) (2005) 32-36.

D030 Golks,A.; Brenner,D.; Fritsch,C.; Krammer,P.H.; Lavrik,I.N. c-FLIPR, a new regulator of death receptor-induced apoptosis. Journal of Biological Chemistry 280 (15) (2005) 14507-14513.

D030 Golks,A.; Brenner,D.; Schmitz,I.*; Watzl,C.*; Krueger,A.*; Krammer,P.H.; Lavrik,I.N. The role of CAP3 in CD95 signaling: new insights into the mechanism of procaspase-8 activation. Cell Death and Differentiation 13 (3) (2006) 489-498.

D030 Gressner,O.*; Schilling,T.*; Lorenz,K.*; Schleithoff,E.S.*; Koch,A.*; Schulze-Bergkamen,H.; Lena,A.M.*; Candi,E.*; Terrinoni,A.*; Catani,M.V.*; Oren,M.*; Melino,G.*; Krammer,P.H.; Stremmel,W.*; Mueller,M.* TAp63 alpha induces apoptosis by activating signaling via death receptors and mitochondria. Embo Journal 24 (13) (2005) 2458-2471.

D030 Guelow,K.; Kaminski,M.; Darvas,K.; Suess,D.; Li-Weber,M.; Krammer,P.H. HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death. Journal of Immunology 174 (9) (2005) 5249-5260.

D030 Haas,J.*; Hug,A.*; Viehover,A.*; Fritzsching,B.; Falk,C.S.*; Filser,A.*; Vetter,T.*; Milkova,L.*; Korporal,M.*; Fritz,B.*; Storch-Hagenlocher,B.*; Krammer,P.H.*; Suri-Payer,E.; Wildemann,B.* Reduced suppressive effect of CD4(+)CD25(high) regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. European Journal of Immunology 35 (11) (2005) 3343-3352.

D030 Herzer,K.; Weyer,S.*; Krammer,P.H.; Galle,P.R.*; Hofmann,T.G. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in

35

human hepatoma cells. Cancer Research 65 (23) (2005) 10830-10837. F080.

D030 Igney,F.H.; Behrens,C.K.; Krammer,P.H. CD95L mediates tumor counterattack in vitro but induces neutrophil-independent tumor rejection in vivo. International Journal of Cancer 113 (1) (2005) 78-87.

D030 Igney,F.H.; Krammer,P.H. Tumor counterattack: fact or fiction? Cancer Immunology Immunotherapy 54 (11) (2005) 1127-1136.

D030 Klussmann,S.; Martin-Villalba,A. Molecular targets in spinal cord injury. Journal of Molecular Medicine-Jmm 83 (9) (2005) 657-671.

D030 Lavrik,I.; Golks,A.; Krammer,P.H. Death receptor signaling. Journal of Cell Science 118 (2) (2005) 265-267.

D030 Lavrik,I.N.; Golks,A.; Krammer,P.H. Caspases: pharmacological manipulation of cell death. Journal of Clinical Investigation 115 (10) (2005) 2665-2672.

D030 Li-Weber,M.; Palfi,K.; Giaisi,M.; Krammer,P.H. Dual role of the anti-inflammatory sesquiterpene lactone: regulation of life and death by parthenolide. Cell Death and Differentiation 12 (4) (2005) 408-409.

D030 Li-Weber,M.; Treiber,M.K.; Giaisi,M.; Palfi,K.; Stephan,N.; Parg,S.; Krammer,P.H. Ultraviolet irradiation suppresses T cell activation via blocking TCR-mediated ERK and NF-kappa B signaling pathways. Journal of Immunology 175 (4) (2005) 2132-2143.

D030 Lundgren,A.*; Stromberg,E.*; Sjoling,A.*; Lindholm,C.*; Enarsson,K.*; Edebo,A.*; Johnsson,E.*; Suri-Payer,E.; Larsson,P.*; Rudin,A.*; Svennerholm,A.M.*; Lundin,B.S.* Mucosal FOXP3-expressing CD4(+) CD25(high) regulatory T cells in Helicobacter pylori-infected patients. Infection and Immunity 73 (1) (2005) 523-531.

D030 Mueller,M.*; Schilling,T.*; Sayan,A.E.*; Kairat,A.*; Lorenz,K.*; Schulze-Bergkamen,H.; Oren,M.*; Koch,A.*; Tannapfel,A.*; Stremmel,W.*; Melino,G.*; Krammer,P.H. TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death and Differentiation 12 (12) (2005) 1564-1577.

D030 Proksch,P.*; Giaisi,M.; Treiber,M.K.*; Palfi,K.*; Merling,A.; Spring,H.; Krammer,P.H.; Min,L.W. Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells. Journal of Immunology 174 (11) (2005) 7075-7084. A120.

D030 Ramadan,S.*; Terrinoni,A.*; Catani,M.V.*; Sayan,A.E.*; Knight,R.A.*; Mueller,M.*; Krammer,P.H.; Melino,G.*; Candi,E.* p73 induces apoptosis by different mechanisms. Biochemical and Biophysical Research Communications 331 (3) (2005) 713-717.

D030 Wing,K.*; Larsson,P.*; Sandstroem,K.*; Lundin,S.B.*; Suri-Payer,E.; Rudin,A.* CD4(+)CD25(+) FOXP3(+) regulatory T cells from human thymus and cord blood suppress antigen-specific T cell responses. Immunology 115 (4) (2005) 516-525.

D030 Wing,K.*; Suri-Payer,E.; Rudin,A.* CD4(+)CD25(+)-regulatory T cells from mouse to man. Scandinavian Journal of Immunology 62 (1) (2005) 1-15.

D030 Zuliani,C.; Kleber,S.; Klussmann,S.; Wenger,T.; Kenzelmann,M.; Schreglmann,N.; Martinez,A.*; del Rio,J.A.*; Soriano,E.*; Vodrazka,P.*; Kuner,R.*; Gröne,H.J.; Herr,I.; Krammer,P.H.; Martin-Villalba,A. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death and Differentiation 13 (1) (2006) 31-40. E095. E090.

36

D040 Ganten,T.M.; Koschny,R.; Haas,T.L.; Sykora,J.; Li-Weber,N.; Herzer,K.; Walczak,H. Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL. Hepatology 42 (3) (2005) 588-597. D030.

D040 Herzer,K.; Ganten,T.M.; Schulze-Bergkamen,H.; Grosse-Wilde,A.; Koschny,R.; Krammer,P.H.; Walczak,H. Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells. Hepatology 42 (1) (2005) 183-192. D030.

D050 Arnold,B.; Schueler,T.; Hämmerling,G.J. Control of peripheral T-lymphocyte tolerance in neonates and adults. Trends in Immunology 26 (8) (2005) 406-411.

D050 Berger,M.; Bergers,G.*; Arnold,B.; Hämmerling,G.J.; Ganss,R. Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood 105 (3) (2005) 1094-1101.

D050 Bierhaus,A.*; Humpert,P.M.*; Morcos,M.*; Wendt,T.*; Chavakis,T.*; Arnold,B.; Stern,D.M.*; Nawroth,P.P.* Understanding RAGE, the receptor for advanced glycation end products. Journal of Molecular Medicine-Jmm 83 (11) (2005) 876-886.

D050 Bierhaus,A.*; Humpert,P.M.*; Stern,D.M.*; Arnold,B.; Nawroth,P.P.* Advanced glycation end product receptor - Mediated cellular dysfunction. Maillard Reaction: Chemistry at the Interface of Nutrition, Aging, and Disease 1043 (2005) 676-680.

D050 Chang,S.C.*; Momburg,F.; Bhutani,N.*; Goldberg,A.L.* The ER aminopeptidase, ERAN1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism. Proceedings of the National Academy of Sciences of the United States of America 102 (47) (2005) 17107-17112.

D050 Dumitriu,I.E.*; Baruah,P.*; Valentinis,B.*; Voll,R.E.*; Herrmann,M.*; Nawroth,P.P.*; Arnold,B.; Bianchi,M.E.*; Manfredi,A.A.*; Rovere-Querini,P.* Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. Journal of Immunology 174 (12) (2005) 7506-7515.

D050 Garbi,N.; Tanaka,S.*; van den Broek,M.*; Momburg,F.; Hämmerling,G.J. Accessory molecules in the assembly of major histocompatibility complex class I/peptide complexes: how essential are they for CD8(+) T-cell immune responses? Immunological Reviews 207 (2005) 77-88.

D050 Hoepken,U.E.*; Lehmann,I.*; Droese,J.*; Lipp,M.*; Schueler,T.; Rehm,A.* The ratio between dendritic cells and T cells determines the outcome of their encounter: Proliferation versus deletion. European Journal of Immunology 35 (10) (2005) 2851-2863.

D050 Itoh,K.*; Fushiki,S.*; Kamiguchi,H.*; Arnold,B.; Altevogt,P.; Lemmon,V.* Disrupted Schwann cell-axon interactions in peripheral nerves of mice with altered L1-integrin interactions. Molecular and Cellular Neuroscience 30 (1) (2005) 131-136. D010.

D050 Kammertoens,T.*; Schueler,T.; Blankenstein,T.* Immunotherapy: target the stroma to hit the tumor. Trends in Molecular Medicine 11 (5) (2005) 225-231.

D050 Kokkola,R.*; Andersson,A.*; Mullins,G.*; Oestberg,T.*; Treutiger,C.J.*; Arnold,B.; Nawroth,P.; Andersson,U.*; Harris,R.A.*; Harris,H.E.* RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scandinavian Journal of Immunology 61 (1) (2005) 1-9. E160.

D050 Limmer,A.*; Ganss,R.; Garbi,N.; Arnold,B.; Hämmerling,G.J. Stimulation of autoimmunity by toll-like receptor ligands. Annals of the Rheumatic Diseases 64 (2005) 15-17.

37

D050 Limmer,A.*; Ohl,J.*; Wingender,G.*; Berg,M.*; Juengerkes,F.*; Schumak,B.*; Djandji,D.*; Scholz,K.*; Klevenz,A.; Hegenbarth,S.*; Momburg,F.; Hämmerling,G.J.; Arnold,B.; Knolle,P.A.* Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance. European Journal of Immunology 35 (10) (2005) 2970-2981.

D050 Schmetzer,O.*; Moldenhauer,G.; Riesenberg,R.*; Pires,J.R.*; Schlag,P.*; Pezzutto,A.* Quality of recombinant protein determines the amount of autoreactivity detected against the tumor-associated epithelial cell adhesion molecule antigen: Low frequency of antibodies against the natural protein. Journal of Immunology 174 (2) (2005) 942-952.

D060 Amtmann,E.; Zöller,M. Stimulation of CD95-induced apoptosis in T-cells by a subtype specific neutral sphingomyelinase inhibitor. Biochemical Pharmacology 69 (8) (2005) 1141-1148.

D060 Claas,C.; Wahl,J.; Orlicky,D.J.*; Karaduman,H.; Schnölzer,M.; Kempf,T.; Zöller,M. The tetraspanin D6.1A and its molecular partners on rat carcinoma cells. Biochemical Journal 389 (2005) 99-110. F030. B100.

D060 Devitt,G.; Meyer,C.; Wiedemann,N.; Eichmüller,S.; Kopp-Schneider,A.; Haferkamp,A.*; Hautmann,R.*; Zöller,M. Serological analysis of human renal cell carcinoma International Journal of Cancer 2005 Dec 5; [Epub ahead of print] D070, C060.

D060 Freyschmidt-Paul,P.*; McElwee,K.J.*; Hoffmann,R.*; Sundberg,J.P.*; Kissling,S.*; Hummel,S.; Vitacolonna,M.; Kopp-Schneider,A.; Zöller,M. Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H/HeJ mice. Journal of Investigative Dermatology 125 (5) (2005) 945-951. C060.

D060 Freyschmidt-Paul,P.*; Zöller,M.; McElwee,K.J.*; Sundberg,J.P.*; Happle,R.*; Hoffmann,R.* The functional relevance of the type ! cytokines IFN-gamma and IL-2 in alopecia areata of C3H/HeJ mice. Journal of Investigative Dermatology Symp. Proc. 10 (3) (2005) 282-283.

D060 Friebolin,W.; Schilling,G.*; Zöller,M.; Amtmann,E. Antitumoral activity of non-platinum xanthate complexes. Journal of Medicinal Chemistry 48 (25) (2005) 7925-7931.

D060 Gesierich,S.; Paret,C.; Hildebrand,D.; Weitz,J.*; Zgraggen,K.*; Schmitz-Winnenthal,F.H.*; Horejsi,V.*; Yoshie,O.*; Herlyn,D.*; Ashman,L.K.*; Zöller,M. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: Impact on cell motility. Clinical Cancer Research 11 (8) (2005) 2840-2852.

D060 Hummel,S.; Apte,R.N.*; Qimron,U.*; Vitacolonna,M.; Porgador,A.*; Zöller,M. Tumor vaccination by Salmonella typhimurium after transformation with a eukaryotic expression vector in mice - Impact of a Salmonella typhimurium gene interfering with MHC class I presentation. Journal of Immunotherapy 28 (5) (2005) 467-479.

D060 Ladwein,M.; Pape,U.F.; Schmidt,D.S.; Schnölzer,M.; Fiedler,S.; Langbein,L.; Franke,W.W.; Moldenhauer,G.; Zöller,M. The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7. Experimental Cell Research 309 (2) (2005) 345-357. A010. B100. D050.

D060 Marhaba,R.; Bourouba,M.; Zöller,M. CD44v6 promotes proliferation by persisting activation of MAP kinases. Cellular Signalling 17 (8) (2005) 961-973.

D060 McElwee,K.J.*; Freyschmidt-Paul,P.*; Hoffmann,R.*; Kissling,S.*; Hummel,S.; Vitacolonna,M.; Zöller,M. Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model. Journal of Investigative Dermatology 124 (5) (2005) 947-957.

38

D060 McElwee,K.J.*; Zöller,M.; Freyschmidt-Paul,P.*; Hoffmann,R.* Regulatory T cells in autoimmune diseases and their potential. Journal of Investigative Dermatology Symp. Proc. 10 (3) (2005) 280-281.

D060 Millet,R.*; Urig,S.*; Jacob,J.*; Amtmann,E.; Moulinoux,J.P.*; Gromer,S.*; Becker,K.*; Davioud-Charvet,E.* Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors. Journal of Medicinal Chemistry 48 (22) (2005) 7024-7039.

D060 Oehlrich,N.; Devitt,G.; Linnebacher,M.*; Schwitalle,Y.*; Grosskinski,S.; Stevanovic,S.*; Zöller,M. Generation of RAGE-1 and MAGE-9 peptide-specific cytotoxic T-lymphocyte lines for transfer in patients with renal cell carcinoma. International Journal of Cancer 117 (2) (2005) 256-264.

D060 Paret,C.; Bourouba,M.; Beer,A.; Miyazaki,K.*; Schnölzer,M.; Fiedler,S.; Zöller,M. Ly6 family member C4.4A binds laminins 1 and 5, associates with galectin-3 and supports cell migration. International Journal of Cancer 115 (5) (2005) 724-733. B100.

D060 Tarbe,N.G.*; Rio,M.C.*; Hummel,S.; Weidle,U.H.*; Zöller,M. Overexpression of the small transmembrane and glycosylated protein SMAGP supports metastasis formation of a rat pancreatic adenocarcinoma line. International Journal of Cancer 117 (6) (2005) 913-922.

D070 Hartmann,T.B.; Bazhin,A.V.; Schadendorf,D.; Eichmüller,S.B. SEREX identification of new tumor antigens linked to melanoma-associated retinopathy. International Journal of Cancer 114 (1) (2005) 88-93.

D070 Kaufmann,R.; Spieth,K.*; Leiter,U.*; Mauch,C.*; den Driesch,P.*; Vogt,T.*; Linse,R.*; Tilgen,W.*; Schadendorf,D.; Becker,J.C.*; Sebastian,G.*; Krengel,S.*; Kretschmer,L.*; Garbe,C.*; Dummer,R.* Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: A randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group. Journal of Clinical Oncology 23 (35) (2005) 9001-9007.

D070 Keilholz,U.*; Punt,C.J.A.*; Gore,M.*; Kruit,W.*; Patel,P.*; Lienard,D.*; Thomas,J.*; Proebstle,T.M.*; Schmittel,A.*; Schadendorf,D.; Velu,T.*; Negrier,S.*; Kleeberg,U.*; Lehman,F.*; Suciu,S.*; Eggermont,A.M.M.* European OrganisationDacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: A randomized phase III trial (18951) of the for Research and Treatment of Cancer Melanoma Group. Journal of Clinical Oncology 23 (27) (2005) 6747-6755.

D070 Mian,S.*; Ugurel,S.; Parkinson,E.*; Schlenzka,I.*; Dryden,I.*; Lancashire,L.*; Ball,G.*; Creaser,C.*; Rees,R.*; Schadendorf,D. Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. Journal of Clinical Oncology 23 (22) (2005) 5088-5093.

D070 Mueller-Berghaus,J.; Olson,W.C.*; Moulton,R.A.*; Knapp,W.T.*; Schadendorf,D.; Storkus,W.J.* IL-12 production by human monocyte-derived dendritic cells - Looking at the single cell. Journal of Immunotherapy 28 (4) (2005) 306-313.

D070 Paschen,A.; Song,M.X.; Osen,W.; Nguyen,X.D.*; Berghaus,J.M.; Fink,D.*; Daniel,N.*; Donzeau,M.*; Nagel,W.*; Kropshofer,H.*; Schadendorf,D. Detection of spontaneous CD4(+) T-Cell responses in melanoma patients against a tyrosinase-related protein-2-derived epitope identified in HLA-DRB1*0301 transgenic mice. Clinical Cancer Research 11 (14) (2005) 5241-5247.

D070 Paschen,A.*; Jing,W.Q.; Drexler,I.*; Klemm,M.*; Song,M.X.; Mueller-Berghaus,J.; Nguyen,X.D.*; Osen,W.; Stevanovic,S.*; Sutter,G.*; Schadendorf,D. Melanoma patients respond to a new HLA-A*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2. International Journal of Cancer 116 (6) (2005) 944-948.

39

D070 Roeckmann,H.; Schadendorf,D. Role of Apaf-1 in melanoma drug resistance and apoptosis. Journal of Investigative Dermatology 125 (2) (2005) 386-387.

D070 Roehn,T.A.; Schadendorf,D.; Sun,Y.S.*; Nguyen,X.D.*; Roeder,D.*; Langen,H.*; Vogt,A.B.*; Kropshofer,H.* Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells. European Journal of Immunology 35 (10) (2005) 2826-2839.

D070 Rohn,T.A.*; Reitz,A.; Paschen,A.; Nguyen,X.D.*; Schadendorf,D.; Vogt,A.B.*; Kropshofer,H.* A novel strategy for the discovery of MHC class II-restricted tumor antigens: Identification of a melanotransferrin helper T-cell epitope. Cancer Research 65 (21) (2005) 10068-10078.

D070 Stenzel,W.*; Soltek,S.; Miletic,H.*; Hermann,M.M.*; Korner,H.*; Sedgwick,J.D.*; Schluter,D.*; Deckert,M.* An essential role for tumor necrosis factor in the formation of experimental murine Staphylococcus aureus-induced brain abscess and clearance. Journal of Neuropathology and Experimental Neurology 64 (1) (2005) 27-36.

D070 Sun,Y.S.*; Song,M.X.; Schwantes,A.*; Kirkpatrick,C.J.*; Schadendorf,D.; Cichutek,K.* The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes Blood. 2005 Oct 18; [Epub ahead of print]

D070 Ugurel,S. Serum markers for melanoma. Hautarzt 56 (2) (2005) 173-184.

D070 Ugurel,S.; Bell,N.; Sucker,A.; Zimpfer,A.; Rittgen,W.; Schadendorf,D. Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma. International Journal of Cancer 117 (5) (2005) 825-830. C060.

D070 Ugurel,S.; Hildenbrand,R.*; Zimpfer,A.; La Rosee,P.*; Paschka,P.*; Sucker,A.; Keikavoussi,P.*; Becker,J.C.*; Rittgen,W.; Hochhaus,A.*; Schadendorf,D. Lack of clinical efficacy of imatinib in metastatic melanoma. British Journal of Cancer 92 (8) (2005) 1398-1405. C060.

D090 Bos,R.*; van Duikeren,S.*; van Hall,T.*; Kaaijk,P.*; Taubert,R.; Kyewski,B.; Klein,L.*; Melief,C.J.M.*; Offringa,R.* Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+T-cell repertoire. Cancer Research 65 (14) (2005) 6443-6449.

D090 Derbinski,J.; Gaebler,J.; Brors,B.; Tierling,S.*; Jonnakuty,S.; Hergenhahn,M.; Peltonen,L.*; Walter,J.*; Kyewski,B. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. Journal of Experimental Medicine 202 (1) (2005) 33-45. B080. B020. C040.

D090 Derbinski,J.; Kyewski,B. Linking signalling pathways, thymic stroma integrity and autoimmunity. Trends in Immunology 26 (10) (2005) 503-506.

Forschungsschwerpunkt E E010 Bahner,M.L.; Bengel,A.; Brix,G.*; Zuna,I.; Kauczor,H.U.; Delorme,S.

Improved vascular opacification in cerebral computed tomography angiography with 80 kVp. Investigative Radiology 40 (4) (2005) 229-234. E050.

E010 Boeckler,D.*; Allenberg,J.R.*; Kauczor,H.U.; Tengg-Kobligk,H. Postprocessing 'fly-through' of multislice computed tomography after thoracic endografting. Vascular Medicine 10 (1) (2005) 61-62.

E010 Boeckler,D.*; Tengg-Kobligk,H.; Schumacher,H.; Ockert,S.*; Schwarzbach,M.*; Allenberg,J.R.* Late surgical conversion after thoracic endograft failure due to fracture of the longitudinal support wire. Journal of Endovascular Therapy 12 (1) (2005) 98-102.

40

E010 Bottmer,C.*; Bachmann,S.*; Pantel,J.*; Essig,M.; Amann,M.; Schad,L.R.; Magnotta,V.*; Schroeder,J.* Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Psychiatry Research-Neuroimaging 140 (3) (2005) 239-250.

E010 David,M.*; Karmrodt,J.*; Bletz,C.*; David,S.*; Herweling,A.*; Kauczor,H.U.; Markstaller,K.* Analysis of atelectasis, ventilated, and hyperinflated lung during mechanical ventilation by dynamic CT. Chest 128 (5) (2005) 3757-3770.

E010 Doebrich,M.*; Markstaller,K.*; Karmrodt,J.*; Kauczor,H.U.; Eberle,B.*; Weiler,N.*; Thelen,M.*; Schreiber,W.G.* Analysis of discrete and continuous distributions of ventilatory time constants from dynamic computed tomography. Physics in Medicine and Biology 50 (8) (2005) 1659-1673.

E010 Eichhorn,J.G.*; Fink,C.; Long,F.*; Arnold,R.*; Ley,S.; Ulmer,H.*; Kauczor,H.U. Multidetector CT of congenital vascular anomalies and associated complications in newborns and infants. Röfo-Fortschritte Auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren 177 (10) (2005) 1366-1372.

E010 Fink,C.; Ley,S.; Kroeker,R.*; Requardt,M.*; Kauczor,H.U.; Bock,M. Time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the chest - Combination of parallel imaging with view sharing (TREAT). Investigative Radiology 40 (1) (2005) 40-48. E020.

E010 Fink,C.; Ley,S.; Risse,F.; Eichinger,M.; Zaporozhan,J.; Buhmann,R.*; Puderbach,M.; Plathow,C.; Kauczor,H.U. Effect of inspiratory and expiratory breathhold on pulmonary perfusion - Assessment by pulmonary perfusion magnetic resonance Imaging. Investigative Radiology 40 (2) (2005) 72-79. E020.

E010 Fink,C.; Puderbach,M.; Ley,S.; Risse,F.; Kuder,T.A.; Bock,M.; Thaler,J.*; Plathow,C.; Kauczor,H.U. Intraindividual comparison of 1.0 m gadobutrol and 0.5 m gadopentetate dimeglumine for time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the upper torso. Journal of Magnetic Resonance Imaging 22 (2) (2005) 286-290. E020.

E010 Fink,C.; Puderbach,M.; Ley,S.; Zaporozhan,J.; Plathow,C.; Kauczor,H.U. Time-resolved echo-shared parallel MRA of the lung: observer preference study of image quality in comparison with non-echo-shared sequences. European Radiology 15 (10) (2005) 2070-2074.

E010 Ganten,M.; Boese,J.M.*; Leitermann,D.*; Semmler,W. Quantification of aortic elasticity: development and experimental validation of a method using computed tomography. European Radiology 15 (12) (2005) 2506-2512. E020.

E010 Gast,K.K.*; Heussel,C.P.*; Schreiber,W.G.*; Kauczor,H.U. Functional Imaging of the lung using a gaseous contrast agent. (3)Helium-magnetic resonance imaging. Röfo-Fortschritte Auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren 177 (5) (2005) 660-669.

E010 Gast,K.K.*; Schreiber,W.G.*; Herweling,A.*; Lehmann,F.*; Erdos,G.*; Schmiedeskamp,J.*; Kauczor,H.U.; Eberle,B.* Two-dimensional and three-dimensional oxygen mapping by He-3-MRI validation in a lung phantom. European Radiology 15 (9) (2005) 1915-1922.

E010 Giesel,F.L.; Hohmann,N.*; Seidl,U.*; Kress,K.R.*; Schoenknecht,P.*; Kauczor,H.U.; Schroeder,J.*; Essig,M. Working memory in volunteers and schizophrenics using BOLD fMRI. Radiologe 45 (2) (2005) 144-152.

E010 Giesel,F.L.; Schöbinger,M.; Hosch,W.*; Tengg-Kobligk,H.*; Meinzer,H.P.; Allenberg,J.R.*; Kauczor,H.U.; Boeckler,D.*

41

Vena cava leiomyosarcoma: preoperative planning with complex vessel reconstruction using 3D surface rendering algorithms. Vascular Medicine 10 (1) (2005) 55-56. E130.

E010 Giesel,F.L.; Wustenberg,T.*; Bongers,A.; Weber,M.A.; Zechmann,C.; Baudendistel,K.T.*; Tengg-Kobligk,H.; Hahn,H.K.* MR-based methods of the functional imaging of the CNS. Röfo-Fortschritte Auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren 177 (5) (2005) 714-730. E020.

E010 Hallscheidt,P.J.*; Fink,C.; Haferkamp,A.*; Bock,M.; Luburic,A.*; Zuna,I.; Noeldge,G.*; Kauffmann,G.* Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI - Prospective study with histopathological correlation. Journal of Computer Assisted Tomography 29 (1) (2005) 64-68. E020.

E010 Heussel,C.P.*; Gast,K.K.*; Dahmen,A.*; Morbach,A.E.*; Kauczor,H.U.; Schreiber,W.G.*; Thelen,M.*; van Beek,E.J.R.* Hyperpolarized (3)Helium gas for functional magnetic resonance imaging of the lung. Medizinische Klinik 100 (7) (2005) 413-424.

E010 Jia,G.*; Baudendistel,K.T.*; Tengg-Kobligk,H.; Heverhagen,J.T.*; Polzer,H.*; Henry,R.*; McAuliffe,M.J.*; Levine,A.L.*; Rosol,T.J.*; Knopp,M.V. Assessing prostate volume by magnetic resonance imaging - A comparison of different measurement approaches for organ volume analysis. Investigative Radiology 40 (4) (2005) 243-248.

E010 Kauczor,H.U. Comprehensive cancer centers in Germany: Role of radiology. Röfo-Fortschritte Auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren 177 (3) (2005) 317-320.

E010 Kreitner,K.F.*; Kunz,R.P.*; Weschler,C.*; Ley,S.; Krummenauer,F.*; Schreiber,W.G.*; Thelen,M.* Analysis of first-pass bolus geometry in contrast-enhanced MRA of thoracic vessels. Röfo-Fortschritte Auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren 177 (5) (2005) 646-654.

E010 Krix,M. Quantification of enhancement in contrast ultrasound: a tool for monitoring of therapies in liver metastases. European Radiology 15 (2005) E104-E108

E010 Krix,M.; Kauczor,H.U.; Delorme,S. Vascular imaging with contrast-enhanced sonography for experimental use. Radiologe 45 (6) (2005) 552-+

E010 Krix,M.; Plathow,C.; Essig,M.; Herfarth,K.*; Debus,J.; Kauczor,H.U.; Delorme,S. Monitoring of liver metastases after stereotactic radiotherapy using low-Ml contrast-enhanced ultrasound - initial results. European Radiology 15 (4) (2005) 677-684.

E010 Krix,M.; Weber,M.A.; Krakowski-Roosen,H.; Huttner,H.B.*; Delorme,S.; Kauczor,H.U.; Hildebrandt,W. Assessment of skeletal muscle perfusion using contrast-enhanced ultrasonography. Journal of Ultrasound in Medicine 24 (4) (2005) 431-441. D020.

E010 Ley,S.; Fink,C.; Zaporozhan,J.; Borst,M.M.*; Meyer,F.J.*; Puderbach,M.; Eichinger,M.; Plathow,C.; Gruenig,E.*; Kreitner,K.F.*; Kauczor,H.U. Value of high spatial and high temporal resolution magnetic resonance angiography for differentiation between idiopathic and thromboembolic pulmonary hypertension: initial results. European Radiology 15 (11) (2005) 2256-2263.

E010 Ley,S.; Puderbach,M.; Fink,C.; Eichinger,M.; Plathow,C.; Teiner,S.*; Wiebel,M.*; Mueller,F.M.*; Kauczor,H.U. Assessment of hemodynamic changes in the systemic and pulmonary arterial circulation in patients with cystic fibrosis using phase-contrast MRI. European Radiology 15 (8) (2005) 1575-1580.

E010 Lichy,M.P.*; Plathow,C.; Schulz-Ertner,D.; Kauczor,H.U.; Schlemmer,H.P.* Follow-up gliomas after radiotherapy: H-1 MR spectroscopic imaging for increasing diagnostic

42

accuracy. Neuroradiology 47 (11) (2005) 826-834.

E010 Lucht,R.E.A.*; Delorme,S.; Heiss,J.; Knopp,M.V.*; Weber,M.A.; Griebel,J.*; Brix,G.* Classification of signal-time curves obtained by dynamic magnetic resonance mammography - Statistical comparison of quantitative methods. Investigative Radiology 40 (7) (2005) 442-447.

E010 Mohrs,O.K.*; Petersen,S.E.*; Erkapic,D.*; Rubel,C.*; Schrader,R.*; Nowak,B.*; Fach,W.A.*; Kauczor,H.U.; Voigtlaender,T.* Diagnosis of patent foramen ovale using contrast-enhanced dynamic MRI: A pilot study. American Journal of Roentgenology 184 (1) (2005) 234-240.

E010 Morbach,A.E.*; Gast,K.K.*; Schmiedeskamp,J.*; Dahmen,A.*; Herweling,A.*; Heussel,C.P.*; Kauczor,H.U.; Schreiber,W.G.* Diffusion-weighted BM of the lung with hyperpolarized helium-3: A study of reproducibility. Journal of Magnetic Resonance Imaging 21 (6) (2005) 765-774.

E010 Nosas-Garcia,S.; Moehler,T.*; Wasser,K.; Kiessling,F.; Bartl,R.*; Zuna,I.; Hillengass,J.*; Goldschmidt,H.*; Kauczor,H.U.; Delorme,S. Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: A comparative study with histology and clinical markers. Journal of Magnetic Resonance Imaging 22 (1) (2005) 154-162. E020. E050.

E010 Plathow,C.; Fink,C.; Sandner,A.*; Ley,S.; Puderbach,M.; Eichinger,M.; Schmaehl,A.*; Kauczor,H.U. Comparison of relative forced expiratory volume of one second with dynamic magnetic resonance imaging parameters in healthy subjects and patients with lung cancer. Journal of Magnetic Resonance Imaging 21 (3) (2005) 212-218.

E010 Plathow,C.; Klopp,M.*; Fink,C.; Sandner,A.*; Hof,H.*; Puderbach,M.; Herth,F.*; Schmaehl,A.*; Kauczor,H.U. Quantitative analysis of lung and tumour mobility: comparison of two time-resolved MRI sequences. British Journal of Radiology 78 (933) (2005) 836-840.

E010 Plathow,C.; Ley,S.; Zaporozhan,J.; Schobinger,M.; Gruenig,E.; Puderbach,M.; Eichinger,M.; Meinzer,H.P.; Zuna,I.; Kauczor,H.U. Assessment of reproducibility and stability of different breath-hold maneuvres by dynamic MRI: comparison between healthy adults and patients with pulmonary hypertension. European Radiology e-pub ahead of print (2005)

E010 Plathow,C.; Lohr,F.*; Divkovic,G.; Rademaker,G.; Farhan,N.*; Peschke,P.; Zuna,I.; Debus,J.; Claussen,C.D.*; Kauczor,H.U.; Li,C.Y.*; Jenne,J.; Huber,P. Focal gene induction in the liver of rats by a heat-inducible promoter using focused ultrasound hyperthermia - Preliminary results. Investigative Radiology 40 (11) (2005) 729-735. E050. E020.

E010 Plathow,C.; Schöbinger,M.; Fink,C.; Ley,S.; Puderbach,M.; Eichinger,M.; Bock,M.; Meinzer,H.P.; Kauczor,H.U. Evaluation of lung volumetry using dynamic three-dimensional magnetic resonance imaging. Investigative Radiology 40 (3) (2005) 173-179. E130. E020.

E010 Plathow,C.; Walz,M.*; Essig,M.; Engelmann,U.; Schulz-Ertner,D.; Delorme,S.; Kauczor,H.U. Teleradiologie: Betriebswirtschaftliche Analyse von CT Untersuchungen eines kleineren Krankenhauses (Teleradiology: Economic analysis of CT investigations of a small hospital). Röfo-Fortschritte Auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren 177 (7) (2005) 1016-1026. E130. E050.

E010 Plathow,C.; Weber,M.A.; Debus,J.; Kauczor,H.U. Imaging of sacral chordoma: comparison between MRI and CT. Radiologe 45 (1) (2005) 63-68. E050.

E010 Plathow,C.; Zimmermann,H.; Fink,C.; Umathum,R.; Schöbinger,M.; Huber,P.; Zuna,I.; Debus,J.; Schlegel,W.; Meinzer,H.P.; Semmler,W.; Kauczor,H.U.; Bock,M. Influence of different breathing maneuvers on internal and external organ motion: Use of fiducial markers in dynamic MRI. International Journal of Radiation Oncology Biology Physics 62 (1) (2005) 238-245. E020. E130. E050. E040.

43

E010 Schluter,M.*; Stieltjes,B.; Hahn,H.K.*; Rexilius,J.*; Konrad-Verse,O.*; Peitgen,H.O.* Detection of tumour infiltration in axonal fibre bundles using Diffusion Tensor Imaging. International Journal of Medical Robotics and Computer Assisted Surgery 1 (3) (2005) 80-86.

E010 Schreiber,W.G.*; Morbach,A.E.*; Stavngaard,T.*; Gast,K.K.*; Herweling,A.*; Sogaard,L.V.*; Windirsch,M.*; Schmiedeskamp,J.*; Heussel,C.P.*; Kauczor,H.U. Assessment of lung microstructure with magnetic resonance imaging of hyperpolarized Helium-3. Respiratory Physiology & Neurobiology 148 (1-2) (2005) 23-42.

E010 Seidl,U.*; Giesel,F.L.; Cantz,M.*; Schmidbauer,M.*; Schroeder,J.*; Pantel,J.* Unusual course of alpha-mannosidosis with symptoms of paranoid-hallucinatory psychosis. Nervenarzt 76 (3) (2005) 335-338.

E010 van Kaick,G.; Delorme,S. Computed tomography in various fields outside medicine. European Radiology 15 (2005) D74-D81

E010 Vomweg,T.W.*; Teifke,A.*; Kauczor,H.U.; Achenbach,T.*; Rieker,O.*; Schreiber,W.G.*; Heitmann,K.R.*; Beier,T.*; Thelen,M.* Self-organizing neural networks for automatic detection and classification of contrast-enhancing lesions in dynamic MR-mammography. Röfo-Fortschritte Auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren 177 (5) (2005) 703-713.

E010 Wasser,K.*; Moehler,T.*; Nosas-Garcia,S.*; Rehm,C.*; Bartl,R.*; Goldschmidt,H.*; Duber,C.*; Kauczor,H.U.; Delorme,S. Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma. Röfo-Fortschritte Auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren 177 (8) (2005) 1116-1122.

E010 Weber,M.A.; Dechow,C.*; Libicher,M.* Magnetic resonance imaging of tropical ulcers. European Radiology 15 (11) (2005) 2375-2376.

E010 Weber,M.A.; Risse,F.; Giesel,F.L.; Schad,L.R.; Kauczor,H.U.; Essig,M. Measurement of perfusion using the first-pass dynamic susceptibility-weighted contrast-enhanced (DSC) MRI in neurooncology. Physical basics and clinical applications. Radiologe 45 (7) (2005) 618-632. E020.

E010 Weber,M.A.; Viehoever,A.*; Stieltjes,B.; Zoubaa,S.*; Wildemann,B.*; Baudendistel,K.; Kauczor,H.U. Intracerebral manifestation of an atypical monoclonal plasma cell hyperplasia depicted by MR perfusion and diffusion imaging and MR spectroscopy. American Journal of Roentgenology 185 (3) (2005) 784-787. E020.

E010 Wuestenberg,T.*; Giesel,F.L.; Strasburger,H.* Methodological principles for optimising functional MRI experiments. Radiologe 45 (2) (2005) 99-112.

E010 Zaporozhan,J.; Ley,S.; Gast,K.K.*; Heussel,C.P.*; Biedermann,A.*; Eberle,B.*; Mayer,E.*; Thelen,M.*; Kauczor,H.U. Visual assessment of functional lungs parenchyma on HRCT and He-3-MRI in patients after single lung transplantation: Comparison with quantitative volumetric results. Röfo-Fortschritte Auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren 177 (4) (2005) 516-523.

E020 Bock,M.; Umathum,R.; Zuehlsdorff,S.*; Volz,S.; Fink,C.; Hallscheidt,P.; Zimmermann,H.; Nitz,W.*; Semmler,W. Interventional magnetic resonance imaging: An alternative to image guidance with ionising radiation. Radiation Protection Dosimetry 117 (1-3) (2006) 74-78.

E020 Greschus,S.*; Kiessling,F.; Lichy,M.P.*; Moll,J.*; Müller,M.M.; Savai,R.*; Rose,F.*; Ruppert,C.*; Guenther,A.*; Luecke,M.*; Fusenig,N.E.; Semmler,W.; Traupe,H.* Potential applications of flat-panel volumetric CT in morphologic and functional small animal imaging. Neoplasia 7 (8) (2005) 730-740. A101. A110.

E020 Kiessling,F.; Le Huu,M.; Kunert,T.; Thorn,M.; Vosseler,S.; Schmidt,K.*; Hoffend,J.*; Meinzer,H.P.; Fusenig,N.E.; Semmler,W.

44

Improved correlation of histological data with DCE MRI parameter maps by 3D reconstruction, reslicing and parameterization of the histological images. European Radiology 15 (6) (2005) 1079-1086. A101. E130. A110.

E020 Kiessling,F.; Schlemmer,H.P. Multimodal diagnosis of multiple and heterogeneous liver lesions in a young patient. Radiologe 45 (10) (2005) 937-940.

E020 Licha,K.*; Debus,N.*; Emig-Vollmer,S.*; Hofmann,B.*; Hasbach,M.*; Stibenz,D.*; Sydow,S.*; Schirner,M.*; Ebert,B.*; Petzelt,D.*; Buhrer,C.*; Semmler,W.; Tauber,R.* Optical molecular imaging of lymph nodes using a targeted vascular contrast agent. Journal of Biomedical Optics 10 (4) (2005)

E020 Schlemmer,H.P.W.*; Sawatzki,T.*; Sammet,S.; Dornacher,I.*; Bachert,P.; van Kaick,G.; Waldherr,R.*; Seitz,H.K.* Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled P-31 magnetic resonance spectroscopy. Journal of Hepatology 42 (5) (2005) 752-759. E010.

E020 Schroeder,L.; Schmitz,C.*; Bachert,P. Cumulative "roof effect" in high-resolution in vivo P-31 NMR spectra of human calf muscle and the Clebsch-Gordan coefficients of ATP at 1.5 T. Journal of Magnetic Resonance 174 (1) (2005) 68-77.

E020 Sun,R.; Dittrich,J.; Le Huu,M.; Müller,M.M.; Bedke,J.; Kartenbeck,J.; Lehmann,W.D.; Krueger,R.; Bock,M.; Huss,R.*; Seliger,C.*; Gröne,H.J.; Misselwitz,B.*; Semmler,W.; Kiessling,F. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells - A comparison. Investigative Radiology 40 (8) (2005) 504-513. A101. A010. B090. E090.

E030 Bauer,C.; Bauder-Wuest,U.; Mier,W.*; Haberkorn,U.; Eisenhut,M. I-131-labeled peptides as caspase substrates for apoptosis imaging. Journal of Nuclear Medicine 46 (6) (2005) 1066-1074. E060.

E030 Fiehn,C.*; Wunder,A.; Krienke,S.*; Max,R.*; Ho,A.D.*; Moehler,T.* Lack of evidence for inhibition of angiogenesis as a central mechanism of the antiarthritic effect of methotrexate. Rheumatology International 25 (2) (2005) 108-113.

E030 Hoffend,J.*; Mier,W.*; Schuhmacher,J.; Schmidt,K.; Dimitrakopoulou-Strauss,A.; Strauss,L.G.; Eisenhut,M.; Kinscherf,R.*; Haberkorn,U. Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo. Nuclear Medicine and Biology 32 (3) (2005) 287-292. E060.

E030 Mier,W.*; Hoffend,J.*; Kraemer,S.*; Schuhmacher,J.; Hull,W.E.; Eisenhut,M.; Haberkorn,U. Conjugation of DOTA using isolated phenolic active esters: The labeling and biodistribution of albumin as blood pool marker. Bioconjugate Chemistry 16 (1) (2005) 237-240. B090. E060.

E030 Schuhmacher,J.; Zhang,H.W.*; Doll,J.; Macke,H.R.*; Matys,R.; Hauser,H.; Henze,M.*; Haberkorn,U.; Eisenhut,M. GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a Ga-68-labeled bombesin(6-14) analog. Journal of Nuclear Medicine 46 (4) (2005) 691-699. E020. E060.

E030 Wolf,M.; Bauder-Wuest,U.; Haberkorn,U.; Mier,W.*; Eisenhut,M. Alkylating benzamides with melanoma cytotoxicity: role of melanin, tyrosinase, intracellular pH and DNA interaction. Melanoma Research 15 (5) (2005) 383-391. E060.

E040 Dietrich,L.; Tuecking,T.; Nill,S.; Oelfke,U. Compensation for respiratory motion by gated radiotherapy: an experimental study. Physics in Medicine and Biology 50 (10) (2005) 2405-2414.

E040 Jakel,O.; Schulz-Ertner,D.*; Karger,C.P.; Heeg,P.; Debus,J.* Experience with carbon ion radiotherapy at GSI. Nuclear Instruments & Methods in Physics Research Section B-Beam Interactions with Materials and Atoms 241 (1-4) (2005) 717-720.

45

E040 Kraemer,M.*; Jäkel,O. Biological dose optimization using ramp-like dose gradients in ion irradiation fields. Physica Medica 21 (3) (2005) 107-111.

E040 Mu,X.K.*; Bjoerk-Eriksson,T.*; Nill,S.; Oelfke,U.; Johansson,K.A.*; Gagliardi,G.*; Johansson,L.*; Karlsson,M.*; Zackrisson,B.* Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study. Acta Oncologica 44 (6) (2005) 554-562.

E040 Neff,T.; Kiessling,F.; Brix,G.*; Baudendistel,K.; Zechmann,C.; Giesel,F.L.; Bendl,R. An optimized workflow for the integration of biological information into radiotherapy planning: experiences with T1w DCE-MRI. Physics in Medicine and Biology 50 (17) (2005) 4209-4223. E020. E010.

E040 Neff,T.; Kiessling,F.; Brix,G.*; Baudendistel,K.; Zechmann,C.; Giesel,F.L.; Bendl,R. An optimized workflow for the integration of biological information into radiotherapy planning: experiences with T1w DCE-MRI. Physics in Medicine and Biology 50 (17) (2005) 4209-4223. E020. E010.

E040 Newhauser,W.D.*; Ding,X.*; Giragosian,D.*; Nill,S.; Titt,U.* Neutron radiation area monitoring system for proton therapy facilities. Radiation Protection Dosimetry 115 (1-4) (2005) 149-153.

E040 Nill,S.; Tuecking,T.; Münter,M.W.; Oelfke,U. Intensity modulated radiation therapy with multileaf collimators of different leaf widths: a comparison of achievable dose distributions. Radiotherapy and Oncology 75 (1) (2005) 106-111. E050.

E040 Nill,S.; Unkelbach,J.; Dietrich,L.; Oelfke,U. Online correction for respiratory motion: evaluation of two different imaging geometries. Physics in Medicine and Biology 50 (17) (2005) 4087-4096.

E040 Nioutsikou,E.*; Webb,S.*; Panakis,N.*; Bortfeld,T.*; Oelfke,U. Reconsidering the definition of a dose-volume histogram. Physics in Medicine and Biology 50 (11) (2005) L17-L19

E040 Sanchez-Doblado,F.*; Capote,R.*; Leal,A.*; Rosello,J.V.*; Lagares,J.I.*; Arrans,R.*; Hartmann,G.H. Microionization chamber for reference dosimetry in IMRT verification: clinical implications on OAR dosimetric errors. Physics in Medicine and Biology 50 (5) (2005) 959-970.

E040 Sanchez-Doblado,F.*; Capote,R.*; Rosello,J.V.*; Leal,A.*; Lagares,J.I.*; Arrans,R.*; Hartmann,G.H. Micro ionization chamber dosimetry in IMRT verification: Clinical implications of dosimetric errors in the PTV. Radiotherapy and Oncology 75 (3) (2005) 342-348.

E040 Unkelbach,J.; Oelfke,U. Incorporating organ movements in inverse planning: assessing dose uncertainties by Bayesian inference. Physics in Medicine and Biology 50 (1) (2005) 121-139.

E040 Unkelbach,J.; Oelfke,U. Incorporating organ movements in IMRT treatment planning for prostate cancer: Minimizing uncertainties in the inverse planning process. Medical Physics 32 (8) (2005) 2471-2483.

E040 Wilkens,J.J.; Oelfke,U. Optimization of radiobiological effects in intensity modulated proton therapy. Medical Physics 32 (2) (2005) 455-465.

E050 Abdollahi,A.; Griggs,D.W.*; Zieher,H.; Roth,A.; Lipson,K.E.*; Saffrich,R.; Gröne,H.J.; Hallahan,D.E.*; Reisfeld,R.A.*; Debus,J.; Niethammerl,A.G.; Huber,P.E. Inhibition of alpha(v)beta(3) integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clinical Cancer Research 11 (17) (2005) 6270-6279. E090.

46

E050 Abdollahi,A.; Hlatky,L.*; Huber,P.E. Endostatin: The logic of antiangiogenic therapy. Drug Resistance Updates 8 (1-2) (2005) 59-74.

E050 Abdollahi,A.; Li,M.L.; Ping,G.; Plathow,C.; Domhan,S.*; Kiessling,F.; Lee,L.B.*; McMahon,G.*; Gröne,H.J.; Lipson,K.E.*; Huber,P.E. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. Journal of Experimental Medicine 201 (6) (2005) 925-935. E020. E090.

E050 Braun,K.; Pipkorn,R.; Waldeck,W. Development and characterization of drug delivery systems for targeting mammalian cells and tissues: A review. Current Medicinal Chemistry 12 (16) (2005) 1841-1858. V270. B045.

E050 Combs,S.E.; Ahmadi,R.*; Schulz-Ertner,D.; Thilmann,C.; Debus,J. Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation. Journal of Neuro-Oncology 71 (3) (2005) 319-323.

E050 Combs,S.E.; Gutwein,S.*; Schulz-Ertner,D.; van Kampen,M.*; Thilmann,C.; Edler,L.; Wannenmacher,M.M.*; Debus,J. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme - Phase I/II study. Strahlentherapie und Onkologie 181 (6) (2005) 372-377. C060.

E050 Combs,S.E.; Gutwein,S.*; Thilmann,C.; Huber,P.; Debus,J.; Schulz-Ertner,D. Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme. Journal of Neuro-Oncology 74 (2) (2005) 167-171.

E050 Combs,S.E.; Schulz-Ertner,D.; Moschos,D.; Thilmann,C.; Huber,P.E.; Debus,J. Fractionated stereotactic radiotherapy of optic pathway gliomas: Tolerance and long-term outcome. International Journal of Radiation Oncology Biology Physics 62 (3) (2005) 814-819.

E050 Combs,S.E.; Schulz-Ertner,D.; Thilmann,C.; Edler,L.; Debus,J. Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma. International Journal of Radiation Oncology Biology Physics 62 (3) (2005) 797-802. C060.

E050 Combs,S.E.; Thilmann,C.; Edler,L.; Debus,J.; Schulz-Ertner,D. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients treated in a single institution. Journal of Clinical Oncology 23 (34) (2005) 8863-8869. C060.

E050 Combs,S.E.; Volk,S.; Schulz-Ertner,D.; Huber,P.E.; Thilmann,C.; Debus,J. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): Long-term results in 106 patients treated in a single institution. International Journal of Radiation Oncology Biology Physics 63 (1) (2005) 75-81.

E050 Haecker,A.*; Risse,F.; Peters,T.*; Knoll,T.*; Jenne,J.; Michel,M.S. Magnetic resonance imaging appearance of RF lesion volume in ex vivo porcine tissue. Journal of Endourology 19 (Supl. 1) (2005) ?

E050 Huber,P.E.; Bischof,M.; Jenne,J.; Heiland,S.*; Peschke,P.; Saffrich,R.; Gröne,H.J.; Debus,J.; Lipson,K.E.*; Abdollahi,A. Trimodal cancer treatment: Beneficial effects of combined antianglogenesis, radiation, and chemotherapy. Cancer Research 65 (9) (2005) 3643-3655. E020. E090.

E050 Kettenbach,J.*; Helbich,T.H.*; Huber,A.*; Zuna,I.; Dock,W.* Computer-assisted quantitative assessment of power Doppler US: effects of microbubble contrast agent in the differentiation of breast tumors. European Journal of Radiology 53 (2) (2005) 238-244.

E050 Krempien,R.*; Münter,M.W.; Huber,P.E.; Nill,S.; Friess,H.*; Timke,C.*; Didinger,B.*; Buechler,P.*; Heeger,S.*; Herfarth,K.K.*; Abdollahi,A.; Büchler,M.W.*; Debus,J. Randomized phase II - study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer - PARC: study protocol [ISRCTN56652283]. BMC Cancer 5 (2005) E040.

47

E050 Milker-Zabel,S.; Zabel,A.; Schulz-Ertner,D.; Schlegel,W.; Wannenmacher,M.*; Debus,J. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: Long-term experience and prognostic factors. International Journal of Radiation Oncology Biology Physics 61 (3) (2005) 809-816. E040.

E050 Münter,M.W.; Christian,T.; Anna,N.; Simeon,N.; Juergen,D.* Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: The Heidelberg experience. Lung Cancer 49 (2005) S83-S86 E040.

E050 Münter,M.W.; Thieke,C.; Nikoghosyan,A.; Nill,S.; Debus,J. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: The Heidelberg experience (vol 49S1, pg S83, 2005). Lung Cancer 50 (3) (2005) 423 E040.

E050 Schaefer,M.; Münter,M.; Sterzing,F.; Haering,P.; Rhein,B.; Debus,J. Measurements of characteristics of time pattern in dose delivery in step-and-shoot IMRT. Strahlentherapie und Onkologie 181 (9) (2005) 587-594. E040.

E050 Schulz-Ertner,D.; Nikoghosyan,A.*; Didinger,B.*; Münter,M.; Jäkel,O.; Karger,C.P.; Debus,J. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 104 (2) (2005) 338-344. E040.

E050 Sterzing,F.; Münter,M.W.; Schaefer,M.; Haering,P.; Rhein,B.; Thilmann,C.; Debus,J. Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy. Strahlentherapie und Onkologie 181 (1) (2005) 42-48. E040.

E050 Zabel,A.; Milker-Zabel,S.; Huber,P.; Schulz-Ertner,D.; Schlegel,W.; Debus,J. Treatment outcome after linac-based radiosurgery in cerebral arteriovenous malformations: Retrospective analysis of factors affecting obliteration. Radiotherapy and Oncology 77 (1) (2005) 105-110. E040.

E050 Zabel,A.; Milker-Zabel,S.; Zuna,I.; Wannenmacher,M.*; Debus,J. External beam radiotherapy in the treatment of male breast carcinoma: Patterns of failure in a single institute experience. Tumori 91 (2) (2005) 151-155.

E060 Altmann,A.; Schulz,R.B.; Glensch,G.; Eskerski,H.; Zitzmann,S.; Eisenhut,M.; Haberkorn,U. Effects of Pax8 and TTF-1 thyroid transcription factor gene transfer in hepatoma cells: Imaging of functional protein-protein interaction and iodide uptake. Journal of Nuclear Medicine 46 (5) (2005) 831-839. E020. E030.

E060 Askoxylakis,V.*; Zitzmann,S.; Mier,W.*; Graham,K.*; Kramer,S.*; von Wegner,F.; Fink,R.H.A.; Schwab,M.; Eisenhut,M.; Haberkorn,U. Preclinical evaluation of the breast cancer cell-binding peptide, p160. Clinical Cancer Research 11 (18) (2005) 6705-6712. B030. E030.

E060 Brix,G.*; Schlicker,A.; Mier,W.*; Peschke,P.; Bellemann,M.E.* Biodistribution and pharmacokinetics of the F-19-labeled radiosensitizer 3-aminobenzamide: assessment by F-19 MR imaging. Magnetic Resonance Imaging 23 (9) (2005) 967-976. E050.

E060 Haberkorn,U.; Eisenhut,M. Molecular imaging and therapy - a programme based on the development of new biomolecules. European Journal of Nuclear Medicine and Molecular Imaging 32 (12) (2005) 1354-1359. E030.

E060 Haberkorn,U.; Mier,W.*; Eisenhut,M. Scintigraphic imaging of gene expression and gene transfer. Current Medicinal Chemistry 12 (7) (2005) 779-794. E030.

E060 Henze,M.*; Dimitrakopoulou-Strauss,A.; Milker-Zabel,S.; Schuhmacher,J.; Strauss,L.G.; Doll,J.; Macke,H.R.*; Eisenhut,M.; Debus,J.; Haberkorn,U. Characterization of Ga-68-DOTA-D-Phe(1)-Tyr(3)- octreotide kinetics in patients with meningiomas. Journal of Nuclear Medicine 46 (5) (2005) 763-769. E050. E020. E030.

E060 Krause,M.*; Hahnel,S.*; Haberkorn,U.; Meinck,H.M.* Dopa-responsive hemiparkinsonism due to midbrain Virchow-Robin spaces? Journal of Neurology 252 (12) (2005) 1555-1557.

48

E060 Ludwig,J.*; Mechtersheimer,G.*; Haberkorn,U.; Nawroth,P.*; Schilling,T.*; Kasperk,C.* Oncogenic osteomalacia in a 49-year old female. Deutsche Medizinische Wochenschrift 130 (5) (2005) 206-209.

E060 Maecke,H.R.*; Hofmann,M.*; Haberkorn,U. Ga-68-labeled peptides in tumor imaging. Journal of Nuclear Medicine 46 (2005) 172S-178S.

E060 Schmidt,K.; Hoffend,J.*; Altmann,A.; Strauss,L.G.; Dimitrakopoulou-Strauss,A.; Engelhardt,B.; Koczan,D.; Peter,J.; Vorwald,S.*; Eskerski,H.; Eisenhut,M.; Metz,J.*; Kinscherf,R.*; Haberkorn,U. Transfer of the sFLT-1 gene in Morris hepatoma results in decreased growth and perfusion and induction of genes associated with stress response. Clinical Cancer Research 11 (6) (2005) 2132-2140. E020. E030.

E060 Schwarzbach,M.H.M.*; Hinz,U.*; Dimitrakopoulou-Strauss,A.; Willeke,F.*; Cardona,S.*; Mechtersheimer,G.*; Lehnert,T.*; Strauss,L.G.; Herfarth,C.*; Büchler,M.W.* Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) Imaging in patients with resectable soft tissue sarcomas. Annals of Surgery 241 (2) (2005) 286-294.

E060 Thireou,T.*; Kontaxakis,G.*; Strauss,L.G.; Dimitrakopoulou-Strauss,A.; Pavlopoulos,S.*; Santos,A.* Feasibility study of the use of similarity maps in the evaluation of oncological dynamic positron emission tomography images. Medical & Biological Engineering & Computing 43 (1) (2005) 23-32.

E060 Zitzmann,S.; Kramer,S.*; Mier,W.*; Mahmut,M.; Fleig,J.*; Altmann,A.; Eisenhut,M.; Haberkorn,U.

Identification of a new prostate-specific cyclic peptide with the bacterial FliTrx system. Journal of Nuclear Medicine 46 (5) (2005) 782-785. E030.

E060 Zitzmann,S.; Mier,W.*; Schad,A.*; Kinscherf,R.; Askoxylakis,N.*; Kramer,S.*; Altmann,A.; Eisenhut,I.*; Haberkorn,U. New prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy. Clinical Cancer Research 11 (1) (2005) 139-146. E030.

E080 Arlt,V.M.*; Stiborova,M.*; Henderson,C.J.*; Osborne,M.R.*; Bieler,C.A.; Frei,E.; Martinek,V.*; Sopko,B.*; Wolf,C.R.*; Schmeiser,H.H.; Phillips,D.H.* Environmental pollutant and potent mutagen 3-nitrobenzanthrone forms DNA adducts after reduction by NAD(P)H : quinone oxidoreductase and conjugation by acetyltransferases and sulfotransferases in human hepatic cytosols. Cancer Research 65 (7) (2005) 2644-2652.

E080 Bieler,C.A.; Cornelius,M.G.; Klein,R.; Arlt,V.M.*; Wiessler,M.; Phillips,D.H.*; Schmeiser,H.H. DNA adduct formation by the environmental contaminant 3-Nitrobenzanthrone after intratracheal instillation in rats. International Journal of Cancer 116 (6) (2005) 833-838.

E080 Cornelius,M.; Woerth,C.G.C.; Kliem,H.C.; Wiessler,M.; Schmeiser,H.H. Detection and separation of nucleoside-5 '-monophosphates of DNA by conjugation with the fluorescent dye BODIPY and capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis 26 (13) (2005) 2591-2598.

E080 Heuser,M.; Kopun,M.; Rittgen,W.; Granzow,C. Cytotoxicity determination without photochemical artifacts. Cancer Letters 223 (1) (2005) 57-66. C060.

E080 Kim,E.Y.L.; Gronewold,C.; Chatterjee,A.*; der Lieth,C.W.; Kliem,C.; Schmauser,B.*; Wiessler,M.; Frei,E. Oligosaccharide mimics containing galactose and fucose specifically label tumour cell surfaces and inhibit cell adhesion to fibronectin. Chembiochem 6 (2) (2005) 422-431. B090.

E080 Osborne,M.R.*; Arlt,V.M.*; Kliem,C.; Hull,W.E.; Mirza,A.*; Bieler,C.A.; Schmeiser,H.H.; Phillips,D.H.* Synthesis, characterization, and P-32-postlabeling analysis of DNA adducts derived from the environmental contaminant 3-Nitrobenzanthrone. Chemical Research in Toxicology 18 (6) (2005) 1056-1070. B090.

49

E080 Stiborova,M.*; Frei,E.; Hodek,P.*; Wiessler,M.; Schmeiser,H.H. Human hepatic and renal microsomes, Cytochromes P450 1A1/2, NADPH : Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer. International Journal of Cancer 113 (2) (2005) 189-197.

E080 Stiborova,M.*; Miksanova,M.*; Sulc,M.*; Rydlova,H.*; Schmeiser,H.H.; Frei,E. Identification of a genotoxic mechanism for the carcinogenicity of the environmental pollutant and suspected human carcinogen o-anisidine. International Journal of Cancer 116 (5) (2005) 667-678.

E080 Stiborova,M.*; Patocka,J.*; Frei,E.; Schmeiser,H.H. Biochemistry and toxicological aspects of etiology of balkan endemic nephropathy. Chemicke Listy 99 (11) (2005) 782-788.

E080 Stiborova,M.*; Sopko,B.*; Hodek,P.*; Frei,E.; Schmeiser,H.H.; Hudecek,J.* The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen. Cancer Letters 229 (2) (2005) 193-204.

E090 Adams,J.*; Kiss,E.; Arroyo,A.B.V.*; Bonrouhi,M.; Sun,Q.; Li,Z.; Gretz,N.*; Schnitger,A.*; Zouboulis,C.C.*; Wiesel,M.*; Wagner,J.*; Nelson,P.J.*; Gröne,H.J. 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. American Journal of Pathology 167 (1) (2005) 285-298.

E090 Hauser,I.A.*; Spiegler,S.*; Kiss,E.; Gauer,S.*; Sichler,O.*; Scheuermann,E.H.*; Ackermann,H.*; Pfeilschifter,J.M.*; Geiger,H.*; Gröne,H.J.; Radeke,H.H.* Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG). Journal of the American Society of Nephrology 16 (6) (2005) 1849-1858.

E090 Hermann,M.*; Shaw,S.*; Kiss,E.; Camici,G.*; Buhler,N.*; Chenevard,R.*; Luscher,T.F.*; Gröne,H.J.; Ruschitzka,F.* Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hypertension 45 (2) (2005) 193-197.

E090 Herrmann,T.*; Gröne,H.J.; Langbein,L.; Kaiser,I.*; Gosch,I.*; Bennemann,U.*; Metzger,D.*; Chambon,P.*; Stewart,A.F.*; Stremmel,W.* Disturbed epidermal structure in mice with temporally controlled Fatp4 deficiency. Journal of Investigative Dermatology 125 (6) (2005) 1228-1235. A010.

E090 Jennemann,R.; Sandhoff,R.; Wang,S.J.; Kiss,E.; Gretz,N.*; Zuliani,C.; Martin-Villalba,A.; Jager,R.*; Schorle,H.*; Kenzelmann,M.; Bonrouhi,M.; Wiegandt,H.; Gröne,H.J. Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth. Proceedings of the National Academy of Sciences of the United States of America 102 (35) (2005) 12459-12464. D030.

E090 Nusing,R.M.*; Pantalone,F.*; Gröne,H.J.; Seyberth,H.W.*; Wegmann,M.* Expression of the potassium channel ROMK in adult and fetal human kidney. Histochemistry and Cell Biology 123 (6) (2005) 553-559.

E090 Patole,P.S.*; Gröne,H.J.; Segerer,S.*; Ciubar,R.*; Belemezova,E.*; Henger,A.*; Kretzler,M.*; Schlondorff,D.*; Anders,H.J.* Viral double-stranded RNA aggravates lupus nephritis through toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. Journal of the American Society of Nephrology 16 (5) (2005) 1326-1338.

E090 Patole,P.S.*; Zecher,D.*; Pawar,R.D.*; Gröne,H.J.; Schloendorff,D.*; Anders,H.J.* G-rich DNA suppresses systemic lupus. Journal of the American Society of Nephrology 16 (11) (2005) 3273-3280.

E090 Ridder,R.M.*; Kreth,H.W.*; Kiss,E.; Gröne,H.J.; Gordjani,N.* Membranous nephropathy associated with familial chronic ulcerative colitis in a 12-year-old girl. Pediatric Nephrology 20 (9) (2005) 1349-1351.

E090 Sandhoff,R.; Geyer,R.*; Jennemann,R.; Paret,C.; Kiss,E.; Yamashita,T.*; Gorgas,K.*; Sijmonsma,T.P.; Iwamori,M.*; Finaz,C.*; Proia,R.L.*; Wiegandt,H.; Gröne,H.J. Novel class of glycosphingolipids involved in male fertility. Journal of Biological Chemistry 280 (29) (2005) 27310-27318. D060.

50

E090 Sandhoff,R.; Grieshaber,H.; Djafarzadeh,R.*; Sijmonsma,T.P.; Proudfoot,A.E.I.*; Handel,T.M.*; Wiegandt,H.; Nelson,P.J.*; Gröne,H.J. Chemokines bind to sulfatides as revealed by surface plasmon resonance. Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids 1687 (1-3) (2005) 52-63.

E090 Schaefer,L.*; Babelova,A.*; Kiss,E.; Hausser,H.J.*; Baliova,M.*; Krzyzankova,M.*; Marsche,G.*; Young,M.F.*; Mihalik,D.*; Goette,M.; Malle,E.*; Schaefer,R.M.*; Gröne,H.J. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. Journal of Clinical Investigation 115 (8) (2005) 2223-2233.

E090 Schmid,H.*; Burg,M.*; Kretzler,M.; Banas,B.*; Gröne,H.J.; Kliem,V.* BK virus associated nephropathy in native kidneys of a heart allograft recipient. American Journal of Transplantation 5 (6) (2005) 1562-1568.

E090 Schmid,H.*; Nitschko,H.*; Gerth,J.*; Kliem,V.*; Henger,A.*; Cohen,C.D.*; Schlondorff,D.*; Gröne,H.J.; Kretzler,M.* Polyomavirus DNA and RNA detection in renal allograft biopsies: Results from a European multicenter study. Transplantation 80 (5) (2005) 600-604.

E090 Yamashita,T.*; Wu,Y.P.*; Sandhoff,R.; Werth,N.*; Mizukami,H.*; Ellis,J.M.*; Dupree,J.L.*; Geyer,R.*; Sandhoff,K.*; Proia,R.L.* Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proceedings of the National Academy of Sciences of the United States of America 102 (8) (2005) 2725-2730.

E095 Gassler,N.*; Herr,I.; Schneider,A.*; Penzel,R.*; Langbein,L.; Schirmacher,P.*; Kopitz,J.* Impaired expression of acyl-CoA synthetase 5 in sporadic colorectal adenocarcinomas. Journal of Pathology 207 (3) (2005) 295-300. A010.

E095 Gassler,N.*; Zhang,C.; Wenger,T.; Schnabel,P.A.*; Dienemann,H.*; Debatin,K.M.*; Mattern,J.; Herr,I. Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo. British Journal of Cancer 92 (6) (2005) 1084-1088.

E095 Herr,I.; Marme,A.* Glucocorticoids and progression of breast cancer. Cancer Biology & Therapy 4 (12) (2005) 1415-1416.

E095 Rutz,H.P.*; Herr,I. Glucocorticoid administration in antiemetic therapy: Is it safe? Cancer 103 (12) (2005) 2656

E100 Baeuerle,T.; Adwan,H.; Kiessling,F.; Hilbig,H.*; Armbruster,F.P.*; Berger,M.R. Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein. International Journal of Cancer 115 (2) (2005) 177-186. E020.

E100 Conzelmann,M.; Linnemann,U.*; Berger,M.R. Detection of disseminated tumour cells in the liver of colorectal cancer patients. Ejso 31 (1) (2005) 38-44.

E100 Conzelmann,M.; Linnemann,U.*; Berger,M.R. Detection of disseminated tumour cells in the liver of cancer patients. European Journal of Surgical Oncology 31 (9) (2005) 977-985.

E100 Conzelmann,M.; Linnemann,U.*; Berger,M.R. Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use? International Journal of Colorectal Disease 20 (2) (2005) 137-146.

E100 Guweidhi,A.*; Kleeff,J.*; Adwan,H.; Giese,N.A.; Wente,M.N.*; Giese,T.*; Büchler,M.W.*; Berger,M.R.; Friess,H.* Osteonectin influences growth and invasion of pancreatic cancer cells. Annals of Surgery 242 (2) (2005) 224-234. F010.

E100 Kolb,A.*; Kleeff,J.*; Guweidhi,A.*; Esposito,I.*; Giese,N.A.*; Adwan,H.; Giese,T.*; Büchler,M.W.*; Berger,M.R.; Friess,H.*

51

Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions. Cancer Biology & Therapy 4 (7) (2005) 740-746.

E100 Martinova,Y.*; Topashka-Ancheva,M.*; Konstantinov,S.*; Petkova,S.*; Karaivanova,M.*; Berger,M.R. Miltefosine decreases the cytotoxic effect of epirubicine and cyclophosphamide on mouse spermatogenic, thymic and bone marrow cells. Archives of Toxicology 80 (2005) 27-33.

E100 Rodenbach,M.; Eyol,E.; Seelig,M.H.*; Berger,M.R. Combination treatment of CC531-lac-Z rat liver metastases by chemoembolization with pemetrexed disodium and gemcitabine. Journal of Cancer Research and Clinical Oncology 131 (5) (2005) 289-299.

E100 Schimanski,C.C.*; Schmitz,G.*; Kashyap,A.*; Bosserhoff,A.K.*; Bataille,F.*; Schafer,S.C.*; Lehr,H.A.*; Berger,M.R.; Galle,P.R.*; Strand,S.*; Strand,D.* Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene 24 (19) (2005) 3100-3109.

E100 Schimanski,C.C.*; Schwald,S.*; Simiantonaki,N.*; Jayasinghe,C.*; Goenner,U.*; Wilsberg,V.*; Junginger,T.*; Berger,M.R.; Galle,P.R.*; Moehler,M.* Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clinical Cancer Research 11 (5) (2005) 1743-1750.

E100 Tsoneva,I.*; Nikolova,B.*; Georgieva,M.*; Guenova,M.*; Tomov,T.*; Rols,M.P.*; Berger,M.R. Induction of apoptosis by electrotransfer of positively charged proteins as Cytochrome C and Histone H1 into cells. Biochimica et Biophysica Acta-General Subjects 1721 (1-3) (2005) 55-64.

E100 Voss,C.; Eyol,E.; Berger,M.R. Plant material used in African traditional medicine shows antineoplastic activity in vitro and in vivo. Forum DKG 20 (Sonderheft 1) (2005) 45

E100 Voss,C.; Zerban,H.; Bannasch,P.; Berger,M.R. Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats. Toxicology 206 (3) (2005) 359-371. E090.

E100 Wente,M.N.*; Kleef,J.*; Guweidhi,A.*; Adwan,H.; Giese,N.A.*; Büchler,M.W.*; Berger,M.R.; Friess,H.* SPARC (Secreted Protein Acidic and Rich in Cysteine) beeinflusst das Wachstum und die Invasivität des Pankreaskarzinoms. gms german medical science (2005) http://www.egms.de/en/meetings/dgch2005/05dgch554.shtml

E110 Baez-Astua,A.; Herraez-Hernandez,E.; Garbi,N.; Pasolli,H.A.*; Juarez,V.*; zur Hausen,H.; Cid-Arregui,A. Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses. Journal of Virology 79 (20) (2005) 12807-12817. D050. F070.

E120 McSheehy,P.M.J.*; Port,R.E.; Rodrigues,L.M.*; Robinson,S.P.*; Stubbs,M.*; van der Borns,K.*; Peters,G.J.*; Judson,I.R.*; Leach,M.O.*; Griffiths,J.R.* Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours. Cancer Chemotherapy and Pharmacology 55 (2) (2005) 117-128.

E120 Radujkovic,A.; Schad,M.; Topaly,J.*; Veldwijk,M.R.; Laufs,S.; Schultheis,B.S.*; Jauch,A.*; Melo,J.V.*; Fruehauf,S.*; Zeller,W.J. Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL - Inhibition of P-glycoprotein function by 17-AAG. Leukemia 19 (7) (2005) 1198-1206.

E120 Shi,J.*; Pfister,M.*; Jenkins,S.G.*; Chapel,S.*; Parrett,J.S.*; Port,R.E.; Howard,D.* Pharmacodynamic analysis of the microbiological efficacy of telithromycin in patients with

52

community-acquired pneumonia. Clinical Pharmacokinetics 44 (3) (2005) 317-329.

E120 Wagner,W.*; Laufs,S.; Blake,J.*; Schwager,C.*; Wu,X.L.*; Zeller,J.W.; Ho,A.D.*; Fruehauf,S.* Retroviral integration sites correlate with expressed genes in hematopoietic stem cells. Stem Cells 23 (8) (2005) 1050-1058.

E130 Azevedo,R.B.R.*; Lohaus,R.; Braun,V.; Gumbel,M.; Umamaheshwar,M.*; Agapow,P.M.*; Houthoofd,W.*; Platzer,U.; Borgonie,G.*; Meinzer,H.P.; Leroi,A.M.* The simplicity of metazoan cell lineages. Nature 433 (7022) (2005) 152-156.

E130 De Simone,R.*; Wolf,I.; Mottl-Link,S.*; Bottiger,B.W.*; Rauch,H.*; Meinzer,H.P.; Hagl,S.* Intraoperative assessment of right ventricular volume and function. European Journal of Cardio-Thoracic Surgery 27 (6) (2005) 988-993.

E130 Fischer,L.*; Thorn,M.; Neumann,J.O.*; Schöbinger,M.; Heimann,T.; Grenacher,L.*; Meinzer,H.P.; Friess,H.*; Büchler,M.W.* The segments of the hepatic veins - is there a spatial correlation to the Couinaud liver segments? European Journal of Radiology 53 (2) (2005) 245-255.

E130 Greil,G.F.*; Kuettner,A.*; Schöbinger,M.; Meinzer,H.P.; Claussen,C.D.*; Hofbeck,M.*; Sieverding,L.* Visualization of peripheral pulmonary artery stenosis using high-resolution multidetector computed tomography. Vascular Medicine 10 (3) (2005) 235-236.

E130 Grenacher,L.*; Thorn,M.; Knaebel,H.P.*; Vetter,M.; Hassenpflug,P.; Krausz,T.*; Meinzer,H.P.; Büchler,M.W.*; Kauffmann,G.W.*; Richter,G.M. The role of 3-D imaging and computer-based postprocessing for surgery of the liver and pancreas. Röfo-Fortschritte Auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren 177 (9) (2005) 1219-1226.

E130 Heimann,T.; Wolf,I.; Williams,T.*; Meinzer,H.P. 3D active shape models using gradient descent optimization of description length. Information Processing in Medical Imaging, Proceedings 3565 (2005) 566-577.

E130 Libicher,M.*; Vetter,M.; Wolf,I.; Noeldge,G.*; Kasperk,C.*; Grafe,I.*; Da Fonseca,K.*; Hillmeier,J.*; Meeder,P.J.*; Meinzer,H.P.; Kauffmann,G.W. CT volumetry of intravertebral cement after kyphoplasty. Comparison of polymethylmethacrylate and calcium phosphate in a 12-month follow-up. European Radiology 15 (8) (2005) 1544-1549.

E130 Mildenberger,P.*; Kämmerer,M.*; Engelmann,U.; Ruggiero,S.*; Klos,G.*; Runa,A.*; Schroeter,A.; Weisser,G.*; Walz,M.*; Schuetze,B.* Teleradiology with DICOM e-mail: Recommendations of @GIT. Röfo-Fortschritte Auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren 177 (5) (2005) 697-702.

E130 Mottl-Link,S.; Böttger,T.; Krueger,J.J.*; Rietdorf,U.; Schnackenburg,B.*; Ewert,P.*; Berger,F.*; Nagel,E.*; Meinzer,H.P.; Juraszek,A.*; Kuehne,T.*; Wolf,I. Cast of complex congenital heart malformation in a living patient. Circulation 112 (24) (2005) E356-E357

E130 Mottl-Link,S.; Wolf,I.; Hastenteufel,M.; Witte,S.*; Meinzer,H.P.; Hagl,S.*; De Simone,R.* Non-invasive assessment of differences between bileaflet and 5 tilting-disc aortic valve prostheses by 3D-Doppler profiles. Interactive CardioVascular and Thoracic Surgery 4 (2005) 383-387.

E130 Schuetze,B.*; Kämmerer,M.*; Engelmann,U.; Weisser,G.*; Mildenberger,P.* Empfehlungen der @GIT für einen Standard für telemedizinische Anwendungen unter Verwendung von DICOM-E-Mail. mdi 7 (1) (2005) 4-7.

E130 Wolf,I.; Vetter,M.; Wegner,I.; Böttger,T.; Nolden,M.; Schöbinger,M.; Hastenteufel,M.; Kunert,T.; Meinzer,H.P. The medical imaging interaction toolkit. Medical Image Analysis 9 (6) (2005) 594-604.

53

E130 Weisser,G.*; Walz,M.*; Ruggiero,S.*; Kämmerer,M.*; Schröter,A.; Runa,A.*; Mildenberger,P.*; Engelmann,U. Standardization of teleradiology using Dicom e-mail: Recommendations of the German Radiology Society European Radiology 2005 [Epub ahead of print].

E160 Bay,J.O.*; Dhedin,N.*; Görner,M.; Vannier,J.P.*; Cardine,A.M.*; Stamatoullas,A.*; Jouet,J.P.*; Yakoub-Agha,I.*; Tabrizi,R.*; Faucher,C.*; Diez-Martin,J.L.*; Nunez,G.*; Parody,R.*; Milpied,N.*; Esperou,H.*; Garban,F.*; Galambrun,C.*; Kwiatkovski,F.*; Darlavoix,I.*; Zinai,A.*; Fischer,A.*; Michallet,M.*; Vernant,J.P.* Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: Retrospective analysis and comparison with other interleukin-2 receptor antibodies. Transplantation 80 (6) (2005) 782-788.

E160 Kornacker,M.*; Luft,T.; Ho,A.D.*; Schaefer,H.J.* Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - report of three cases. European Journal of Haematology 74 (3) (2005) 250-253.

E160 Luft,T.; Maraskovsky,E.*; Schnurr,M.* ID0 production, adaptive immunity, and CTL killing. Blood 106 (7) (2005) 2228-2229.

E160 Munder,M.; Mollinedo,F.*; Calafat,J.*; Canchado,J.*; Gil-Lamaignere,C.*; Fuentes,J.M.*; Luckner,C.; Doschko,G.; Soler,G.*; Eichmann,K.*; Mueller,F.M.*; Ho,A.D.*; Goerner,M.; Modolell,M.* Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105 (6) (2005) 2549-2556.

E160 Raab,M.S.*; Cremer,F.W.*; Breitkreutz,I.N.*; Gerull,S.*; Luft,T.; Benner,A.; Goerner,M.*; Ho,A.D.*; Goldschmidt,H.*; Moos,M.* Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myeloma. Annals of Oncology 16 (4) (2005) 611-617. C060.

E180 Jesnowski,R.; Fuerst,D.*; Ringel,J.; Chen,Y.; Schroedel,A.; Kleef,J.*; Kolb,A.*; Schareck,W.D.*; Löhr,M. Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine. Laboratory Investigation 85 (10) (2005) 1276-1291.

E180 Löhr,M.; Kloppel,G.*; Maisonneuve,P.*; Lowenfels,A.B.*; Luttges,J.* Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinorna and chronic pancreatitis: A meta-analysis. Neoplasia 7 (1) (2005) 17-23.

E180 Ryschich,E.*; Jesnowski,R.; Ringel,J.; Harms,W.*; Fabian,O.V.*; Saller,R.*; Schrewe,M.*; Engel,A.*; Schmidt,J.*; Löhr,M. Combined therapy of experimental pancreatic cancer with CYP2B1 producing cells: low-dose ifosfamide and local tumor irradiation. International Journal of Cancer 113 (4) (2005) 649-653.

E190 Egner,A.*; Hell,S.W. Fluorescence microscopy with super-resolved optical sections. Trends in Cell Biology 15 (4) (2005) 207-215.

E190 Marme,N.*; Weston,K.D.*; Staudt,T.; Spatz,J.*; Knemeyer,J.P. A fluorescence-based assay for exopeptidases using self-quenching peptide probes with single-molecule sensitivity. International Journal of Environmental Analytical Chemistry 85 (9-11) (2005) 741-751. B070.

Forschungsschwerpunkt F F010 Bleker,S.; Sonntag,F.; Kleinschmidt,J.A.

Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type

54

2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity. Journal of Virology 79 (4) (2005) 2528-2540.

F010 Geletneky,K.; Calle,M.H.Y.; Rommelaere,J.; Schlehofer,J.R. Oncolytic potential of rodent parvoviruses for cancer therapy in humans: A brief review. Journal of Veterinary Medicine Series B-Infectious Diseases and Veterinary Public Health 52 (7-8) (2005) 327-330.

F010 Kronenberg,S.; Boettcher,B.*; von der Lieth,C.W.*; Bleker,S.; Kleinschmidt,J.A. A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1N termini. Journal of Virology 79 (9) (2005) 5296-5303. B090.

F010 Lang,S.I.; Boelz,S.; Stroh-Dege,A.Y.; Rommelaere,J.; Dinsart,C.; Cornelis,J.J. The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different. Journal of Virology 79 (1) (2005) 289-298.

F010 Li,J.H.*; Werner,E.; Hergenhahn,M.; Poirey,R.; Luo,Z.Y.*; Rommelaere,J.; Jauniaux,J.C. Expression profiling of human hepatoma cells reveals global repression of genes involved in cell proliferation, growth, and apoptosis upon infection with parvovirus H-1. Journal of Virology 79 (4) (2005) 2274-2286. C040.

F010 Moehler,M.H.*; Zeidler,M.*; Wilsberg,V.*; Cornelis,J.J.; Woelfel,T.*; Rommelaere,J.; Galle,P.R.*; Heike,M.* Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and cross-presentation by dendritic cells. Human Gene Therapy 16 (8) (2005) 996-1005.

F010 Nueesch,E.R.; Lachmann,S.; Rommelaere,J. Selective alterations of the host cell architecture upon infection with parvovirus minute virus of mice. Virology 331 (1) (2005) 159-174.

F010 Raykov,Z.; Savelyeva,L.; Balboni,G.*; Giese,T.*; Rommelaere,J.; Giese,N.A. B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression. Journal of Virology 79 (6) (2005) 3517-3524. B030.

F010 Twizere,J.C.*; Lefebvre,L.*; Collete,D.*; Debacq,C.*; Urbain,P.*; Heremans,H.*; Jauniaux,J.C.; Burny,A.*; Willems,L.*; Kettmann,R.* The homeobox protein MSX2 interacts with tax oncoproteins and represses their transactivation activity. Journal of Biological Chemistry 280 (33) (2005) 29804-29811.

F020 Chen,R.W.*; Sehr,P.; Waterboer,T.; Leivo,I.*; Pawlita,M.; Vaheri,A.*; Aaltonen,L.M.* Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue. Journal of Clinical Microbiology 43 (3) (2005) 1408-1410.

F020 Kreimer,A.R.*; Clifford,G.M.*; Snijders,P.J.F.*; Castellsague,X.*; Meijer,C.J.L.M.*; Pawlita,M.; Viscidi,R.*; Herrero,R.*; Franceschi,S.* HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. International Journal of Cancer 115 (2) (2005) 329-332.

F020 Löchelt,M.; Romen,F.; Bastone,P.; Muckenfuss,H.*; Kirchner,N.; Kim,Y.B.; Truyen,U.*; Rosler,U.*; Battenberg,M.*; Saib,A.*; Flory,E.*; Cichutek,K.*; Munk,C.* The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proceedings of the National Academy of Sciences of the United States of America 102 (22) (2005) 7982-7987.

F020 Riezebos-Brilman,A.*; Regts,J.*; Freyschmidt,E.J.; Dontje,B.*; Wilschut,J.*; Daemen,T.* Induction of human papilloma virus E6/E7-specific cytotoxic T-lymphocyte activity in immune-tolerant, E6/E7-transgenic mic. Gene Therapy 12 (18) (2005) 1410-1414.

F020 Steinberg,T.; Oehlschlaeger,P.; Sehr,P.; Osen,W.; Gissmann,L. Modification of HPV 16 E7 genes: correlation between the level of protein expression and CTL response after immunization of C57BL/6. Vaccine 23 (9) (2005) 1149-1157. D070.

55

F020 Waterboer,T.; Sehr,P.; Michael,K.M.; Franceschi,S.*; Nieland,J.D.*; Joos,T.O.*; Templin,M.F.*; Pawlita,M. Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clinical Chemistry 51 (10) (2005) 1845-1853.

F030 Baldus,S.E.*; Schwarz,E.; Lohrey,C.; Zapatka,M.*; Landsberg,S.*; Hahn,S.A.*; Schmidt,D.*; Dienes,H.P.*; Schmiegel,W.H.*; Schwarte-Waldhoff,I.* Smad4 deffiency in cervical carcinoma cells. Oncogene 24 (5) (2005) 810-819. F065.

F030 Gutmann,S.; Zawatzky,R.; Müller,M. Characterisation and quantification of equine interferon gamma. Veterinary Immunology and Immunopathology 104 (1-2) (2005) 105-115. F035.

F030 Hoffmann,M.*; Görögh,T.*; Gottschlich,S.*; Lohrey,C.; Rittgen,W.; Ambrosch,P.*; Schwarz,E.; Kahn,T.* Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Letters 218 (2) (2005) 199-206. C060.

F030 Hoffmann,M.*; Gottschlich,S.*; Görögh,T.*; Lohrey,C.; Schwarz,E.; Ambrosch,P.*; Kahn,T.* Human papillomaviruses in lymph node neck metastases of head and neck cancers. Acta Oto-Laryngologica 125 (4) (2005) 415-421.

F030 Hoffmann,M.*, Klose,N.*, Gottschlich,S.*, Görögh,T.*, Fazel,A.*, Lohrey,C., Rittgen,W., Ambrosch,P.*, Schwarz,E., Kahn,T*. Detection of human papillomavirus DNA in benign and malignant sinonasal neoplasms. Cancer Letters (2005) [Epub ahead of print]. C060

F030 Leiros,G.J.*; Galliano,D.R.*; Ember,M.E.*; Kahn,T.*; Schwarz,E.; Eiguchi,K.* Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urology 5 (2005) 15-206.

F030 Samuelsson,C.V.*; Lienenklaus,S.*; Mueller,P.P.*; Zawatzky,R.; Hauser,H.*; Weiss,S.* Transformation of mouse fibroblasts alters the induction pattern of type IIFNs after virus infection. Biochemical and Biophysical Research Communications 335 (2) (2005) 584-589.

F030 van Riggelen,J.; Buchwalter,G.*; Soto,U.; de Castro Arce,J.; zur Hausen,H.Z.; Wasylyk,B.*; Rösl,F. Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells. Journal of Biological Chemistry 280 (5) (2005) 3286-3294. F040.

F035 Eisenberger,T.*; Lipps,H.J.*; Müller,M.; Baiker,A.* A Human Papillomavirus (HPV) - based pseudoviral gene delivery system for the non-viral, episomally replicating vector pEPI-1. Gene Therapy and Molecular Biology 9 (2005) 371-376.

F035 Kieback,E.*; Müller,M. Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein. Virology 2005 [Epub ahead of print].

F035 Müller,M. Codon-optimization of Papillomavirus genes. Methods in Molecular Medicine 119 (2005) 433-444.

F040 Pagans,S.*; Pedal,A.; North,B.J.*; Kaehlcke,K.; Marshall,B.L.*; Dörr,A.; Hetzer-Egger,C.; Henklein,P.*; Frye,R.*; McBurney,M.W.*; Hruby,H.*; Jung,M.*; Verdin,E.*; Ott,M. SIRT1 regulates HIV transcription via Tat deacetylation. Plos Biology 3 (2) (2005) 210-220.

F040 zur Hausen,H.; de Villiers,E.M. Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas. International Journal of Cancer 115 (1) (2005) 1-5. F070.

F045 Faehling,M.*; Steege,A.*; Perlewitz,A.; Nafz,B.*; Mrowka,R.*; Persson,P.B.*; Thiele,B.J.* Role of nucleolin in posttranscriptional control of MMP-9 expression. Biochimica et Biophysica Acta-Gene Structure and Expression 1731 (1) (2005) 32-40.

56

F045 Timofeev,O.; Lee,T.Y.*; Bulavin,D.V.* A subtle change in p38 MAPK activity is sufficient to suppress in vivo tumorigenesis. Cell Cycle 4 (1) (2005) 118-120.

F045 Volkening,M.; Hoffmann,I. Involvement of human MCM8 in prereplication complex assembly by recruiting hcdc6 to chromatin. Molecular and Cellular Biology 25 (4) (2005) 1560-1568.

F050 Bravo,I.G.; Crusius,K.; Alonso,A. The E5 protein of the human papillomavirus type 16 modulates composition and dynamics of membrane lipids in keratinocytes. Archives of Virology 150 (2) (2005) 231-246.

F050 Bravo,I.G.; Müller,M. Codon usage in papillomavirus genes: practical and functional aspects. Papillomavirus Report 16 (2005) 63-72. F035.

F050 Garcia-Vallve,S.*; Alonso,A.; Bravo,I.G. Papillomaviruses: different genes have different histories. Trends in Microbiology 13 (11) (2005) 514-521.

F050 Gould,V.E.*; Mosquera,J.M.*; Leykauf,K.; Gattuso,P.*; Duerst,M.*; Alonso,A. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries. Human Pathology 36 (5) (2005) 536-545.

F050 Haas,U.*; Podda,M.*; Behne,M.*; Gurrieri,S.*; Alonso,A.; Fürstenberger,G.; Pfeilschifter,J.*; Lambeau,G.*; Gelb,M.H.*; Kaszkin,M.* Characterization and differentiation-dependent regulation of secreted phospholipases A(2) in human keratinocytes and in healthy and psoriatic human skin. Journal of Investigative Dermatology 124 (1) (2005) 204-211. A140.

F065 Hengstermann,A.*; D'silva,M.A.*; Kuballa,P.*; Butz,K.; Hoppe-Seyler,F.; Scheffner,M.* Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53. Journal of Virology 79 (14) (2005) 9296-9300.

F070 de Villiers,E.M.; Sandstrom,R.E.*; zur Hausen,H.; Buck,C.E.* Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Research 7 (1) (2005) R1-R11

F070 Egawa,K.*; Kimmel,R.; de Villiers,E.M. A novel type of human papillomavirus (HPV 95): comparison with infections of closely related human papillomavirus types. British Journal of Dermatology 153 (3) (2005) 688-689.

F070 Fei,J.W.; Wei,Q.X.; Angel,P.; de Villiers,E.M. Differential enhancement of a cutaneous HPV promoter by Delta NP63 alpha, Jun and mutant p53. Cell Cycle 4 (5) (2005) 689-696. A100. C040.

F070 Koppikar,P.*; deVilliers,E.M.; Mulherkar,R.* Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. International Journal of Cancer 113 (6) (2005) 946-950.

F070 Sospedra,M.*; Zhao,Y.*; zur Hausen,H.; Murano,P.A.*; Hamashin,C.*; de Villiers,E.M.; Pinilla,C.*; Martin,R.* Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PLoS Pathogens 1 (4) (2005) e41

F080 Hofmann,T.G.; Jaffray,E.*; Stollberg,N.*; Hay,R.T.*; Will,H.* Regulation of homeodomain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification. Journal of Biological Chemistry 280 (32) (2005) 29224-29232.

F080 Mohrmann,G.*; Hengstler,J.G.*; Hofmann,T.G.; Endele,S.U.*; Lee,B.*; Stelzer,C.*; Zabel,B.*; Brieger,J.*; Hasenclever,D.*; Tanner,B.*; Sagemueller,J.*; Sehouli,J.*; Will,H.*; Winterpacht,A.* SPOC1, a novel PHD-finger protein: Association with residual disease and survival in ovarian

57

cancer. International Journal of Cancer 116 (4) (2005) 547-554.

F090 Cartellieri,M.*; Herchenroeder,O.*; Rudolph,W.*; Heinkelein,M.*; Lindemann,D.*; Zentgraf,H.; Rethwilm,A.* N-terminal gag domain required for foamy virus particle assembly and export. Journal of Virology 79 (19) (2005) 12464-12476.

F090 Gareiss,M.*; Eberhardt,K.*; Krueger,E.*; Kandert,S.*; Böhm,C.; Zentgraf,H.; Mueller,C.R.*; Dabauvalle,M.C.* Emerin expression in early development of Xenopus laevis. European Journal of Cell Biology 84 (2-3) (2005) 295-309.

F090 Gerke,P.*; Sellin,L.*; Kretz,O.*; Petraschka,D.*; Zentgraf,H.; Benzing,T.*; Walz,G.* NEPH2 is located at the glomerular slit diaphragm, interacts with nephrin and is cleaved from podocytes by metalloproteinases. Journal of the American Society of Nephrology 16 (6) (2005) 1693-1702.

F090 Gombert,M.*; Dieu-Nosjean,M.C.*; Winterberg,F.*; Bunemann,E.*; Kubitza,R.C.*; Da Cunha,L.*; Haahtela,A.*; Lehtimaki,S.*; Mueller,A.*; Rieker,J.*; Meller,S.*; Pivarcsi,A.*; Koreck,A.*; Fridman,W.H.*; Zentgraf,H.W.; Pavenstadt,H.*; Amara,A.*; Caux,C.*; Kemeny,L.*; Alenius,H.*; Lauerma,A.*; Ruzicka,T.*; Zlotnik,A.*; Homey,B.* CCL1-CCR8 interactions: An axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. Journal of Immunology 174 (8) (2005) 5082-5091.

F090 Nebe,C.T.*; Rother,M.*; Brechtel,I.*; Costina,V.*; Neumaier,M.*; Zentgraf,H.; Boecker,U.*; Meyer,T.F.*; Szczepek,A.J.* Detection of Chlamydophila pneumoniae in the bone marrow of two patients with unexplained chronic anaemia. European Journal of Haematology 74 (1) (2005) 77-83.

F090 Schermer,B.*; Hoepker,K.*; Omran,H.*; Ghenoiu,C.*; Fliegauf,M.*; Fekete,A.*; Horvath,J.*; Koettgen,M.*; Hackl,M.*; Zschiedrich,S.*; Huber,T.B.*; Kramer-Zucker,A.*; Zentgraf,H.; Blaukat,A.*; Walz,G.*; Benzing,T.* Phosphorylation by casein kinase 2 induces PACS-1 binding of nephrocystin and targeting to cilia. Embo Journal 24 (24) (2005) 4415-4424.

F090 Schlieker,C.*; Zentgraf,H.; Dersch,P.*; Mogk,A.* ClpV, a unique Hsp100/Clp member of pathogenic proteobacteria. Biological Chemistry 386 (11) (2005) 1115-1127.

F090 Soba,P.*; Eggert,S.*; Wagner,K.*; Zentgraf,H.; Siehl,K.*; Kreger,S.*; Loewer,A.*; Langer,A.*; Merdes,G.*; Paro,R.*; Masters,C.L.*; Mueller,U.*; Kins,S.*; Beyreuther,K.* Homo- and heterodimerization of APP family members promotes intercellular adhesion. Embo Journal 24 (20) (2005) 3624-3634.

F090 Stange,A.*; Mannigel,I.*; Peters,K.*; Heinkelein,M.*; Stanke,N.*; Cartellieri,M.*; Goettlinger,H.*; Rethwilm,A.*; Zentgraf,H.; Lindemann,D.* Characterization of prototype foamy virus Gag late assembly domain motifs and their role in particle egress and infectivity. Journal of Virology 79 (9) (2005) 5466-5476.

F100 Bhende,P.M.*; Seaman,W.T.*; Delecluse,H.J.; Kenney,S.C.* BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. Journal of Virology 79 (12) (2005) 7338-7348.

F100 Chen,L.W.*; Chang,P.J.*; Delecluse,H.J.; Miller,G.* Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus. Journal of Virology 79 (15) (2005) 9635-9650.

F100 Farina,A.*; Feederle,R.; Raffa,S.*; Gonnella,R.*; Santarelli,R.*; Frati,L.; Angeloni,A.*; Torrisi,M.R.*; Faggioni,A.*; Delecluse,H.J. BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress. Journal of Virology 79 (6) (2005) 3703-3712.

F100 Feederle,R.; Shannon-Lowe,C.*; Baldwin,G.*; Delecluse,H.J. Defective infectious particles and rare packaged Genomes produced by cells carrying terminal-

58

repeat-negative Epstein-Barr virus. Journal of Virology 79 (12) (2005) 7641-7647.

F100 Gonnella,R.*; Farina,A.*; Santarelli,R.*; Raffa,S.*; Feederle,R.*; Bei,R.*; Granato,M.*; Modesti,A.*; Frati,L.*; Delecluse,H.J.; Torrisi,M.R.*; Angeloni,A.*; Faggioni,A.* Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: Interactions with BFRF1 and with the nuclear lamina. Journal of Virology 79 (6) (2005) 3713-3727.

F100 Hong,G.K.*; Gulley,M.L.*; Feng,W.H.*; Delecluse,H.J.; Holley-Guthrie,E.*; Kenney,S.C.* Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model. Journal of Virology 79 (22) (2005) 13993-14003.

F100 Hong,G.K.*; Kumar,P.*; Wang,L.*; Damania,B.*; Gulley,M.L.*; Delecluse,H.J.; Polverini,P.J.*; Kenney,S.C.* Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines. Journal of Virology 79 (22) (2005) 13984-13992.

F100 Schelcher,C.*; Valencia,S.*; Delecluse,H.J.; Hicks,M.*; Sinclair,A.J.* Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLFI) prevents reactivation of EBV from latency. Journal of Virology 79 (21) (2005) 13822-13828.

F100 Shannon-Lowe,C.*; Baldwin,G.*; Feederle,R.; Bell,A.*; Rickinson,A.*; Delecluse,H.J. Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth. Journal of General Virology 86 (2005) 3009-3019.

Verschiedene Schlatterer,K.*; Gminski,R.*; Schlatterer,J.*; Hecker,E.; Chandra,P.*; Schlatterer,B.*; Krauter,G.*;

Chandra,A.* 12-O-retinoylphorbol-13-acetate (RPA) behaves like a retinoid-derivative in binding to retinol-binding-protein: a correlation with its specific action as an incomplete tumor promoter? Anticancer Research 25 (5) (2005) 3355-3365.

M010 Calaminus,G.*; Bamberg,N.*; Harms,D.*; Jurgens,H.*; Kortmann,R.D.*; Sorensen,N.*; Wiestler,O.D.; Gobel,U.* AFP/beta-HCG secreting CNS germ cell tumors: Long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Neuropediatrics 36 (2) (2005) 71-77.

M010 Majores,M.*; Blumcke,I.*; Urbach,H.*; Meroni,A.*; Hans,V.*; Holthausen,H.*; Elger,C.E.*; Schramm,J.*; Galli,C.*; Spreafico,R.*; Wiestler,O.D.; Becker,A.J.* Distinct allelic variants of TSC1 and TSC2 in epilepsy-associated cortical malformations without balloon cells. Journal of Neuropathology and Experimental Neurology 64 (7) (2005) 629-637.

M010 Montesinos-Rongen,M.*; Schmitz,R.*; Courts,C.*; Stenzel,W.*; Bechtel,D.*; Niedobitek,G.*; Bluemcke,I.*; Reifenberger,G.*; von Deimling,A.*; Jungnickel,B.*; Wiestler,O.D.; Kueppers,R.*; Deckert,M.* Absence of immunoglobulin class switch in primary lymphomas of the central nervous system. American Journal of Pathology 166 (6) (2005) 1773-1779.

M010 Pels,H.*; Montesinos-Rongen,M.*; Schaller,C.*; Schlegel,U.*; Schmidt-Wolf,I.G.H.*; Wiestler,O.D.; Deckert,M.* VH gene analysis of primary CNS lymphomasy. Journal of the Neurological Sciences 228 (2) (2005) 143-147.

M010 Waha,A.*; Guntner,S.*; Huang,T.H.M.*; Yan,P.S.*; Arslan,B.*; Pietsch,T.*; Wiestler,O.D.; Waha,A.* Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas. Neoplasia 7 (3) (2005) 193-199.

M050 Boyle,P.*; Ariyaratne,M.A.Y.*; Bartelink,H.*; Baselga,J.*; Berns,A.*; Brawley,O.W.*; Burns,H.*; Davidov,M.H.*; Dinshaw,K.A.*; Dresler,C.*; Eggermont,A.M.M.*; Gajurel,D.*; Gordina,G.*; Gray,N.*; Kakizoe,T.*; Karki,B.S.*; Kasler,M.*; Kerr,D.J.*; Khayat,D.*; Kiselev,A.*;

59

Khuhaprema,T.*; Klocker,H.*; Levshin,V.*; Martin-Moreno,J.M.*; Mcvie,J.G.*; Mendelsohn,J.*; Napalkov,N.P.*; Ngoma,T.A.*; Park,J.G.*; Philip,T.* u.a. Curbing tobacco's toll starts with the professionals: World No Tobacco Day. Lancet 365 (9476) (2005) 1990-1992. M010.

M050 Schulze,A.; Mons,U. Trends in cigarette smoking initiation and cessation among birth cohorts of 1926-1970 in Germanv. European Journal of Cancer Prevention 14 (5) (2005) 477-483.

M070 Efferth,T. Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy. Drug Resistance Updates 8 (1-2) (2005) 85-97.

M070 Efferth,T. Microarray-based prediction of cytotoxicity of tumor cells to cantharidin. Oncology Reports 13 (3) (2005) 459-463.

M070 Efferth,T.; Rauh,R.*; Kahl,S.*; Tomicic,M.*; Bochzelt,H.*; Tome,M.E.*; Briehl,M.M.*; Bauer,R.*; Kaina,B.* Molecular modes of action of cantharidin in tumor cells. Biochemical Pharmacology 69 (5) (2005) 811-818.

M070 Efferth,T.; Volm,M. Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate. In Vivo 19 (1) (2005) 225-232.

M070 Schwarzl,S.M.*; Smith,J.C.*; Kaina,B.*; Efferth,T. Molecular modeling of O-6-methylguanine-DNA methyltransferase mutant proteins encoded by single nucleotide polymorphisms. International Journal of Molecular Medicine 16 (4) (2005) 553-557.

V232 Dong,W.*; Kloz,U.; Accardi,R.*; Caldeira,S.; Tong,W.M.*; Wang,Z.Q.*; Jansen,L.*; Duerst,M.*; Sylla,B.S.*; Gissmann,L.; Tommasino,M.* Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type. Journal of Virology 79 (23) (2005) 14899-14908. F020.

V310 Gutjahr,C.*; Murphy,D.*; Lueking,A.*; Koenig,A.*; Janitz,M.*; O'Brien,J.*; Korn,B.; Horn,S.*; Lehrach,H.*; Cahill,D.J.* Mouse protein arrays from a T(H)1 cell cDNA library for antibody screening and serum profiling. Genomics 85 (3) (2005) 285-296.

V310 Stelzl,U.*; Worm,U.*; Lalowski,M.*; Haenig,C.*; Brembeck,F.H.*; Goehler,H.*; Stroedicke,M.*; Zenkner,M.*; Schoenherr,A.*; Koeppen,S.*; Timm,J.*; Mintzlaff,S.*; Abraham,C.*; Bock,N.*; Kietzmann,S.*; Goedde,A.; Toksoz,E.*; Droege,A.*; Krobitsch,S.*; Korn,B.; Birchmeier,W.*; Lehrach,H.*; Wanker,E.E.* A human protein-protein interaction network: A resource for annotating the proteome. Cell 122 (6) (2005) 957-968.

Z060 Luecker,E.*; Biedermann,W.*; Lachhab,S.*; Heuss,E. Transmissible spongiform encephalopathies: Assessment of exposure risk in the histological working environment using GC-MS detection of fatty acids as marker for central nervous tissues. International Journal of Hygiene and Environmental Health 208 (5) (2005) 391-399.

Bücher B020 Vinayagam,A.; del Val,R.; Koenig,R.; Schubert,F.; Eils,R.; Glatting,K.H.; Suhai,S.

GOPET: a tool for automatic Gene Ontology term prediction. Proceedings of the First AFP SIG in ISMB 2005 ed. Detroit,MI: 2005. 37 S. B080.

C060 Edler,L.; Kitsos,C.P.* Recent advances in quantitative methods in cancer and human health risk assessment. Chichester, West Sussex, UK: 2005. (Wiley Series in Probability and Statistics.). D070 Schadendorf,D.

Aktuelle Aspekte der Immuntherapie in der Dermatologie. Bremen: Uni-Med Science, 2005.

60

E040 Bille,J.*; Schlegel,W. Medizinische Physik 3. Berlin: Springer, 2005. 448 S.

E040 Korb,W. Control and Kinematic Modeling of a Neurosurgical High-Precision Manipulator. Reihe 17, Nr. 251. VDI-Verlag, 2005. 120 S. (Fortschritt-Berichte VDI.).

E040 Schlegel,W.; Bortfeld,T.*; Grosu,A.-L.* New Technologies in Radiation Oncology. Berlin Heidelberg New York: Springer Verlag, 2005. 460 S.

E130 Meinzer,H.P.; Handels,H.*; Horsch,A.*; Tolxdorff,T.* Bildverarbeitung für die Medizin. Heidelberg: Springer, 2005.

E180 Löhr,M.; Friess,H.* Pancreatic Cancer. Bremen: Uni•Med-Verlag, 2005.

Buchbeiträge Forschungsschwerpunkt A A090 Rius,M.; Hofmann,A.F.*; Nies,A.T.; Keppler,D.

Bile Salt and Glutathione Coefflux Mediated by Multidrug Resistance Protein MRP4 (ABCC4), a Basolateral Transporter of the Hepatocyte. G.Paumgartner et al ed. Dordrecht: Springer, 2005. S. 101-106. (Bile Acid Biology and its Therapeutic Implications). A180.

A105 Rost,D.*; Kopplow,K.*; Gehrke,S.*; Stiehl,A.*; Mayer,D. Gender-specific expression of liver organic anion transporters. In: Bile Acid Biology and its Therapeutic Implications. Hrsg.: U.L.G.P.A.S.D.Keppler. 2005. S. 118-121. (Falk Symposium).

A135 Pyerin,W.; Kasperk,C.*; Noeldge,G.* Tumorassoziierte Osteoporose. In: REPORT Tumorzentrum Heidelberg/Mannheim 2002-2004. 2005. S. 286-290.

A150 Klingmüller,U. Biological foundations of Signal Transduction and the Systems Biology Perspective. In: Computational Systems Biology. Elsevier Academic Press, 2005.

A150 Timmer,J.*; Kollmann,U.*; Klingmüller,U. Systems Biology of the JAK-STAT Signaling Pathway. In: Chemical Biology. 2005.

Forschungsschwerpunkt B B030 Schwab,M.

Molecular Cytogenetics. In: Neuroblastoma. Hrsg.: V.C.Nai-Kong u.a. Springer Verlag, 2005. S. 27-40.

B040 Bodnar,A.*; Vamosi,G.*; Toth,K.; Jenei,A.*; Matyus,L.*; Damjanovich,S.* Non-random patterns of membrane proteins and their roles in transmembrane signaling. In: Biophysical aspects of transmembrane signaling. Hrsg.: S.Damjanovich. Berlin Heidelberg New York: Springer, 2005.

B060 Kramer,H.; Schlingemann,J. RNA-Amplifikation für Oligonukleotid-Microarrays. In: Praktische Anwendung in der Krebsforschung.Teil 1. 2005. S. 350-353. (MTA-Dialog Mai 2005).

B060 Kramer,H.; Schlingemann,J. RNA-Amplifikation für Oligonukleotid-Microarrays. In: Praktische Anwendung in der Krebsforschung Teil 2. 2005. S. 410-413. (MTA-Dialog Juni 2005).

61

B060 Schwaenen,C.*; Nessling,M.; Radlwimmer,B.; Wessendorf,S.*; Lichter,P. Applications of Matrix-CGH (Array-CGH) for Genomic Research and Clinical Diagnostics. In: Microarray Technology and Its Applications. Hrsg.: U.R.Mueller u.a. Berlin Heidelberg: Springer-Verlag, 2005. S. 251-263.

B070 Beier,M.; Hoheisel,J.D. DNA-microarray preparation by light-controlled in situ synthesis. In: Curr. Protocols Nucleic Acid Chem. 2005.

B070 Beier,V.; Mund,C.; Schanne,M.; Lyko,F.; Hoheisel,J.D. Characterisation of genomic methylation patterns in tumours. In: Exocrine Pancreas Cancer. Hrsg.: T.M.Gress u.a. Solvay: 2005. S. 254-260. A130.

B070 Buchholz,M.*; Kestler,H.A.*; Bauer,A.; Hoheisel,J.D.; Gress,T.M.* Development of diagnostic arrays for the differential diagnosis of a pancreatic mass. In: Exocrine Pancreas Cancer. Hrsg.: T.M.Gress u.a. Solvay: 2005. S. 396-403.

B070 Kusnezow,W.; Pulli,T.; Syagailo,Y.; Hoheisel,J.D. Microarray immunoassay of complex specimens; problems and technologic challenges. In: Handbook of Immunohistochemistry & In Situ Hybridisation of Human Carcinomas. Hrsg.: M.A.Hayat. 2005. S. 23-35.

B070 Rapp,B.*; Herrmann,D.*; Guber,A.*; Welle,A.*; Schild,D.*; Jacob,A.; Dauber,M.; Hoheisel,J.D. Mikrotiterplatte mit integrierter funktionalisierter Filterstruktur. In: Proceedings Mikrosystemtechnik Kongress 2005. Berlin, Offenbach: VDE Verlag, 2005. S. 773-776.

B080 Belitz,H.*; Rohr,K.; Müller,H.*; Wagenknecht,G.* Automatische, modellbasierte Segmentierung subkortikaler Areale aus MRT-Daten des menschlichen Gehirns: Erste Ergebnisse. In: Proc. Workshop Bildverarbeitung für die Medizin (BVM'05) Algorithmen, Systeme, Anwendungen. Hrsg.: H.-P.Meinzer u.a. Berlin, Heidelberg: Springer, 2005. S. 118-122. (Informatik aktuell).

B080 Castellanos,J.*; Rohr,K.; Tolxdorff,T.*; Wagenknecht,G.* De-noising MRI Data -- An Iterative Method for Filter Parameter Optimization. In: Proc. Workshop Bildverarbeitung für die Medizin (BVM'05) Algorithmen, Systeme, Anwendungen. Hrsg.: H.-P.Meinzer u.a. Berlin, Heidelberg: Springer, 2005. S. 40-44. (Informatik aktuell).

B080 Woerz,S.; Rohr,K. Adaptive Model-Based Segmentation of Human Vessels from 3D MRA and CTA Data. In: Proc. Workshop Bildverarbeitung für die Medizin (BVM'05). Hrsg.: H.-P.Meinzer u.a. Berlin, Heidelberg: Springer, 2005. S. 103-107. (Informatik aktuell).

B090 Jakubowski,N.*; Mihalopoulos,N.*; Mann,S.*; Lehmann,W.D. Speciation of Sulfur. In: Handbook of Element Speciation II: Species in the Environment, Food, Medicine & Occupational Health. Hrsg.: R.Cornelis u.a. New York: Wiley, 2005. S. 378-404.

B090 Krueger,R.; Lehmann,W.D. Determination of Phosphorus and Sulfur by LC-HR-ICP-MS for Analysis of Protein Phosphorylation. In: Handbook of High Resolution ICP-Mass Spectrometry. Hrsg.: C.Douthitt. Wiley, 2005.

B090 Lehmann,W.D. Covalent protein modification analysis by electrospray tandem mass spectrometry. In: Toxicogenomics: A Strategic View of Current Research and Applications. Hrsg.: J.Borlak. Weinheim: Wiley-VCH, 2005. S. 115-142.

B100 Poland,J.*; Wandschneider,S.; Urbani,A.*; Bernardini,S.*; Federici,G.*; Sinha,P.* Use of Proteomics to Study Chemosensitivity. In: Chemosensitivity.Vivo Models, Imaging, and Molecular Regulators. Hrsg.: Blumenthal. Totowa: Humana Press, 2005. S. 267-282. (Methods in Molecular Medicine.).

Forschungsschwerpunkt C C010 Risch,A.; Dally,H.; Edler,L.

Genetic polymorphisms in metabolising enzymes as lung cancer risk factors.

62

In: Recent advances in quantitative methods in cancer and human health risk assessment. Hrsg.: L.Edler u.a. Chichester, West Sussex, UK: 2005. S. 43-62. (Wiley Series in Probability and Statistics.). C060.

C030 Jedrychowski,W.*; Schmidt,M.; Wahrendorf,J.; Penar,A.* Protective effect of physical activity on the occurrence of colorectal cancer. In: Focus on Colorectal Cancer Research. Hrsg.: J.D.Martinez. Nova Science Publisher, 2005. S. 25-40.

C060 Edler,L.; Burkholder,I. Overview of phase I trials. In: Handbook of Statistics in Clinical Oncology, Second Edition. Hrsg.: J.Crowley. New York: Dekker, 2005. S. 3-29.

C060 Edler,L.; Kopp-Schneider,A.; Heinzl,H.* Dose reponse modeling. In: Recent advances in quantitative methods in cancer and human health risk assessment. Hrsg.: L.Edler u.a. Chichester, West Sussex, UK: 2005. S. 211-237. (Wiley Series in Probability and Statistics).

C060 Kitsos,C.P.*; Edler,L. Cancer risk assessment for mixtures. In: Recent advances in quantitative methods in cancer and human health risk assessment. Hrsg.: L.Edler u.a. Chichester, West Sussex, UK: 2005. S. 283-298. (Wiley Series in Probability and Statistics.).

C060 Pilz,L.; Edler,L. Klinische Studien. In: Therapieoptionen beim nicht-kleinzelligen Bronchialkarzinom. Revidierte 2. Auflage. Hrsg.: C.Manegold. Bremen: Uni-Med-Verlag, 2005. S. 179-190.

C060 Zorin,A.V.*; Hanin,L.*; Yakovley,A.Y.*; Edler,L. Estimating the natural history of breast cancer from bivariate data on age and tumor size. In: Recent advances in quantitative methods in cancer and human health risk assessment. Hrsg.: L.Edler u.a. Chichester, West Sussex, UK: 2005. S. 317-327. (Wiley Series in Probability and Statistics.).

Forschungsschwerpunkt D D010 Schirrmacher,V.

Anti-tumor immune memory and its activation for control of residual tumor cells and improvement of patient survival. In: Virus therapy of human cancers. Hrsg.: J.Sinkovics u.a. Marcel Decker, 2005. S. 481-531.

D020 Dröge,W. Oxidative stress and autophagy. In: Autophagy and Aging. Hrsg.: D.K.A.M Cuervo. 2005.

D020 Dröge,W. Oxidative stress in HIV infection. In: Oxidative Stress, Disease and Cancer. Hrsg.: K.K.Singh. Imper. Coll. Press London, 2005.

D070 Garbe,G.*; Hauschild,A.*; Volkenandt,M.*; Schadendorf,D.; Stolz,W.*; Reinhold,U.*; Kortmann,R.D.*; Kettelhack,C.*; Frerich,B.*; Keilholz,U.*; Dummer,R.*; Sebastian,G.*; Tilgen,W.*; Schuler,G.*; Mackensen,A.*; Kaufmann,R. Deutsche Leitlinie: Malignes Melanom. In: Interdisziplinäre Leitlinien zur Diagnostik und Behandlung von Hauttumoren. Hrsg.: C.Garbe. Stuttgart: Georg Thieme Verlag, 2005. S. 23-55.

D070 Goerdt,S.*; Dippel,E.*; Schadendorf,D. Maligne Tumoren der Haut. In: Klinische Pharmakologie. Hrsg.: M.Wehling. Stuttgart: Georg Thieme Verlag GmbH, 2005. S. 596-607.

D070 Paschen,A. Vakzination mit bakteriellen Vektoren. In: Aktuelle Aspekte der Immuntherapie in der Dermatologie. Hrsg.: D.Schadendorf. Bremen: Uni-Med Science, 2005.

63

D070 Roeckmann,H.; Schadendorf,D. Apoptosis in Melanoma: Approaches to Therapy. In: From Melanocytes to Melanoma: The Progression to Malignancy. Hrsg.: V.J.Hearing u.a. Totowa, New Jersey: Humana Press, 2005. S. 605-618.

D070 Schadendorf,D. Autologe dendritischen Zellen in der Tumortherapie - ein Überblick. In: Aktuelle Aspekte der Immuntherapie in der Dermatologie. Hrsg.: D.Schadendorf. Bremen: Uni-Med Science, 2005.

Forschungsschwerpunkt E E010 Zechmann,C.

Radiologie. In: Mediscript - Kommentierte Examensfragen 03/2005. Hrsg.: B.Haake. Urban & Fischer Verlag, 2005.

E010 Zechmann,C. Radiologie. In: Mediscript - Kommentierte Examensfragen 08/2005. Hrsg.: B.Haake. Urban & Fischer Verlag, 2005.

E020 Peter,J.; Ruehle,H.; Stamm,V.; Semmler,W. On the use of asymmetrical pinhole collimators for small animal SPECT Imaging. In: European Journal of Nuclear Medicine. 2005. E074.

E020 Risse,F.; Fink,C.; Peters,T.*; Vallo,S.*; Haecker,A.*; Huber,P.E.; Jenne,J. Investigation of radio-frequency (RF) abaltion in istolated kidneys by Magnetic Resonance Imaging - Preliminary results. In: Biomedizinische Technik/Biomedical Engineering. 2005. S. 1164-1165. E010. E050.

E040 Bendl,R. Virtual Therapy Simulation. In: New Technologies in Radiation Oncology. Hrsg.: W.Schlegel u.a. Berlin Heidelberg New York: Springer Verlag, 2005. S. 179-186.

E040 Brons,S.*; Hasch,B.*; Heeg,P.*; Kraemer,M. Angular scattering of light ions in therapy planning at GSI. In: GSI. 2005. (GSI Annual Report).

E040 D'Humieres,E.*; Lefebvre,E.*; Gremillet,L.*; Patin,D.*; Bourdier,A+.; Malka,V.*; Fuchs.T. New setups to improve proton acceleration with high intensity lasers. In: ECA. 2005. S. 2.170 (Proceedings of the 32nd EPS Conference on Plasma Physics.).

E040 Faiß,K.; Oertel,S.*; Schlegel,W.; Wetter,T.*; Bendl,R. Wissensbasierte Segmentierung von Risikoorganen in der Strahlentherapieplanung. In: Bildverarbeitung für die Medizin 2005, Algorithmen - Systeme - Anwendungen. Hrsg.: P.Meinzer. Berlin Heidelberg New York: Springer Verlag, 2005. S. 193-197.

E040 Filipenko,O.; Jäkel,O.; Hartmann,G.; Andreo,P.*; Sobolevsky,N.* Calculation of correction factors for heavy ion dosimetry. In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick u.a. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 348-349.

E040 Greger,K.*; Bille,J.*; Schlegel,W.; Sturm,V.* Stereotaktische Laserneurochirurgie. In: Medizinische Physik. Hrsg.: J.Bille u.a. Berlin Heidelberg New York: Springer Verlag, 2005. S. 391-411.

E040 Grosu,A.-L.*; Kneschaurek,P.*; Schlegel,W. Stereotactic Radiotherapy/Radiosurgery. In: New Technologies in Radiation Oncology. Hrsg.: W.Schlegel u.a. Berlin Heidelberg New York: Springer Verlag, 2005. S. 267-276.

E040 Haering,P.; Nill,S.; Rhein,B.; Pruisken,J.* A fluence based IMRT verification system: Results from the first 78 patients. In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick u.a. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 971-972.

E040 Hartmann,C.*; Karger,C.P.; Peschke,P.; Borkenstein,K. Computer simulation of tumour growth and radiation response: Implementation and analysis of

64

oxygen supply. In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick u.a. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 703-704. E050.

E040 Hartmann,G. Quality Management in Radiotherapy. In: New Technologies in Radiation Oncology. Hrsg.: W.Schlegel u.a. Berlin Heidelberg New York: Springer Verlag, 2005. S. 425-447.

E040 Hub,M.; Schad,L.; Karger,C.P. Analysis of distortions in MR images and quality assurance of MR images for treatment planning in radiotherapy. In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 1180-1181. E020.

E040 Jäkel,O. Heavy Ion Radiotherapy. In: New Technologies in Radiation Oncology. Hrsg.: W.Schlegel u.a. Berlin Heidelberg New York: Springer Verlag Berlin, 2005. S. 365-377.

E040 Jäkel,O.; Karger,C.P.; Kraemer,M.*; Debus,J. Medical Physics aspects of heavy ion therapy. In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick u.a. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 334-335.

E040 Karger,C.P. Biological Models in Treatment Planning. In: New Technologies in Radiation Oncology. Hrsg.: U.Schlegel u.a. Berlin Heidelberg New York: Springer Verlag, 2005. S. 221-235.

E040 Karger,C.P.; Heeg,P.; Jäkel,O. Quality assurance requirements for a hospital-based charged particle therapy facility. In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick u.a. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 350-351.

E040 Kyas,I.; Hof,H.*; Debus,J.; Karger,C.P. Modeling of complication probabilities in the lung for stereotactic radiosurgery. In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick u.a. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 1356-1357.

E040 Land,B.; Jäkel,O.; Combs,S.E.; Schulz-Ertner,D. Cost-effectiveness of carbon ion radiation therapy. In: Proc. of the 9th Workshop on Charged Particles in Biology and Medicine. 2005.

E040 Li,P.; Barthold-Beß,S.; Dickhaus,H.*; Schlegel,W. Respiratory gated radiation Therapy and Patient Repositioning in radiation oncology. In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick u.a. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 617-618.

E040 Nill,S.; Hinderer,R.; Oelfke,U. X-MRT. In: New Technologies in Radiation Oncology. Hrsg.: W.Schlegel u.a. Berlin Heidelberg New York: Springer Verlag, 2005. S. 289-298.

E040 Oelfke,U.; Scholz,C. Dose Calculation Algorithms. In: New Technologies in Radiation Oncology. Hrsg.: W.Schlegel u.a. Berlin Heidelberg New York: Springer Verlag, 2005. S. 187-196.

E040 Peter,J.; Ruehle,H.; Stamm,V.; Schulz,R.B.; Semmler,W.; Smith,M.F.*; Welch,B.*; Popov,V.*; Kross,B.*; Wojcik,R.*; Weisenberger,A.*; Majewski,S.* Development and Initial results of a Dual-Modality SPECT/Optical Small Animal Imager. In: Proc. IEEE Medical Imaging Conference. 2005. S. 1685 E074.

E040 Pflugfelder,D.; Wilkens,J.J.; Szymanowski,H.; Oelfke,U. Towards risk adapted inverse planning for protons: Avoiding risks due to lateral tissue inhomogeneities. In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick u.a. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 342-343.

65

E040 Qamhiyeh,S.; Ellerbrock,M.; Jäkel,O.; Schardt,D.* CT calibration for Heavy-ion treatment planning at the DKFZ. In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick u.a. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 453-454.

E040 Reitz,I.; Hesse,B.-M.; Oelfke,U.; Tuecking,T. An iterative scatter correction algorithm for kV CBCT (kilovoltage cone-beam computed tomography). In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick u.a. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 1024-1025.

E040 Rhein,B.; Haering,P. 3D Quality Assurance (QA) Systems. In: New Technologies in Radiation Oncology. Hrsg.: W.Schlegel u.a. Berlin Heidelberg New York: Springer Verlag, 2005. S. 411-423.

E040 Schlegel,W.; Grosser,K.H.*; Haering,P.; Rhein,B. Beam Delivery in 3D Conformal Radiotherapy Using Multi-Leaf Collimators. In: New Technologies in Radiation Oncology. Hrsg.: W.Schlegel u.a. Berlin Heidelberg New York: Springer Verlag, 2005. S. 257-266.

E040 Seeber,A.; Nill,S.; Tuecking,T.; Oelfke,U. Reconstruction of linac based cone-beam CT data for extended field-of-views: analysis quality for a novel imaging setup. In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick u.a. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 619-620.

E050 Bortfeld,T.*; Thieke,C. Optimization of Treatment Plans, Inverse Planning. In: New Technologies in Radiation Oncology. Hrsg.: W.Schlegel u.a. Berlin Heidelberg New York: Springer Verlag, 2005. S. 207-220.

E050 Divkovic,G.; Juergen,W.; Jenne,J. Egg White Phantoms for HIFU. In: 4th International Symposium on Therapeutic Ultrasound. New York: Melville, 2005. S. 143-146. (AIP Conference Proceedings).

E050 Jenne,J.; Wilzbach-Divkovic,G.; Braun,K.; Huber,P.E. Visualization of lesion formation during the appliction of high intensity focused ultraound (HIFU). In: Biomedizinische Technik/Biomedical Engineering. 2005. S. 366-367.

E050 Wilzbach-Divkovic,G.; Huber,P.E.; Jenne,J. Sound field modification for high intensity focused ultrasound therapy using a phased array transducer. In: Biomedizinische Technik. 2005. S. 382-383.

E050 Wirkner,U.; Maercker,C.; Abdollahi,A.; Wagner,M.*; Selig,J.*; Drzonek,H.; Radelof,U.*; Kellermann,A.*; Ansorge,A.*; Maurer,J.*; Schwager,C.*; Korn,B.; Wagner,W.*; Ho,A.D.*; Huber,P.E.; Ansorge,W.* Human genome on a chip in biomedical research. In: Molecular Diagnostics. Hrsg.: G.P.Patrinos u.a. Amsterdam, The Netherlands.: Elsevier Science, 2005. B050.

E060 Haberkorn,U. Modulation of tracer accumulation in malignant tumors: gene expression, gene transfer and phage display. In: Current Topics in Developmental Biology - In Vivo Cellular and Molecular Imaging. 2005. S. 145-169. (Ahrens ET (ed).).

E060 Mier,W.*; Hoffend,J.*; Haberkorn,U.; Eisenhut,M. Current strategies in tumor-targeting. In: Apoptotic Pathways as Targets for Novel Therapies in Cancer & Other Diseases. Boston London: Kluwer Academic Publ. Dordrecht, 2005. S. 343-356. (Gibson SB, Los M (eds).).

E060 Schoenknecht,P.*; Pantel,J.*; Hunt,A.R.; Henze,M.; Strowitzki,T.*; Schroeder,J.* Estrogens in Alzheimer's Disease: A Clinical and Neurobiological Perspective. In: Estrogene Effects in Psychiatric Disorders. Hrsg.: N.Bergemann u.a. Wien New York: Springer Verlag, 2005. S. 253-269.

66

E095 Herr,I. Molecular Biotechnology, Gene Therapy: Strategies and Vectors. In: Molecular Biotechnology, Gene Therapy: Strategies and Vectors. Hrsg.: M.Wink. WILEY-VCH, 2005. S. 527-546.

E095 Herr,I.; Weiher,H.*; Zwacka,R.* Molecular Biotechnology, The Use of Enzymes in the Modification of Nucleic Acids. Hrsg.: M.Wink. WILEY-VCH, 2005. S. 179-185.

E095 Mohr,A.*; Weiher,H.*; Herr,I.; Zwacka,R.* Molecular Biotechnology, Polymerase Chain Reaction (PCR). Hrsg.: M.Wink. WILEY-VCH, 2005. S. 187-194.

E095 Weiher,H.*; Zwacka,R.*; Herr,I. Molecular Biotechnology, Chromatography and Electrophoresis of nucleic acids. Hrsg.: M.Wink. WILEY-VCH, 2005. S. 169-172.

E095 Weiher,H.*; Zwacka,R.*; Herr,I. Molecular Biotechnology, Isolation of DNA and RNA. Hrsg.: M.Wink. WILEY-VCH, 2005. S. 163-167.

E095 Weiher,H.*; Zwacka,R.*; Herr,I. Molecular Biotechnology, Hybridization of nucleic acids. Hrsg.: M.Wink. WILEY-VCH, 2005. S. 173-178.

E095 Zwacka,R.*; Mohr,A.*; Herr,I.; Weiher,H.* Molecular Biotechnology, DNA Sequencing. Hrsg.: M.Wink. WILEY-VCH, 2005. S. 195-199.

E120 Fruehauf,S.*; Stiefelhagen,M.; Topaly,J.*; Seeger,T. Periphere Blutstammzellen - Einsatz für die Hochdosischemo- und -radiotherapie. In: Zeller/zur Hausen, Onkologie (ecomed). 2005. S. 1-26.

E120 Zeller,J.W. Immuntherapeutika und Zytostatika. In: Arzneiverordnungsreport. Hrsg.: U.Schwabe u.a. 2005. S. 672-685.

E130 Böttger,T.; Kunert,T.; Meinzer,H.P.; Wolf,I. Interactive constraints for 3D-simplex meshes. In: Proc. SPIE Medical Imaging 2005: Image Processing. Hrsg.: C.K.Galloway RL. 2005. S. 1692-1702.

E130 Engelmann,U.; Mildenberger,P.*; Schuetze,B.*; Schroeter,A.; Weisser,G.*; Walz,M.*; Kämmerer,M.* DICOM-E-Mail: the German minimal standard for teleradiology. In: Proceedings of the 19th International Congress and Exhibition Computer Assisted Radiology and Surgery CARS 2005. Hrsg.: I.K.D.K.V.M.F.A.Lempke HU. Amsterdam: Elsevier, 2005. S. 926-931.

E130 Engelmann,U.; Schuetze,B.*; Schroeter,A.; Weisser,G.*; Walz,M.*; Kämmerer,M.*; Mildenberger,P.* Teleradiologie per DICOM-E-Mail: Der empfohlene Minimalstandard der Deutschen Röntgengesellschaft. In: Proceedings Telemed 2005. bit for bit - Halbzeit auf dem Weg zur Telematikinfrastruktur. Hrsg.: T.T.Steyer G. Berlin: Akademische Verlagsanstalt, 2005. S. 102-107.

E130 Fischer,L.*; Thorn,M.; Neumann,J.O.*; Heimann,T.; Grenacher,L.*; Meinzer,H.P.; Friess,H.*; Büchler,M.W.* Die computergestützte Analyse von Größe, Position und Form venöser Lebersegmenten und deren Lagebeziehung zu dem Couinaud und portalen Lebersegmenten. In: Bildverarbeitung für die Medizin 2005. Hrsg.: H.H.H.A.T.T.Meinzer HP. Heidelberg: Springer, 2005. S. 21-25.

E130 Hastenteufel,M.; Vetter,M.; Mottl-Link,S.; De Simone,R.*; Meinzer,H.P.; Wolf,I. Interference of Electromagnetic Sensors Close to 3D Ultrasound Probes. In: Proc. Computers in Cardiology. Lyon: IEEE, 2005.

E130 Hastenteufel,M.; Yang,S.*; Christoph,C.*; Vetter,M.; Meinzer,H.P.; Wolf,I. Ultrasound-based navigation for minimally invasive surgical atrial fibrillation treatment. In: Proc. SPIE Medical Imaging: Visualization, Image-Guided Procedures, and Display. Hrsg.: C.K.Galloway R. Bellingham: 2005. S. 400-407.

67

E130 Maleike,D.; Unkelbach,J.; Oelfke,U. Simulation and visualization of dose uncertainties in radiation therapy due to interfractional internal organ motion. In: Biomedizinische Technik (Medical Physics Proceedings of the ICMP and BMT in Nürnberg). Hrsg.: U.Boenick. Berlin: Fachverlag Schiele & Schön GmbH, 2005. S. 227-228. E040.

E130 Mottl-Link,S.; Horsch,W.*; Wolf,I.; Hastenteufel,M.; Schwarz,T.; Meinzer,H.P.; Hagl,S.*; De Simone,R.* Klinische Anwendung verschiedener Segmentierungsverfahren in der Live-3D Echokardiographie Evaluation im Vergleich zum MRT. In: Bildverarbeitung für die Medizin 2005. Hrsg.: H.H.H.A.T.T.Meinzer HP. Heidelberg: Springer, 2005. S. 128-132.

E130 Münch,H.; Engelmann,U.; Schröter,A.; Meinzer,H.P. A secure software architecture for the collection and processing of medical image data in competence centers. In: Proceedings of the 19th International Congress and Exhibition Computer Assisted Radiology and Surgery CARS 2005. Hrsg.: I.K.D.K.V.M.F.A.Lemke HU. Amsterdam: Elsevier, 2005. S. 938-942.

E130 Vetter,M.; Libicher,M.*; Wolf,I.*; Ucar,M.; Neuhaus,J.; Hastenteufel,M.; Richter,G.M.*; Meinzer,H.P. Navigationssystem für die perkutane CT-gesteuerte Radiofrequenz-Ablationstherapie von Lebertumoren. In: Bildverarbeitung für die Medizin 2005. Hrsg.: H.H.H.A.T.T.Meinzer HP. Heidelberg: Springer, 2005. S. 227-231.

E130 Vetter,M.; Neuhaus,J.; Wegner,I.; Schöbinger,M.; Meinzer,H.P.; Wolf,I. Bounding-object segmentation. In: Proc. SPIE Medical Imaging 2005: Image Processing. Hrsg.: C.K.Galloway RL. 2005. S. 1628-1635.

E130 Wegner,I.; Vetter,M.; Schöbinger,M.; Wolf,I.*; Harms,W.*; Becker,H.*; Meinzer,H.P. Entwicklung eines Navigationssystems für die endoluminale Brachytherapie. In: Bildverarbeitung für die Medizin 2005. Hrsg.: H.H.H.A.T.T.Meinzer HP. Heidelberg: Springer, 2005. S. 213-216.

E130 Wolf,I.; Hastenteufel,M.; Wegner,I.; Vetter,M.; Greil,G.F.*; Kuettner,A.*; Claussen,C.D.*; Meinzer,H.P. Curved reformations using the medical imaging interaction toolkit (MITK). In: Proc. SPIE Medical Imaging 2005: Visualization, Image-Guided Procedures, and Display. Hrsg.: C.K.Galloway RL. 2005. S. 831-838.

E170 Pekrun,A.*; Reinhardt,D.*; Witt,O. Angeborene Erythrozytenenzymdefekte. In: Pädiatrische Hämatologie und Onkologie. Hrsg.: Gadner u.a. Heidelberg: Springer-Verlag, 2005. S. 139-146.

E180 Haas,S.*; Ringel,J.; Löhr,M. Pankreaskarzinom. In: Alkoholfolgekrankheiten. Hrsg.: M.V.Singer u.a. Heidelberg: Springer Verlag, 2005. S. 222-229.

E190 Hell,S.W. Hochauflösende 3D-Lichtmikroskopie. In: Medizinische Physik. Hrsg.: J.Bille. Springer Verlag, 2005. S. 179-214. Forschungsschwerpunkt F F010 Rommelaere,J.; Giese,N.; Cornelis,J.J.; Cziepluch,C.

Parvoviruses as anti-cancer agents. In: Virus Therapy of Human Cancers. Hrsg.: G.Sinkovics u.a. New York: Marcel Dekker, 2005. S. 627-675.

F070 de Villiers,E.-M.; Bernard,H.-U.*; Broker,T.*; Delius,H.; zur Hausen,H. Papillomaviridae.

68

In: VIIIth Report of the ICTV. Hrsg.: C.M.Fauquet u.a. London: Elsevier/Academic Press, 2005. S. 239-253. (Virus Taxonomy).

F070 de Villiers,E.-M.; Whitley,C.; Gunst,K. Identification of New Papillomavirus Types. In: Human Papillomaviruses: Methods and Protocols. Hrsg.: C.Davy u.a. 2005. S. 1-13. (Methods in Molecular Medicine.).

Verschiedene S020 Beitel,C.; Hiller,B.

Krebsinformation qualitätsgesichert generieren. In: Community Services: Healthcare. Hrsg.: u.a.H.Krcmar. Köln: EUL Verlag, 2005. S. 139-156. (Schriften zu Kooperations- und Mediensystemen).

S020 Hiller,B. Qualitätsziele und Qualitätsmanagement: Vertrauen im die neuen Medien? In: Community Services: Healthcare. Hrsg.: u.a.H.Krcmar. Köln: EUL Verlag, 2005. S. 47-65. (Schriften zu Kooperations- und Mediensystemen).

S020 Leimeister,J.M.*; Daum,M.*; Arnold,Y.*; Krcmar,H.*; Hiller,B.; Roessle,S.*; Mueller,K.* Nachhaltigkeit und Transferkonzept von krebsgemeinschaft.de - Geschäftsmodellkonzeption für eine Virtuelle Patienten - Community. In: Community Services: Healthcare. Hrsg.: u.a.H.Krcmar. Köln: EUL Verlag, 2005. S. 223-247. (Schriften zu Kooperations- und Mediensystemen).

Habilitationsschriften A101 Müller,M.M.

Parakrine und autokrine Mechanismen der Tumorprogression und Stromamodulation: Aktivierung des Tumorstromas als Schlüssel zur Regulation des Tumorphänotyps. Habil. 2005.

C050 Kumar,R. Somatic genetic alterations in cutaneous melanoma and significance. Univ. Heidelberg, Med. Fak. Habil. 2005.

D010 Beckhove,P. Tumorreaktive Gedächtnis T-Zellen: Generierung und funktionelles Potential bei Tumorpatienten. Univ, Heidelberg, Fak. für Biowiss. Habil. 2005.

E050 Niethammer,A. Univ. Heidelberg, Med.Fak. Habil. 2005.

E050 Zabel-du Bois,A. Habil. 2005.

Dissertationen A010 Alonso Hess,A.

Molekulare Charakterisierung von Zell-Zell-Verbindungen und differenzierungsspezifische Verteilung von Keratinen im Urothel. Univ. Heidelberg, Med. Fak. 2005.

A010 Boda-Heggemann,J. Zell- und molekularbiologische Charakterisierung neuartiger Zell-Zell-Verbindungsarten in Glioma-Zellen und mesenchymalen Stammzellen. Univ. Heidelberg, Fak. f. Biologie. Diss. 2005.

A060 Gosenca,D. Univ.Heidelberg, Fak. Diss. 2005.

A090 Michalski,C. Identifizierung und funktionelle Charakterisierung einer natürlich vorkommenden Mutation im SLC21A6-Gen. Univ. Heidelberg, Med. Fak. Diss. 2005.

69

A090 Rius,M. Functional characterization of recombinant human multidrug resistance protein 4 (MRP4/ABCC4). Univ. Heidelberg, Med. Fak. Diss. 2005.

A100 Florin,L. Regeneration of skin as a model to analyse trans-regulatory functions of AP-1 and identification of critical target genes. Univ. Heidelberg, Fak. f. Biologie. Diss. 2005.

A100 Gebhardt,C. Identification and analysis of tumor-associated cFos/AP-1 target genes in mouse skin carcinogenesis. Univ. Heidelberg, Med. Fak. Diss. 2005.

A100 Pein,O. The role of transcription factor JunB in cellular hypoxia response and angiogenesis: upstream signalling pathways and identification and functional analysis of the JunB target gene CBFβ. Univ. Heidelberg, Fak. f. Biologie. Diss. 2005.

A101 Obermüller,E. Veränderte Wachstumsfaktorexpression in der Tumorprogression humaner Plattenepithelkarzinome der Haut: Einfluss auf Tumor-Stroma Interaktion, Invasion und Angiogenese. Diss. 2005.

A105 Hermani,A. Identification and functional characterization of novel markers for prostate cancer. Role of the calcium binding proteins S100A8 and S100A9 and the receptor for advanced glycation end products (RAGE) in human prostate cancer. Univ. Bonn, Fak. Math-Nat. Diss. 2005.

A110 Moshir,S. The role of telomere length and the threedimensional structure of telomeres in aging and cancer. Univ. Heidelberg, Fak. f. Biologie. Diss. 2005.

A130 Kunert,N. Identifizierung und Charakterisierung von IPOD, einem neuen Interaktionspartner der DNA-Methyltransferase Dnmt2 aus Drosophila melanogaster. Univ. Heidelberg, Fak. für Biowiss. Diss. 2005.

A135 Eisenberger,S. Genexpressionsänderungen in Osteozyten induziert durch Metastasen und andere destruktive Erkrankungen des Knochens. Univ. Kaiserslautern, FB Biologie. Diss. 2005.

A135 Hoppe,G. Promotervariation des Aromatase-Gens (CYP19) und Genexpressionsmuster bei Osteoporose. Univ. Kaiserslautern, FB Biologie. Diss. 2005.

A135 Schröck,S. Einfluss von Proteinkinase CK2 auf die Genexpressionsänderungen im Kontext der Knochenmetastasierung. Univ. Kaiserslautern, FB Biologie. Diss. 2005.

A140 Neumann,M. Ein Cyclooxygenase-2 transgenes Mausmodell: Molekulare und histologische Veränderungen der Haut. Univ. Heidelberg, Fak. Nat-Math. Diss. 2005.

B020 Ernst,P. Complex analysis pipelines in bioinformatics. Univ. Heidelberg, Med. Fak. Diss. 2005.

B020 Knapp-Mohammady,M. Kooperative Effekte in der Strukturbildung von Biomolekülen. Univ. Heidelberg, Med. Fak. Diss. 2005.

B030 Arnold,K. Genetische Instabilität bei heterozygoten BRCA2-Mutatioonsträgern. Univ Kaiserlautern, FB Biologie. Diss. 2005.

70

B050 Schneider,J. cDNA-Mikroarray Analysen zur molekularen Charakterisierung des invasiv duktalen Mammakarzinoms. Univ. Heidelberg, Fak. Diss. 2005.

B060 Adamowicz,M. Expression profiling and fine-mapping of high-level amplifications on chromosome 5p14 in soft tissue tumours using matrix-CGH. Diss. 2005.

B060 Hummerich,L. Identifizierung vom tumorrelevanten Genen epithelialer Hauttumoren mittels Expressionsanalyse. Diss. 2005.

B060 Schlingemann,J. Entwicklung neuer RNA-Amplifikationstechniken für das Erstellen von Expressionsprofilen mittels DNA-Microarrays. DIss. 2005.

B060 Sticht,C. Genomische Charakterisierung der chromosomalen Regionen 11q13 und 3q25-q29 in Platten-epithelkarzinomen der Kopf-Hals-Region. Diss. 2005.

B060 Tews,B. Transkriptomstudien humaner Tumoren des zentralen Nervensystems: Identifizierung pathogenetisch relevanter Onko- und Suppressorgene. Diss. 2005.

B080 Bacher,C. Computational imaging of dynamic nuclear processe in living somatic and germ line cells. Univ. Heidelberg, Biol. Fak. Diss. 2005.

B080 Bulashevska,A. Model-based classification for subcellular localization prediction of proteins. Univ. Karlsruhe, Fak. für Inf. Diss. 2005.

B080 Gao,J. Quantitative Analysis of Chromosome / Gene Spatial Distribution. Univ. Heidelberg, Bio.Fak. Diss. 2005.

B090 Born,K. Neue Ansätze der Analyse von Kohlenhydrat-Protein-Wechselwirkungen durch Verwendung von aprotischen Lösungsmittelgemischen in Protonen-NMR Spektroskopie und Molekulardynamik Simulationen. Univ. Heidelberg, Fak. für Ch.-Geowiss. Diss. 2005.

B090 Luetteke,T. Automatische Extraktion und Analyse von glykorelevanten Daten aus der Proteine Data Bank (PDB). Ein Beitrag zur Entwicklung von Bioinformatik-Werkzeugen für die Glykobiologie. Univ. Heidelberg, Fak. für Biowiss. Diss. 2005.

B120 Beyer,M. Entwicklumg und Amwendung neusrtiger Trägeroberflächen zur kombinatorischen Peptidsynthese mit Aminosäure- Tonpartikeln. Univ. Heidelberg. Diss. 2005.

C010 Bertl,E. Inhibition of angiogenesis by potential cancer chemopreventive agents - establishment of a human in vitro anti-angiogenesis assay and mechanistic evaluation of potent inhibitors. Univ. Heidelberg, Med.Fak. Diss. 2005.

C010 Frank,A.P. Immunhistochemisch nachgewiesene promutagene Etheno-DNA-Addukte in humanen Leberbiopsien korrelieren mit pathologischen Veränderungen. Univ.Heidelberg, Med.Fak. Diss. 2005.

C010 Gassner,K. Die Relevanz des Cytochrom P450 1B1 Polymorphismus für das Lungenkrebsrisiko. Univ. Heidelberg, Med.Fak. Diss. 2005.

71

C020 Tan,X.L. Genetic polymorphisms in DNA-repair and cell cycle control genes as biomarkers for the development of acute side effects of radiotherapy in breast cancer patients. DIss. 2005.

C020 Verla-Tebit,E. Active and passive smoking and the risk of colorectal cancer. Diss. 2005.

C030 Poltermann,S. The Role of Herpesviruses in Brain Tumor Development. Univ. Gießen, Vet.Med. Fak. Diss. 2005.

C030 Schmidt,M. Design and evaluation of a short questionnaire for the assessment of physical activity in women. Univ. Heidelberg, Fak. Diss. 2005.

C050 Rawal,R. Univ. Heidelberg, Med. Fak. Diss. 2005.

D010 Ehlert,K. Tumor-reaktive T-Zellen des Knochenmarks - neue Perspektiven für die adoptive Immuntherapie des metastasierten Mammakarzinoms. Univ. Heidelberg, Fak. für Biowiss. Diss. 2005.

D010 Janke,M. Einführung rekombinant-veränderter Newcastle Disease Viren als Vektoren für therapeutisch nutzbare Gene in der Tumortherapie. Univ., Fak. für Pharm.u. Molek.Biothech. Diss. 2005.

D010 Sommerfeld,N. Immunogenität und Expression verschiedener Tumor-assoziierter Antigene bei Brustkrebspatientinnen. Univ. Heidelberg, Nat.-Math. Fak. Diss. 2005.

D010 Stoeck,A. Funktionelle Untersuchungen zur Expression von L1 beim Ovarialkarzinom. Univ. Kaiserslautern, Fak. für Chem. Diss. 2005.

D030 Fas,S. Mechanismen zur Apoptoseresistenz bei T-Zellen und ihre Resensibilisierung. Univ. Witte/Herdecke, Fak. für Biowiss. Diss. 2005.

D030 Fritsch,C. Regulation des Aktivierungs-Induzierten Zelltods in peripheren humanen T-Zellen durch das anti-apopto-tische Protein c-FLIP. Univ. Jena, Bio.-Pharm. Fak. Diss. 2005.

D030 Golks,A. Zelluläre Regulation von Leben und Tod durch Todes-effektordomänen(DED)-enthaltende Proteine: CAP3, c-FLIPR und p22-FLIP. Univ. Heidelberg, Nat.-Math. Fak. Diss. 2005.

D030 Kleber,S. γ-Bestrahlung führt zu CD95-abhängiger Invasivität in apoptoseresistenten Glioblastomzellen. Univ. Heidelberg, Nat.-Math. Fak. Diss. 2005.

D030 Weyd,H. Die Rolle von Annexin I auf der Oberfläche apoptotischer Zellen. Univ. Hamburg, Fak. für Biol. Diss. 2005.

D030 Zuliani,C. The CD95/CD95L system and its role in the developing brain. Univ. Heidelberg, Med.Fak. Diss. 2005.

D040 Schader,M. Das tumortherapeutische Potential optimierter Agonisten der Rezeptoren des Apoptose-induzierenden Liganden TRAIL. Diss. 2005.

D050 Tiwari,N. Peptide selection in the MHC class I pathway. Diss. 2005.

72

D060 Bourouba,M. The importance of CD44v7 variant isoforms in chronic inflammatory colitis as a model for an autoimmune disease. Univ. Karlsruhe, Fak. für Chem. u. Biowiss. Diss. 2005.

D060 Fries,F. Studien zur Regulation des Metastasierung-assoziierten Oberflächenproteins C4.4A. Univ. Karlsruhe, Fak. für Chem.u.Biowiss. Diss. 2005.

D060 Ladwein,M. Direkte Assoziation zwischen dem Zell-Zelladhäsionsmolekül EpCAM und Claudin-7: Charakterisierung und funktionelle Konsequenzen. Univ. Karlsruhe, Fak. für Chem.u.Biowiss. Diss. 2005.

D060 Wahl,J. Molekulare und funktionelle Charakterisierung des Tetraspanins D6.1A. Univ. Heidelberg, Med. Fak. Diss. 2005.

D060 Würfel,J. Klonierung und Charakterisierung eines neuen Metastasierungs-assoziierten Antigens. Univ. Lübek, Med. Fak. Diss. 2005.

D070 Ehlken,H. Humorale Immunantwort gegen Tumorantigene des Melanoms im Vergleich vor und nach einer Impftherapie mit Zytokin-Gen-modifizierten autologen Tumorzellen. Univ, Heidelberg, Fak. für Klin. Med. Mannheim. Diss. 2005.

D070 Jing,W. Identification of a new HLA-A*01 restricted T cell epitope from the melanoma differentiation antigen tyrosinase related protein 2. Univ. Heidelberg, Fak. für Klin. Med. Mannheim. Diss. 2005.

D070 Lee,M. Serologische Identifizierung von Tumorantigenen des kutanen T-Zell Lymphoms mit Fokus auf Plasmamembran-Proteine. Univ. Heidelberg, Nat.-Math. Fak. Diss. 2005.

D070 Reitz,A. Analyse der T-Zellstimulation durch RNA elektroporierte Dendritische Zellen. Univ. Heidelberg, Fak. für Biowiss. Diss. 2005.

D070 Song,M. Identification of HLA-DRB1*0301-restricted T cell epitopes derived from melanoma antigen Tyrosinase-related protein-2 and its bacterial vector Listeria monocytogenes. Univ. Heidelberg, Fak. für Klin. Med. Mannheim. Diss. 2005.

E010 Huebener,M. Einfluss von Relaxivität, Molarität und Dosis gadoliniumhaltiger Kontrastmittel auf die T2-gewichtete MR-Perfusionsmessung des Gehirns. Univ. Heidelberg, Med. Fak. Diss. 2005.

E020 Zimmermann,H. Hochfrequenzspulen und Meßtechniken zur Instrumentenlokalisation in der Interventionellen Magnetresonanzbildgebung. Univ. Heidelberg, Fak. für Phys. u. Astr. Diss. 2005.

E040 Dietrich,L. Berücksichtigung von inter- und intrafraktionellen Organbewegungen in der adaptiven Strahlentherapie. Univ. Heidelberg, Nat.-Math. Fak. Diss. 2005.

E040 Land,B. Socio-economic aspects of the introduction of a new form of radiation therapy. Univ. Mannheim, Fak. für BWL. Diss. 2005.

E040 Mafopa Njunda,B. Verification of the effect of a flat panel detector on the dosimetric properties of a treatment beam. Univ. Heidelberg, Fak. für Phys. u. Astr. Diss. 2005.

E040 Neff,T. Verbesserung der Zielvolumendefinition in der Strahlentherapieplanung durch den Einsatz der

73

biologischen Bildgebung. Univ. Mannheim, Fak. für Math. u. Inf. Diss. 2005.

E050 Funk,A. Univ. Heidelberg, Med. Fak. Diss. 2005.

E050 Poerschke,D. Univ. Heidelberg, Med. Fak. Diss. 2005.

E050 Wilzbach-Divkovic,G. Univ. Heidelberg, Nat.-Math. Fak. Diss. 2005.

E080 Gronewold,C. In vitro Untersuchungen zur Wirkung von Sacharidmimetika auf verschiedene Schritte der Metastasierung von malignen Melanomzellen. Univ. Heideleberg, Nat.-Math. Fak. Diss. 2005.

E080 Heuser,M. Reproduzierbare Quantifizierung der Zytostatikaempfindlichkeit menschlicher Tumorzelllinien durch Beseitigung photochemischer Artefakte. Univ. Heidelberg, Med. Fak. Diss. 2005.

E080 Mark,E. Synthese und Charakterisierung neuer bor- und siliziumreicher Strukturen für Anwendungen in der Elektronenmikroskopie und in der Bor-Neutroneneinfangtherapie. Univ. Heidelberg, Nat.-Math. Fak. Diss. 2005.

E090 Li,Y. Microarry Expression Analysis of Prostatic Intraepithelial Neoplasia. Diss. 2005.

E090 Li,Z. Tagging of apoptotic cells by the ß-chemokine CCL5/RANTES stimulates phagocytosis by macrophages. Diss. 2005.

E090 Licina,T. Monocyte/Macrophage function in mice with somatic inactivation of lipoprotein receptor related proteins. Diss. 2005.

E090 Schulze,M. Genexpressionsanalyse zur Rolle des angeborenen Immunsystems bei Hydronephrose. Diss. 2005.

E095 Okouoyo,S. Rescue of death receptor and mitochondrial apoptosis signaling in resistant human NSCLC in vivo. Univ. Ulm, Med.Fak. Diss. 2005.

E095 Wenger,T. Induction of apoptosis in tumors by recombinant lentiviruses. Univ. Frankfurt, Fak. für Biochem. Disss. 2005.

E095 Zhang,Z. Glucocorticoids but not non-steroidal antiemetic drugs mediate resistance toward cancer therapy in tumours. Univ. Hohenheim, Fak. für Biochem. u. Ernährungswiss. Diss. 2005.

E100 Conzelmann,M. Detektion abgeschilferter Tumorzellen kolorektaler Karzinome in Lymphknoten-, Leber- und Knochenmark-Proben: Evaluation und Vergleich der molekularen Marker K-ras, Cytokeratin 20 und Guanylylcyclase C. Univ. Heidelberg, Med. Fak. Diss. 2005.

E100 Rodenbach,M. Kombination von Alimta und Gemcitabin bei der Wachstumshemmung von CC531-lac-Z Kolonkarzinomzellen in-vitro sowie bei der Chemoembolisations - Therapie von CC531-lac-Z Lebermetastasen der Ratte. Univ. Heidelberg, Med. Fak. Diss. 2005.

E100 Voss,C. Identifizierung und Charakterisierung des antineoplastischen Wirkstoffs Riproximin, ein neues

74

Ribosomen-inaktivierendes Protein vom Typ 2 aus Ximenia americana. Univ. Heidelberg, Med. Fak. Diss. 2005.

E130 Böttger,T. Entwicklung und Anwendung von Segmentierungsverfahren zur Erstellung klinisch nutzbarer Bildverarbeitungsanwendung. Univ. Heidelberg, Med. Fak. Diss. 2005.

E130 Hastenteufel,M. Ultrasound-based navigation for minimally-invasive atria fibrillation treatment. Univ. Karlsruhe, Fak. f. Informatik. Diss. 2005.

E140 Kienel,J. Diss. 2005.

E170 Krenz,K. Induktion neuronaler Differenzierung in Neuroblastomzellen. Univ. Göttingen, Med. Fak. Diss. 2005.

E170 Moenkemeyer,S. Medikamentöse Therapie der ß-Thalassämie. Univ. Göttingen. Med. Fak. Diss. 2005.

E170 Roenndahl,G. Induktion von Tumorzelldifferenzierung durch Histondeacetylase-Inhibitoren. Univ. Göttingen, Med. Fak. Diss. 2005.

E180 Fuerst,D. Charakterisierung immortalisierter und weiter maligne transfizierter humaner Pankreasgangzellen. Diss. 2005.

E180 Nakchbandi,W. Der Effekt des niedrigdosierten Warfarins und regionaler Chemotherapie auf die Überlebenszeit bei Patienten mit Pankreaskarzinom. Diss. 2005.

E180 Pintoffl,J. ras und p53 Mutationen in Relation zu ‚Life-Style'-Faktoren bei chronischer Pankreatitis und Pankreaskarzinom im Pankreassaft. Diss. 2005.

F010 Abschuetz,A. Gen-immuntherapy im Gehirn: anti-Tumor-Aktivitäten von Mikroglia und Beeinflussung durch den Parvovirus MVM. Univ. Heidelberg, Nat.-Math.Fak. Diss. 2005.

F010 Enderlin,M. Evaluation of IP-10 and TNF-transducing parvoviral vectors as antitumoral agents in animal glioblastoma models. Univ. Heidelberg, Nat.-Math.Fak. Diss. 2005.

F010 Krueger,L. Charakterisierung eines parvoviralen Hybridvektors hinsichtlich der Transduktion und präferentiellen Expression in transformierten Zellen. Univ. Heidelberg, Nat.-Math. Fak. Diss. 2005.

F010 Nikolova,D. Characterization of anti-oncogenic effects of autonomous parvoviruses in permanent and tissue-preserving short time cultures of solid tumors. Univ. Heidelberg, Med. Fak. Diss. 2005.

F010 Peters,J. Phospholipase A2 in der Parvovirus MVMp induzierten Zelllyse. Univ. Heidelberg, Mad. Fak. Diss. 2005.

F010 Wenig,C. Untersuchungen zur klinischen Bedeutung der in-utero Infektion mit humanem Cytomegalievirus. Univ. Heidelberg, Med. Fak. Diss. 2005.

F010 Winkelhoefer; N. Autonome Parvoviren. Die zentrale Region des H-1 Genoms spielt eine kritische Rolle für eine produktive Infektion von A9-Mäusezellen. Univ. Hohenheim, Inst. für Gen. Diss. 2005.

75

F020 Bastone,P. Konstruktion und Charakterisierung replikationsdefizienter Gentherapievektoren basierend auf dem Felinen Foamyvirus. Univ. Kaiserslautern, FB Biologie. Diss. 2005.

F020 Pisch,T. Präklinische Evaluation einer Vakzinierungsstrategie gegen HIV-1 basierend auf konformationellen Epitopen des Env-Glykoproteins. Univ. Heidelberg, Fak. für Biowiss. Diss. 2005.

F020 Waterboer,T. Multiplex-Serologie - Simultane Analyse von Antikörper-Antworten gegen humane Papillomviren (HPV) mit Protein-Arrays. Univ. Heidelberg, Fak. für Biowiss. Diss. 2005.

F020 Wirtz,R. Pseudotypisierung des Felinen Foamy Virus. Univ. Heidelberg, Med.Fak. Diss. 2005.

F030 Karl,Th.E. Sulindac als anti-neoplastische Substanz zur Behandlung des humanen Zervixkarzinoms. HS Hannover, Fak. für Veterinärmed. Diss. 2005.

F030 Klehr,M. Biochemische Charakterisierung und physiologische Bedeutung eines neuen durch Typ I Interferon induzierten Gens. Univ. Heidelberg, Nat.-Math. Fak. Diss. 2005.

F030 van Riggelen,J. Analyse der c-fos Deregulation in HPV-positiven Zervixkarzinomzellen. Univ. Heidelberg, Nat.-Math. Fak. Diss. 2005.

F030 Ventz,R. Charakterisierung der Onkogen-Regulation durch Histondeacetylaseinhibitoren in HPV-positiven Zellen. Univ. Heidelberg, Med. Fak. Diss. 2005.

F035 Bolte,S. Erste Schritte zum Nachweis antigen-spezifischer zellulärer Immunantworten gegen das E7-Protein des bovinen Papillomvirus Typ 1 beim Pferd. Diss. 2005.